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Abstract. A new category of health-promoting foods has emerged on food markets. This
study examines the background of the development of the products that belong to this
category. It aims for a more holistic view to the subject area than what has been typical in
the previous studies. The key framework used in the study, the foodweb, is based on the
model of industrial networks. The model is adapted for the purposes of this study.
The study has an empirical basis. Product related cases are examined. These five Finnish
cases are: Benecol, Hyla, LGG, Xylitol, and Yosa. The study is mainly based on findings
made from these cases. Some aspects of the international markets are also brought up.
It was found that this new food product category has brought with it many new questions
that previously have not been of major significance in the food context. The basic char-
acteristics of foods and the relationships of health-promoting foods with other product
categories were examined under a new framework for foods: body-centred foods. It was
observed that foods are linked to different body linked purposes under which foods can
be functional. Health-functionality is one of the respective functionalities.
Empirical development processes described using the foodweb as conceptual framework
showed the interdependency of the development process from many activities, actors,
and resources that usually cannot be captured if the development is viewed from a single
organisation point of view. It also seemed that development of these products is a multi-
layered process of many concurrent and sequential interactions.
There are many obstacles within food system that hinder the development processes of
these specific foods. There are many unresolved questions and questions that have not
yet explicitly been asked that have to be encountered before it is relevant to expect goal
oriented smooth development processes for health-functional foods.
Keywords: functional foods, new foods, food and health, food product development,
product cases, industrial networks, food economics, food markets, food marketing
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91. Introduction
1.1. Health-promoting foods – a new research approach is needed
A new category of health-promoting1 foods has emerged on food markets2. Even though
it can be said that all foods promote health, the market segment is characterised by a
more specific orientation to health subjects than has been typical in food context. It has
been cautiously3 estimated that the market value of this category would in Europe be
US$ 2.5-3.3 billion by the year 2003 (Hilliam 1998). When divided by the population of
the EU countries (~ 300 millions), it would mean that by that time every European con-
sumer would spend approximately 8-11 euros yearly on these specific foodstuffs. This
would still be a small share of the total per capita expenditure on foods.
What characterises these new products?  They could be considered as high-technology
products because often there are links to new technologies. However, technology, even in
its broadest sense, would probably give a wrong image of the product group as a whole.
It is not the technology but the effect of foods on bodily health that matters.  If a simple
label would be needed as a sign of the modernity of these foods, it could be something
like high-health foods.
What is the research base of the new growing market segment? Most of the scientific re-
search concerning these foods has taken place within the natural and technological sci-
ences. In Finland alone scientific research in this area is being done in several institutions
and a considerable amount of resources are being allocated to the research. Much less
resources are being used to study the new market segment within the sciences of applied
economics and management.
There is an economics and management based study field that has a specific focus on
foods. It consists of subjects such as food economics, food business, food (industry or
service) management, and food marketing. Even within this area of research there are not
many studies concerning the new market segment. There are a few studies where pro-
duction point of view has been chosen (e.g. Göransson and Kuiper 1997). In most studies
concerning the phenomenon a consumer point of view is the dominant one (e.g. Poulsen
1999, Morten and Beckman 1998). A more holistic view to the subject area is missing.
Another gap in the current research is evident as an attempt is made to position the
health-promoting foodstuffs within foods in general. It concerns the essence of foodstuffs
themselves. There are studies that describe the emergence of traditional foods from a
historical point of view (see e.g. Mennell 1986) or foods from a nutrition policy point of
view (e.g. Mennell et all 1992). There is however no such a framework that would make
it possible to position the new health-promoting foodstuffs within the context of modern
foods. Food-as-a-commodity approach or from-medicines-to-foods -dimension are not
very helpful in this respect.
Besides foodstuffs themselves, another question concerns the context of these new foods.
How should they be described and conceptualised? This is an important subject because
it is difficult to understand these new products if they are isolated from their context.
                                                
1
 Health-promotion means here a specific positive effect of  a foodstuff on health of a human body
2
 Food markets refer to the price-valued exchanges of foodstuffs in general.
3
 Harkki & Miller (1997) estimated US$ 3-10 billion by the year 2001.
10
Given the background of the study, it would appear natural to assume that foodstuffs are
considered as products on markets. This was an approach used in the beginning of the
introduction as estimates were given concerning the expected price-values of products on
the markets in the near future.
However, there are reasons why a market approach may not be the best alternative. In the
following a very narrow and simplified picture of the relationship between a product and
a market is given. It is assumed that it corresponds sufficiently to a general idea of mar-
kets. The problem here is that although the same concept –market- is used, the content
given to them varies in different disciplines. Markets in economics4 has not necessary the
same content as markets, for example, in marketing science.
A common starting point for markets in economics is to assume that products already
exist. Values and respective volumes of products are emphasised. Given a certain price
an optimal product volume can be determined. The development of products is not an
issue compared to these. If exchange phenomena is at the forefront in marketing science,
the relationship aspects are emphasised (see e.g. Easton and Araujo 1994, Houston and
Gassenheimer 1987, Bagozzi 1975). This can be interpreted to mean that products are
simply caused by relationships. As soon as there are relationships there are also products.
Products do not have any independent role and the development of products is subordi-
nate to the development of relationships.
In case of health-promoting foodstuffs the situation is different. There are exchangeable
products not only on a limited scale but also on a limited scope. There are, however, ex-
pectations of utilities of future products. This means that product development aspects
are emphasised. Products are not hidden in general relationships but there are special re-
lationships based on these expectations. Both the above mentioned starting points do not
adequately take these aspects into consideration. They emphasise other aspects than those
that are important in development of health-promoting foods.
There is also a question of who are the relevant actors in markets. According to one
widely respected view market products are bundles of attributes (Lancaster 1966). Those
bundles are typically linked to two types of actors in the markets: firms and consumers.
The role of a firm has traditionally being emphasised. A firm is an interpreter of con-
sumer needs and actually a maker of a product. The development of a product in turn
takes place inside a firm before it is launched to markets.
A different approach is to consider products as services. In that case both a firm and a
customer concurrently develop and make the product (see e.g. Glynn and Lehtinen 1995,
Grönroos 1990). From the traditional exchange point of view it either means that there
are no market partners until an exchange takes place or that there are many exchanges
(and market partners) and a product emerges gradually. In the former case the develop-
ment of a product does not take place in markets. In the latter case the assumption of a
single product corresponding to a single exchange is not valid as a service product con-
sists of several marginal products.
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 ” A market is an arrangement by which buyers and sellers of a commodity interact to determine its price
and quantity.” (Samuelsson 1989,39)
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What is typical both in traditional and service market approaches is that the producer-
consumer axis is emphasised. In the case of health-promoting foodstuffs it is however not
necessary realistic to assume that this dyad can decide all the characteristics of a product.
If product development is for example based on many separate exchanges between a pro-
ducer and a customer it could also be thought that in-between these exchanges there are
exchanges with other actors that are of relevance from a development point of view.
There is also a question related to positions of actors in markets. In imperfect markets it
can be assumed that there is a market space where actors locate on vertical and horizontal
dimensions. Horizontal positions could be linked to product substitution and vertical po-
sitions to value differences in products. As the interest is especially in the development of
a product, vertical dimension is of special interest. It can be assumed that there is a verti-
cal chain linked to a certain product in which different actors perform different tasks that
add to the market value of a product. This chain can be called a value chain of a product.
There is a special model, called the food chain, that has been used as a descriptive
framework in food systems (see e.g. Street 1990, Spedding 1989). The idea of a food
chain has close relationship with vertical market relationships. Vertical arrangements are
basically the business arrangements between buyers and sellers. These relationships are
often said to be between upstream parties, such as the original producers of goods, and
downstream parties, meaning final users or distributors (Azzam and Pagoulatos 1999).
The food chain can also be linked to the idea of a supply chain, which is a term used very
often in technological contexts (see e.g. King and Phumpiu 1996).
The basic simple food chain (Figure 1) can be considered to be a representation of a
product based view as a product has an important role in it even though it is not a part of
the explicit structure. To a large extent the product defines the links and relationships
between actors. It can be said that the food chain is a specific food product based govern-
ance form.
              
             Farmers       Food manufacturers    Wholesalers/Retailers                           Consumers
           Foodservices
Figure 1. The traditional basic food chain
What makes a food chain different from a value chain of a product is that a food chain is
based on technical changes taking place in a food product as all the actors in the food
chain are specialised to certain technologically differentiable operations. In the market
context it is the change in market value that is of importance. When it comes to the de-
velopment of health-promoting foods it is realistic to assume that both market value and
technological aspects direct product development. Simple market value can not capture
all the development aspects.
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The food chain model has weaknesses when it comes to the description of the develop-
ment of health-promotional foodstuffs. There are at least two issues. Firstly, to what ex-
tent it is valid to link the development of products to such a predetermined order of influ-
ence by certain actors as the food chain model describes? Are all these actors influential
only at one single phase as the products are being developed?  Secondly, for the health-
promoting foodstuffs it is also questionable whether the above mentioned actors are the
only important ones. It would seem more reasonable to assume that it is difficult to an-
ticipate who are the actors and in which order they contribute to the development of a
product. The more turbulent and changing is the food context the more there are uncer-
tainties. In such a situation it is not realistic to fix these variables in advance.
What has been typical in food context is that the depth of product development process
has not typically been very deep, if deepness is measured by the extent of how much
foods are altered in a material sense. In most cases product development has meant only
small incremental changes. Changes have commonly taken place within those character-
istics of a product that can be linked to the variability seeking behaviour of consumers
(see e.g. Kujala 1994). This tendency to incremental development is also evident as the
product development process in food context is described (see e.g. Graf and Saguy
1991). In general product development is described as taking place on a relatively short-
term basis in a context dominated by a single organisation (see e.g. Urban et.al. 1987).
This is typical even in those cases where the multifunctional approach is emphasised (see
e.g. Jones 1997). There are some studies where a more long-term perspective on product
development is prevalent (see e.g. Utterback and Abernathy 1975, Lindman 1997).
When product development is linked to more radical changes the situation is different.
There are reasons to expect that for health-promoting foods in many cases it is a matter
of more innovative products 5. In such cases it is not relevant to focus only on direct pro-
ducer-consumer relationships. There are probably also other parties involved. This is not
contrary to the view that it is ultimately consumers who decide whether a development
process is successful. It means that direct consumer influence does not extend over the
whole development process. It is also relevant to assume that the early stages in the de-
velopment of such a food product are important because they will to large extent estab-
lish the basis for a consumer product.
Especially in case of more radical changes the development process can be thought to
initially take place between few key actors. In this sense the situation is actually closer to
a situation where a small amount of independent partners interact together than to a
situation where there is a single organisation and a large number of individual consum-
ers. It is also probable that the former contains links that are typical for industrial and in-
ter-organisational relations.
An environment where the traditional firm-consumer based view is a too limited cluster
type of an approach has also been used. Clusters contain elements (e.g. non-profit organi-
sations, knowledge as resource) that have not traditionally been included in market types
of frameworks. Clusters have typically a strong national or geographical basis (see e.g.
Porter 1998). Usually they are used to describe very general potentialities. They have not
usually been applied to specific product contexts and their analytical structure is not usu-
ally very well suited to that.
                                                
5
 Something  that is innovative introduces changes and new ideas in the way things are done or made
(English Language Dictionary 1987)
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Based on the different aspects mentioned above it can be concluded that all the treated
frameworks seem to have deficiencies when used in description of development of
health-promotional foodstuffs. In search of a new framework a relatively new industrial
networks6 based approach was found. Use of network structure and processes as a con-
ceptual framework has became popular in studies of industrial markets (see e.g. Back-
haus and Büschken 1997, Möller and Wilson 1995, 605). The relationship between the
network approach and the traditional industrial market approach could be described as
complementary and not substitutive.
The network based approach is promising as different aspects of the context of health-
promotional foods are taken into consideration. Industrial networks are linked to the
market context but without the often very demanding assumptions of the more traditional
market approaches. It can be thought that in the network context also the development of
a product and not only the exchange of a product are of significance. Networks also use a
multi-actor perspective, which is not limited to chain-of-actors types of constellations.
The framework that is used to describe the food context could be called food networks.
However, in this study there is more emphasis on the context – specific food context - of
the network than on the network itself. It is thought that the use of a web as a central
concept would better reflect this aspect. For these reasons the framework which is used to
describe the context of health-promotional foodstuffs is generally called a foodweb.
1.2. Objectives and the scope of the research
It is assumed that health-promotional foods have brought with them problems and ques-
tions, concerning the development of food products, which go beyond those in traditional
food product development. This has implications in the determination of the objectives
and the scope of the research. There is a need to go deeper into problems than has been
typical in the food development context and also to explore the subject from a more ho-
listic perspective.
1.2.1. Research objectives
The objectives of the study are:
* to position health-promoting foods within foods in general
* to describe the empirical development process of health-promoting foods using the
    foodweb as a conceptual framework
* to increase understanding of the underlying problems in the development process,
  specifically of those which are new in the food development context.
* to explore the properties of the foodweb in the context of  health-promoting  foods.
                                                
6
 ”Networks” have meant exchange relations, in which a change in one relation affects other relations.
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These objectives lead to a set of questions that need to be answered:
1. How do health-promoting foods relate to other foods?
In this study health-promoting foods and the context from which they emerge are a key
starting point. There is a need for evaluation of foods to the extent that health-promoting
foodstuffs can conceptually be positioned in relation to other foods
2. What are the properties of a foodweb as a holistic development framework?
The foodweb as a framework is based on the model of industrial networks. It is adjusted
in order to make possible an analytical approach in which the emphasis is on develop-
ment of food products. Development is not restricted to the traditional prior to the market
phase but is assumed to continue as the products enter the markets. A foodweb is more
than just a metaphor but less than a parametric or ideal model. The empirical fit of the
framework is considered to be more important than the theoretical coherence within the
framework itself.
3. What kind of special problems are countered as development of health-promotional
foods takes place in empirical context? It is expected that the special nature of these
products cause problems that are new in the food development context.
4. What kind of initial generalisations concerning the respective foodweb can be made
based on empirical findings?  There are not many studies concerning the development
process of health-promoting foods. It is expected that empirical findings can lead to ini-
tial generalisations concerning the foodweb in general.
1.2.2. Scope of the study
Food phenomena are very complex and linked to different kinds of questions. This is
even more so when it comes to a new context integrated by health-promotional foods. In
this study a broad perspective is chosen when it comes to the background of foods. Ref-
erences are made to research done in many areas both in the social and natural sciences.
Industrial networks create a basis for the framework of foodwebs. Industrial networks
here refer more specifically to the so-called Uppsala school of networks (Tikkanen
1997,14). The perspective in network studies is broader than in many other traditional
subjects within the field of economics and management. This means that also the context
of foods will be seen from a broad perspective where different economics, marketing,
and management related subjects are being confronted.
The scope of the empirical study is limited to the Finnish context when it comes to the
selection of primary sources. The limited resources available restrict the scope and the
depth of the empirical study. The study is not part of any research programme; it repre-
sents a one-man-one-study approach.
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1.3. Methodological questions and structure of the study
1.3.1. Qualitative research as a starting point
Scientific research can be divided into two main categories: qualitative and quantitative
research. Qualitative research tradition originates from criticism raised by the social sci-
entist towards the basic assumptions of the positivistic sciences (Creswell 1994, 4). Cur-
rently qualitative research consists of a very heterogeneous research base. Denzin and
Lincoln (1994, 2) define qualitative research in the following way: “Qualitative research
is multimethod in focus, involving an interpretative, naturalistic approach to its subject
matter. This means that qualitative researchers study things in their natural settings, at-
tempting to make sense of, or interpret, phenomena in terms of the meanings people
bring to them.”
Creswell (1994,5) has collected different paradigmatic assumptions of qualitative and
quantitative research (Figure 2) which show the different basic natures of these research
types. There are differences at the ontological, epistemological, axiological, rhetorical
and methodological level.
                                        Question Quantitative          Qualitative
Ontological What is the nature of reality? Reality is objective and Reality is subjective
Assumption       singular, apart from multiple as seen by
      researcher participants in a study
Epistemological What is the relationship of the Researcher is independent Researcher interacts
Assumption researcher to that researched? from that being researched with that is being
  researched.
Axiolocical What is the role of the       Value-free and unbiased Value-laden and
Assumption values ? biased
Rhetorical What is the language of the      Formal Informal
Assumption research ?        Based on set definitions Evolving decisions
      Impersonal voice Personal voice
       Use of  accepted Accepted qualitative
quantitative words words
Methodological What is the process of the Deductive process Inductive process
Assumption research ?        Cause and effect Mutual simultaneous
shaping of factors
       Static design- categories Emerging design -
       isolated before study categories identified
            Context-free during research 
      Generalisations leading to process
      prediction, explanation, and Context bound
                    understanding Patterns, theories
     Accurate and reliable through developed for
      validity and reliability understanding
Accurate and reliable
through verification
Figure 2. Paradigmatic assumptions of qualitative and quantitative research
(Creswell 1994, 5)
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In this study the key phenomenon under study, development of health-promotional foods,
has an empirical background. The objective of the study is mainly to describe and to un-
derstand and not so much to explain and to predict. For these reasons it is quite natural
that a qualitative research approach is adopted. This is, however, not to say that the re-
search meets in all aspects and all levels the assumptions that are set for a qualitative ap-
proach.
The assumptions are very complicated in a deeper sense. It is very easy for example to
state simply that the reality where foodwebs exist is subjective and multiple. Does this
mean that there are no objectivity and singularity in that reality? A more realistic stance
is to assume that some parts of the reality can be considered as objective and others sub-
jective. An example of the former would be many events in the natural environment. In
the long run it is probable that many parts of the reality that are now considered as objec-
tive, will turn out to be more subjective and vice versa. In this study it is realistic to as-
sume that reality consist of both objective and subjective elements.
Theory has a different role in qualitative than in quantitative research.  In the former the-
ory is used to help understanding and not so much to explain or predict. In qualitative
research there are no similar procedures for testing theories as for example in the posi-
tivistic tradition (see e.g. Popper 1965, 241-242).  In qualitative research the relationship
between the research process and the following theory are close to each other (see spe-
cifically grounded theory: Glaser and Strauss 1967, Strauss and Corbin 1990) whereas in
quantitative research theory is typically a result of a study. The boundaries are, however,
not very distinct. For example it can be thought that even in the case of qualitative theo-
ries there are types of falsification procedures although in more discreet forms than in the
positivistic tradition. As this study is more of the qualitative type, this means that the
theories in the study are primarily used to help understanding the phenomenon under re-
search.
In qualitative research verification is a very important methodological procedure. Miles
and Huberman (1994, 11) describe the spectrum of verification: “Verification may be as
brief as a fleeting second thought crossing the analyst’s mind during writing, with a short
excursion back to the field notes, or it may be thorough and elaborate, with lengthy ar-
gumentation and review among colleagues to develop ”intersubjective consensus”, or
with extensive efforts to replicate a finding in another data set.”. As the assessment of the
research in concerned Creswell (1994, 158) recommends that also in qualitative studies
both validity and reliability considerations should be distinguished between. A specific
evaluation of these themes, concerning empirical research, will take place in section 4.4.
1.3.2. Strategic choices in the study
The qualitative research approach was chosen because it responds better with the objec-
tives of the study than a quantitative approach. Because of this many alternatives that are
of strategic nature are already fixed. However it can be thought that even within the
qualitative research type there are choices that are of a strategic nature.
In qualitative research it is not necessary to separate theoretical and empirical parts in a
study because the theoretical and empirical are interlinked (Creswell 1994).  However, in
this study such a division is made. Theoretical themes are being treated mainly at the be-
ginning of the study.  From that perspective the study is not quite in the mainstream
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under the qualitative approach. In principle this could be done in a reverse order. First
going into the empirical phenomena, then relating that to theoretical subjects. Specifi-
cally this could be justified, as the whole idea of specific health-promoting foods is not
very well established. There is considerable obscurity concerning the subject and there
are various views about it.
It is assumed that the prior knowledge that the researcher has of the subject area justifies
the chosen approach. Consequently more emphasis will be given to examining the devel-
opment of products. It is recognised that in the chosen procedure, there is a danger that if
those theory-based frameworks that are constructed are biased, the validity of the study
will suffer. An a priori conceptual framework can also lead to a situation where the un-
derstanding of the phenomena becomes subordinate to the testing of a framework.
The evolving decisions made in the study make it qualitative in nature. It is also assumed
that there are weaknesses in causal structures. A probable outcome is that there are inde-
pendent elements that can initially be linked together with the relationships between them
not being very clear. The subjective elements in the study mean that certain choices can
be made on an inductive basis without thorough explicit explanation because the choice
is so obvious from the perspective of the researcher. This of course brings with it the risk
that important decisions are made too intuitively without taking into consideration the
demands of the target group for the study. Specifically an area where the subjective ap-
proach is prevalent concerns the area of traditional food product development.  Refer-
ences to this area are very much based on the experiences of the researcher in the respec-
tive area and not so much on any theoretically based approach concerning food specific
development processes.
Within the qualitative approach there are many research traditions that use different kinds
of research methodologies (see e.g. Denzin and Lincoln 1994). A case study was consid-
ered to be a viable option. The choice of a case study is, however, not a methodological
choice. The case study approach can be used both in quantitative and qualitative studies
(see. e.g. Stake 1994, 236). What is typical for a case study is that it makes possible the
approach of the phenomena from different angles, use data from multiple sources and
study selected issues in detail and depth (Patton 1990). These features support the pur-
poses of this study. Therefore the case-study approach was chosen as the empirical phe-
nomenon was studied. It was also discovered that industrial network approach favours
qualitative methodologies and that case studies are commonly undertaken (Araujo and
Easton 1996).
When it comes to case studies there are several ways a case can be defined. In this study
a product-based approach is considered as the most suitable option. There are certain re-
quirements concerning these product cases. It is expected that products are commercially
successful and there is already some history behind the products. Then it will be possible
to approach the subjects more holistically and to examine the specific development proc-
esses and to identify respective foodwebs.
1.3.3. Structure of the study
Chapter one is an introduction to the study. In chapter two a short exploration is made of
the area of foods in order to position health-promotional foods within the domain of
foods. The basic characteristics of foodwebs are introduced in chapter three. The
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construction is based on the model of industrial networks, which is adjusted in order to
make it more responsive to the phenomenon under study. In chapter four the questions
relevant to a case study are considered. The choice of the cases is justified and factors
concerned with the validity and reliability are discussed.
In chapter five the individual cases are described applying the frameworks developed in
chapters two and three to guide the analysis. In chapter six a more general perspective on
the phenomenon under study is taken and some initial generalisations concerning the
foodweb and the development of the respective products are made. In the concluding
chapter general conclusions are made, practical implications are presented, possibilities
for the generalisations of the foodweb framework to other contexts are discussed, and
some suggestions for further research are examined.
The structure of the study could also be divided into three parts based on the object of
interest (Figure 3). First, there is the level of products that is specially centred around
health-promotional foods. Secondly, there is the environment of these products. Thirdly,
there is the relationship between the products and their environment that is of special sig-
nificance to the development of the products.
Environment of health-promotional foodstuffs
           Health-
   promoting
    foodstuffs
Figure 3. Objects of interest in the study
1.4. Central concepts in the study
The central concepts in the study are foodstuff, health-promoting foodstuffs, a foodweb,
and the development of a product.  The starting point of the study directs the contents
given to the concepts. It is assumed that the concepts are linked to each other so that they
together cover the phenomena under study. Concepts are more related to the phenomena
under study than to how other researchers have possibly defined them. The numbers in
parenthesis in headings indicate the chapter or section in which the concepts or related
subjects are further examined.
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Foodstuff (or a food product, foods)
A foodstuff is a product that is given a foodstuff status in a social context. It is not ex-
pected that a foodstuff can be defined based only on its material properties (e.g. nutritive
value), but the status of a foodstuff is influenced by many social and individual factors. It
is assumed that foodstuffs are produced industrially and they are commercially available.
Health-promoting foodstuffs (2.2.1, 2.2.2)
Health is limited mainly to bodily health and it can be characterised as the balanced state
of the body. Health-promoting foodstuffs contain positive health relevant factors that are
of a major significance for the identity of these foodstuffs. It is expected that these fac-
tors have a scientifically validated basis.
A distinction is made between health promoting qualities and the safety of foodstuff.
Health-promotion relates to specific intended effects whereas safety concerns also its re-
alisation. For many reasons there is typically only a probability of reachieving the in-
tended effects.
Foodweb (3.2)
A foodweb can be defined as a network in which foodstuffs are being developed.
What is typical in a foodweb is that interaction in one part of a foodweb affects interac-
tion in other parts of the foodweb. A mutual interdependency prevails in a foodweb
Development of a product (3.2.2, 6.2.)
A product in this study is not only limited to concrete exchangeable objects that is typical
in the market context. A product exists already on an idea level and at the stages where
there are a lot of uncertainties concerning its possible market value. Development of a
product is a continuum and no final products are assumed.
Development is assumed to take place in a network type of a context where there are
several more or less independent actors and many other factors that affect the develop-
ment. It is assumed that the development of a product is partly based on purposeful ac-
tivities and partly based on emerging opportunities.
1.5.  Significance of the study and the audience
The main significance of the study is expected to be a new holistic view on the develop-
ment of health-promotional foods. The actual development process is not very well taken
into consideration in traditional market views. Typically products are seen either from a
macro level (national, international), in which case the actual development process is not
seen at all, or from a micro level (within organisation), in which case only part of the de-
velopment process is taken into consideration. Foodweb can flexibly cover parts of both
the traditional microenvironment and macroenvironment. A food chain approach has in
principle a similar type of broad coverage. However, it very much emphasises the distri-
bution related matters of physical products. It is therefore a more partial view on the de-
velopment process than that based on a foodweb.
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The study also contributes to food studies in general by constructing a new reference
point for foods. An attempt is made to define dimensions and boundaries that are specifi-
cally relevant to health-promoting foods. It is also evident that the development point of
view is broader than that used in a traditional in product development context. This is
thought to bring new insights to the development of new food products.
The study also makes a contribution to network studies, specifically to industrial network
studies. Even though the subject under study is industrial, the perspective of the study
differs from previous network studies. The concept of an industrial network is typically
the same as the concept of a network of industrial organisations, whereas in this study the
starting point is different. The role of a product has more significance. This means that
both the structure and the processes of a network will be seen from a different point of
view. This can be expected to bring new insights concerning industrial networks.
The main audience of the study consists of researchers interested in the area traditionally
treated under the theme of markets of health-promoting foodstuffs. It is also probable that
there are elements in the study that will be of interest to researchers of new foods in gen-
eral. Due to the specific point of view to industrial networks it can be assumed that the
study also brings up factors that are of interest to those doing research in industrial net-
works applied to certain specific context.
2. Understanding health-promoting foods
2.1. Background of health-promoting foods
In the following the background of health-promoting foods will be examined. It needs to
be pointed out that the starting point in this study is not health and health promotion but
foods. On the other hand it can be anticipated that health-promoting foods have charac-
teristics which make them different from traditional foods. To bring out the problematic
related to health-promoting foods, a more broad approach than that typically used in a
food context is needed. A new category of foods, called body-centred foods, is intro-
duced and some key questions linked to them are described. The category is then exam-
ined based on the idea of functionality of foods. According to this foods are not an end
product themselves but they contribute to certain bodily objectives. In this respect body-
centred foods can be considered to be functional.
2.1.1.  Body-centred foods
Body-centred foods consist of foods in which the material relation between the foods and
a human body is specially emphasised. The focus on the body means that for example
foods whose use is based mainly on such social aspects like rituals are excluded. Body-
centred foods are examined from three points of view: natural, social and individual
(Figure 4). It is assumed that thereby different characteristics of body-centred foods can
be revealed.
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                                 Natural                                                 Social
Body-centred
 foods
   Individual
Figure 4. Body-centred foods seen from three points of view
Natural point of view
The natural point of view is linked to the biologic-physiological environment. Foods
carry materials and sources of energy from the environment to a human body. Usually
foods are taken orally. There is a continuous dependency on the environment because the
ability of the body to store materials and energy is limited. To emphasise the many as-
pects of this dependency, foods that are ingested can be considered to make up a flow of
foods. This covers different aspects than, for example, what is included to the concept of
a diet, which usually refers to the real or targeted selection of specific foods ingested in a
certain period of time.
A physical food flow can be divided into three phases in relation to the body (Figure 5).
A relationship between a food and the body is formed in a phase called the pre-oral
phase. In it foods and the body are not yet in direct physical contact. In the second phase,
called the oral phase, foods enter the body stimulating sense organs located in the mouth
and its proximity. The following phase, here called the post-oral phase, begins as foods
pass to metabolic processes through the gastric system. Typically the first two phases are
separated from the last one in a food context. In this study a more holistic view is chosen
and the post-oral phase is emphasised.
Food flow leads to body reactions (Figure 5). Every food causes some reactions in the
body. Here physically recognisable reactions are of main interest. Examples of such re-
actions are the process that takes place as foodstuff in an oral phase stimulate the recep-
tors of sense organs or the process by which a substance in foods contribute to a meta-
bolic process. Typically this takes place in reaction chains. For example, the above men-
tioned sense organs are linked via the nervous system to the human brains in which mes-
sages integrate in complicated neurophysiological processes (see e.g. Booth 1994,164-
172). The body reaction is then perceived at the cognitive level. Metabolic processes in
the body are all linked to different chains of reactions that lead for example to visible
movements of the body.
Body reactions can by nature be positive or negative. An example of a positive reaction
is a physiological change that enhances body health. An example of a negative reaction is
an allergic reaction by the body. There are many different mechanisms that link foods to
body reactions and reaction chains. Some body reactions are directly perceivable some
are perceived based on indirect information that is acquired for example by different
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measuring devices. In the case of body-centred foods body reactions are central when it
comes to assessing the value of foods.
  HUMAN BODY
               
FOOD FLOW             pre-oral   oral     post-oral               BODY
         phase      phase   phase    REACTIONS
Figure 5. Food flow and body reaction
Body-centred foods are not only based on bodily needs but they also depend on raw ma-
terials that are available and the technological possibilities to produce foods. There is al-
ways a dependency on nature as food products are concerned. In an underdeveloped food
system it is typical to rely on products that are spontaneously being produced by nature.
Foods are more or less given by nature because know-how is limited and the technologi-
cal possibilities to intervene in natural processes are restricted. In a developed food sys-
tem controlled intervention in natural processes at many levels is a typical feature which
gives more predictability to the system.
The social point of view
The body depends on its social environment. Changes in that environment have direct
consequences to bodily needs. An example of that are changes that take place at work.
For example it is well known that the need for energy content of foods has been continu-
ously decreasing, as physical strength at work has become less important. At the same
time the significance of mental performance is growing. There is a need to achieve a high
level of mental performance at work. For potential new foods this means that they are
expected to cause different body reactions than the old foods. Even energy is still needed
but with different emphasis. In old foods the focus was on energy for muscles whereas in
the new context it is more a matter of energy for the brains.
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In the social context the differences between social classes have always been of a con-
cern. According to Bourdieu (1984) traditional social classes exhibit differences in taste
which can be seen as different preferences for foods. However, it is argued that even
there are foods, which have a socially differentiating role, it is more probable that under-
neath the social classes lie many other factors. It is not very probable that, for example, in
the case of health-promoting foods social class would be found to be the most important
explanatory factor of the consumption. Such factors like nationality, age, sex, lifestyle,
and psychological factors are probably as valid bases as traditional social class. It seems
also that only seldom food related matters lead to convictions where foods strongly dif-
ferentiate social groups (an example of such an outcome is vegetarianism).
Taste can be examined also in a more limited sense in relation to the oral phase. Taste
consisting of such elements like flavour and texture of foodstuff. The taste of foods in the
oral phase has always been a major determinant of their value. But the post-oral influence
of foods is also important. It is very probable that for example the increasing preference
for less fat containing foods is to large extent based on the fear of negative health conse-
quences that excess intake of fat may have. This has happened even if the taste of new
low-fat products initially were not preferred.  Those products have then become preferred
products for the majority of consumers.  This means that there is link between the post-
oral qualities of foods and oral qualities.
An important basic determinant in a social context concerns the value given to the body.
It is from this value that also the value of foods derives. What makes the question diffi-
cult is that there is not any single body determinant. Even on a materialistic level the
value of the body is far more than for example the value of its physical parts. In a society
the value of the body can indirectly be assessed based for example on the amount of re-
sources that are allocated to sustain the health of bodies. Body value can also be assessed
from an instrumental point of view. The body can be used, for example, to give aesthetic
pleasure to its owner or to improve one’s performance in a task. It seems that taking into
consideration different aspects the overall value of the body is increasing in modern so-
cieties.
It could be thought that the increased value of the body means that automatically the
value of foods is also increasing as body and foods are so dependant on each other. How-
ever, this is not always the case. It is obvious that although in earlier societies most of the
materials ingested could be called foods in a modern western society a diversification has
taken place where foods form just one category of ingested products.
As an example of such a development we could think that there are consumers who are
worried about the optimal intake of vitamins. They know that the concentrations of vita-
mins vary in foods and therefore they may prefer to take vitamins supplements in order to
make sure they insert right amounts. If the intake of separate vitamins is the first priority
and foods come as second, the consequence of this is that actually a consumer should eat
foods containing no vitamins, to avoid obtaining an excess of vitamins. The more there
are similar developments, the more probably the value of foods will decrease, as part of
the previous value of foods is actually transferred to other products.
In a social context there is a question of responsibility. Who is responsible and to what
extent for an individual’s body. For example, is it an individual him/herself or society?
We could assume that there are two extreme alternatives. One is a case where society is
fully responsible of an individual’s body. It would resemble a situation where society
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actually owns the body and an individual has mainly a right to use his/her body. In order
to preserve the societal asset an individual would have to obey strict rules of behaviour
concerning his/her body. That could include only specific officially approved foods to be
eaten under controlled conditions.
In another alternative society is based on extreme individual decision making. An indi-
vidual is solely responsible for his/her own body. Whatever an individual desires con-
cerning his/her body is always supported by society. On a food level this would mean
extremely diversified foods. Foods could contain any ingredients at any levels. In reality
there are no such extremes but in societies the responsibilities are typically shared. Con-
sequently there is more or less freedom for different kinds of foods.
The individual point of view
First a division can be made between the human mind and body which together can be
considered to form an individual7. The relationship between them could be described as
that between a consumer and a customer. The mind is a customer who typically decides
what is available for consumption. The body then utilises foods in a very physical sense
(or rejects them if there is for example a severe negative body reaction). There is a mu-
tual interdependence between the mind and the body. The relation, however, is not al-
ways in balance and there can be a constant tension between them.
The power of the mind is revealed in the fact that despite the body expressing symptoms
of a need for food, a mind can decide that food will not be eaten. This can be taken to its
extremes for example in a hunger strike. After a certain period of time the feeling of hun-
ger disappears. If that state continues it leads to a situation where even if the mind would
prefer to eat, it is not any more possible because the body has taken the lead. This results
finally in the destruction of the body. Besides hunger strikes, which are conscious deci-
sion, there are at least partly unconscious psychological (and social) reasons that can lead
to similar types of situations (e.g. bulimia, anorexia). These examples show that there are
limits to conscious decision making and that there are unconscious reasons that direct the
intake of foods.
If an individual can even destroy his/her body by a conscious decision it is easy to under-
stand that decisions can be made where the health of the body is not the first priority.
Even in less dramatic conditions there can be a willingness to sacrifice the health of the
body. The reason can be for example that pleasure is valued over health or that there is a
serious attempt to perform in a task (e.g. within sport) even knowing that there is a risk to
body health. Foods are not necessarily an outside factor. They can be more or less im-
portant instruments in an attempt to attain certain goals. The more committed an individ-
ual is the more probable it is that all the factors, including foods, are taken into consid-
eration.
Even if the promoting of health is the dominating value for an individual it is not self-
evident how this goal can be achieved. What makes the situation difficult from an indi-
vidual point of view is that there are limitations in direct communication between the
mind and the body. Even if an individual prefers health-promoting foods, the information
system within the body has a very limited capability to provide this directly. Positive
                                                
7
 In a sociological context they are typically united (see e.g. Falk 1994)
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health active properties cannot usually be seen or tasted. Indirect information is therefore
needed.
Every individual can be considered unique when it comes to both body and mind. This
means that from an individual point of view the actual scope of products valid as food-
stuffs can be very limited. We could think of an individual who rejects most of the com-
mon foods. There can be negative factors emerging at any phase – pre-oral, oral or post-
oral -for a food flow, which alone or together make us reject foods. In the middle of an
apparent abundance such an individual confronts a scarcity of foods. The more all food
related needs are taken into consideration, the more probable is the situation that can be
expressed by modifying the Malthusian thought: the requirements for foods grow on a
geometric scale whereas the possibilities to meet them grow only on an arithmetic scale.
2.1.2. Functionality and body-centred foods
In the previous chapter the concept of body-centred foods was introduced. They were
defined as foods in which the relation to a human body was of special importance.  This
relation is broader than the traditional nutrition based relation. Body reaction was used to
describe the outcome of the influence of foods. It was also seen that the body is instru-
mental towards certain goals. When foodstuffs specifically support the attainment of
these goals they can be called functional foods.
The following categorisation of functional areas has been adapted from Winkler (1998,
186-191), who considered different kinds of foods (Disease-Specific Foods, Risk Group
Specific Foods, Foods to Reduce the Effects of Ageing, Performance Foods- Physical,
Performance Foods- Mental, Mood Foods) and not directly functional areas. In this sec-
tion it is not so much the foods itself than the various areas that are of interest. The fol-
lowing categories are examined: nutrition, health, performance, pleasure, and esthetic. It
is not argued that this is the most valid categorisation including all the areas and being
exclusive within categories. The subject is approached in a materialistic manner so that
the characteristics of the physical substances linked to the respective areas are empha-
sised.
Nutrition (nutrition functional)
Nutrition is of specific significance in a food context because usually health related sub-
jects of foods are treated within the domain of nutrition. Foods and nutrition have tradi-
tionally been closely linked to each other. This in turn means that questions concerning
foods are often of direct significance when it comes to nutrition. In the following some
basic questions are examined at a general level without trying to go deeper into nutrition
as a science or an actual field of inquiry.
A question can be asked what is the relationship between nutrients and foods? To what
extent are they separable and to what extent interdependent? If the former case is true,
foods are mainly carriers of nutrients. If there is interdependency, the question can be
asked to what extent a food context matters? Probably not all foods are similar. One
context is better than another context from a health point of view. In such cases nutrients
can not be viewed only as substances in the reduced (e.g. chemical) form. They should be
viewed as a combination of a specific substance in a certain context. In order to produce
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such a nutrient it means that something needs to be taken away from a specific food or
something has to be added to a certain reduced natural (or synthetic) substance. If this is
true, then it can be asked to what extent the current way in which nutrients are described
takes these factors into consideration. Should not for example a vitamin then be a combi-
nation of a chemical substance in a certain context?
Within nutrition a change has taken place from nutrient levels needed to prevent defi-
ciency diseases to levels needed to reduce the risk for chronic disease and achieve opti-
mal health and well being (Berner et all 1999, 91).  This usually refers to the develop-
ment within the traditional well-established nutrients. There are, however, many ques-
tions concerning new possible nutrients: What are the criteria for a nutrient? Is it more its
essentiality in specific bodily metabolism than its contribution to bodily health that mat-
ters? Do nutrients have to be exclusive in that no other substance can have similar ef-
fects? How will the status for a new nutrient be granted? Because of the high esteem of
nutrients in a health context it can be anticipated that the borderline between nutrients
and other substances that have a positive health-promoting effect, will attract more inter-
est in the future.
There is one important question when it comes to the relationship between foods and nu-
trients. Is it necessary that new nutrients can only be found in traditional foods? If total
scientific evidence shows that a substance of non-food origin has a nutrient like contri-
bution, would it be accepted as a nutrient? Can we assume that all the nutrient potential
substances are already in foods? It would seem rather unlikely considering the basis that
is behind the original selection of foods. The emergence of foods has traditionally been
influenced very much by supply related questions. Bodily needs are only one aspect that
is taken into consideration.
Health (health-functional)
Health and nutrition are not exclusive categories. The aim to improve the health of the
body is also the key aim in nutrition. Actually nutrition should be considered as part of
the health and nutrition functionality should be included in health-functionality. This
separate treatment is however justified because nutrition has such a strong a position in
the food context.
The typical difference between health and nutrition concepts is that nutrition refers
mainly to the objective biologic-physiological basis whereas health typically includes
also psychological elements and an individual basis for assessment of health status (see
e.g.  Blaxter 1990, 4-12, Erikssson 1976). Even within the more objective body sphere
the concept of health covers a broader field than the concept of nutrition. An individual’s
health is impacted by many diverse factor such as genetics, mental state, immune system,
activity levels, environment and diet (Berner et al. 1999, 93)
Following the same materialistic approach as in case of nutrition we could assume that
there is a special health product category in which the core of the products would consist
of healthients. Healthients would consist of all those material substances that have been
shown to have a positive effect on health. When scientific evidence is required the scien-
tific basis has not to be only natural sciences but also for example psychology because
health has a subjective element in it.
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The actual content of a foodstuff could be described as consisting of four different kinds
of factors (Figure 6). Factors having positive health effect are part of the above men-
tioned healthients. Foods typically have also factors that have a negative health effect.
Typically there is tendency to remove, eliminate or reduce the amount of those factors
(e.g. salt). There are also hundreds of factors (factors as substances) in foods, whose
physiological effects are not very well known (Tansey and Worsley 1995, 52).
*Factors having positive health effect
*Factors having negative health effect
*Factors, which are neutral to health
*Factors, whose health effect is not known
Figure 6. The content of a foodstuff in relation to health
Potentially it could be thought that if the factors and their contribution to health are
known, a health value of a foodstuff could be determined. A food flow within a certain
time period would consist of different kinds of foods and their related health factors. It
would be the aggregate of those factors that would be of significance. A health-balance
could indicate the total effect on health when the positive and negative factors were taken
into consideration. In practice there are many difficulties: all the factors are not known,
they are interrelated and both the food and the body contexts are also of significance.
There are other differences between nutrients and healthients. Nutrients are typically
elementary raw materials used for metabolic processes in the body. They support the
self-sufficiency of the body. Healthients can also be secondary products that are pro-
duced by the human body but not for example in optimal amounts from the health point
of view. Within healthients there is a specific category of products - medicines. They are
products that are justified based on their effect on bodily processes; their origin or natural
existence in the body is only of secondary concern.
It can be asked to what extent foods differ from medicines. Here the substance itself is
not a valid starting point. The difference can be assumed to originate from different
starting points when it comes to a bodily state. In the case of foods it is typical to assume
that the body exists in a self controlled state that is close to a balance (homeostasis). The
purpose of foods is to support this state by providing raw materials for continuously re-
petitive processes. In the case of medicines the starting point is usually a significant de-
viation from this balance. Typically the purpose is to restore the balance using more or
less strong outside controls.
This is a strongly simplified differentiation. There can hardly be an exact line between
these areas. However, it brings up some new questions.  Some negative factors in foods
can actually lead the body away from balance. In this sense foods can be considered even
as opposites to medicines. On the other hand there can be factors in foods that support the
recovery of this balance.  Or recovery can be linked to different combinations of foods
and medicines.
It can be assumed that there is a grey area where the body is not in full balance but not
significantly out of the balance. It can also be assumed that the scope of this grey area
increases the more we know about the body. Now it can be asked who takes control of
this grey area? What usually happens is that as soon as a specific bodily condition is
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given a status (e.g. a disease status) in the medical context, the role of medical system
increases and the role of traditional food system decreases. There are not usually ways
that food system could define its domain when it comes to these new health questions.
Actually the medical system is already dominating the food area, if nutrition is consid-
ered as just one area of medicine (see e.g. Rayner 1998, 175). Accordingly, nutrients
would then be a specific product category within medicine. This does not mean that
foods would be seen as being the same as medicines because within medicine there are
also other product categories than medicines. In many respects health-promoting foods
could then be comparable with vaccines based on their aims.  It seems evident that even
though foods have been separated from medicines on a product level there are still strong
uniting links.
In health products the characteristics of foods and medicines are typically mixed. As an
example we could think of a situation where there is a bodily unbalanced state that is
permanent (e.g. due to genetic reasons). As a result of this there are specific substances
that needs to be taken daily to support the overall balance of the body. This is a food type
of a property even though such products would typically not be included in foods. To
what extent foods can be extended to the area of medicines or medicines to the area of
foods is a question that has no simple answer and there are probably no definite bounda-
ries.  Despite this an attempt is made to characterise foods, health products and medicines
(see Figure 7).  In the figure some features that typically differentiate the product catego-
ries are presented.  It is however obvious is that there is a lot of overlapping between
these product areas.
Foods Health products         Medicines
(e.g. toothpaste)
Bodily
purpose             continuity prevention          restitution
Focus             unfocused                       generic focus       specific focus
Effect                 mild              moderate           strong
Value
assessment                 sensoric(hedonistic)         information based             advantages/disadvantages
Authorisation       average consumer        informed consumer           professional supervision
Product form             traditional               consumable          reduced
Figure 7.    Typical characteristics of foods, health products and medicines compared
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Performance (performance functional)
All foods have more or less strong effect on performance. If foods are being used to im-
prove either physiological or/and mental performance the setting is however different
from the ordinary food use. On a material level it typically means that there are specific
substances in foods which cause the performance improvement or/and that the food flow
is designed in order to improve performance. An example of the former is caffeine found
in coffee. Its stimulating effect can be considered as performance improving. An example
of the latter is the food flow of an athlete preparing for a competition. Even if the design
of a food flow takes place only within traditional nutrients and foods its effect can be
significant.
The context where performance improvement is taking place is of great significance. It is
a very different situation if the goal is to improve long term mental performance at work
than if the aim is to gain a momentary performance improvement at the highest level of
sports. Performance improvement can mean that a performer is ready to accept a con-
scious risk for body injury that is higher than in normal conditions. This could also mean
an increased willingness to take risks where foods are concerned if performance is
thereby expected to improve.
Pleasure (pleasure functional)
Pleasure can here be defined as a positive mental sensation. It is an important theme in
the food context. Pleasure based on the sensory characteristics and the subsequent he-
donistic values to a large extent determine the value of most traditional foods. The diffi-
culty here is that pleasure due to its individual nature is difficult to observe and validate.
Typically sources of pleasure are active in pre-oral and oral phases. When pleasure is
specially emphasised as a goal also the post-oral influence of foods becomes relevant.
Products that cause pleasure can generally be called pleasurables (see Falk 1990,36).
Pleasurables have links to foods. Spices are an example of products that are used mainly
in foods because of the body reaction they cause that ultimately leads to pleasure. There
are other pleasurables (e.g. alcohol) that are only loosely thought of as foods. In the case
of pleasurables we must make the same kind of considerations as we did for the relation-
ship between medicines and foods. There is a limit after which a product containing a
substance typical in pleasurable is no longer a food. Alcohol being a typical example of
such a relationship. Products with a very high alcohol content are not typically consid-
ered as foods. This is also the case with psychochemical substances in general. Typically
high concentrations of such substances are not tolerated in foods.
It is very probable that the role of the pleasure function is increasing. According to Falk
(1992, 36) in the modern period typical representations of the orality are the marginalisa-
tion of the common meal and appearance of different nonritual, individual meal habits
that typically aim for the sensation of pleasure by the use of oral stimulants. Also, in the
recent sociological literature it has been typical to link foods to the general phenomena of
consumption (e.g. Warde 1997). This indicates that in foods the necessity aspect, al-
though not disappearing, will be more and more hidden behind other aspects, such as
pleasure aspects.
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Esthetics (esthetics functional)
There is also an area where an increase of the esthetic value of the body is a goal. The
respective activity is here called body design. This does not refer to procedures, e.g.
weight reductions that are done for medical reasons. Body design refers to activities
where the esthetic values direct the changes made to the body.  As a consequence of this
foods may for example contain non-nutritive substances. They can be substances that
have no energy value from the point of view of the body.
An analogy could be taken from plastic surgery where certain materials that are not nor-
mally part of the body, are inserted into it to permanently increase a body’s esthetic
value. In the food context this would mean that substances not traditionally used in foods,
are repetitively taken into gastric system to attain certain body design purposes.  The un-
derlying strategy here is that in order to reach a certain goal changes are made to foods
and not so much to food habits.
Conclusion
The purpose of the treatment above was to describe the dimensions of functionality,
which are typical for body-centred foods. The health-functionality dimension that lies
behind the health-promoting foods is only one part of that. There are other areas in which
the same kinds of questions appear concerning the role and limits of foods. It should be
noticed that even health-promotion is not self-evident. Like in other functional areas its
goals can be can be set to different levels. If the purpose is to avoid a shortage of basic
nutrients in the short term, the respective foods are very different from those that are used
when the purpose is to meet long-term individual health-promoting needs.
Even though it is possible to assume that there could be a food consisting of a single
function, a more realistic stance is that foods are usually multifunctional. The dominance
of certain functions may however lead to a situation where a food is labelled by a single
function e.g. a health-functional food.
2.2. Health-functional foods in an empirical context
2.2.1. Emergence of the product category
In the previous chapter the properties of body centred foods were examined. Several ar-
eas of functionality were found. From now on the focus is on health-functional foods as
they have emerged as an empirical product category. For reasons of brevity in what fol-
lows the concept functional food is used almost as a synonym for the health-functional
foods unless otherwise specified.
Associating health and foods is not a new invention. A product category called health
foods has been known for a long time.  The difference between the modern functional
foods and the health foods approach is that there was not such a scientific basis for health
foods as there is now for functional foods (Labuza 1994, xii). The assumptions concern-
ing health-promoting effects of health foods were usually based on traditions and empiri-
cal knowledge. Health foods used to be a special segment and not in the mainstream of
industrial foods.
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However, it would be wrong to claim that other foods than health foods have been free
from beliefs concerning their effects on health. There are many common beliefs con-
cerning traditional foods that have not been validated by modern scientific methods.
There is also room for such beliefs. Even experts in the field (see e.g. Tansey and Wor-
sley 1995, 52) recognise that traditional foods still contain many unknown properties. As
long as this is the case there are at the same time both scientifically based knowledge and
traditional beliefs concerning foods.
What has also affected the emergence of health-functional foods is that borderline be-
tween medicine, biology and foods has become an area of major new interest. There are
many reasons behind this development (see e.g. Hasler 1996). The reasons that have been
mentioned are, for example, an increase of scientific knowledge concerning relationships
between foods and illnesses, a raised interest in preventive care due to the growth in
health care costs, consumers better awareness of the role of foods in health, and need of
industrial firms to find new profitable product areas.
2.2.2. Characteristics of health-functional foods
There are no official definitions of functional foods. Definitions that have been proposed
are based on the development that has taken place in the field and they differ to some
extent due to differences in backgrounds of the people who are making them. In the fol-
lowing some examples of these definitions are quoted:
“ a functional food can be defined as any food that has a positive impact on an individ-
ual’s health, physical performance or state of mind in addition to its nutritive value “
(Goldberg 1994,xvi; referring to J.Rabe)
“ A food can be regarded as ‘functional’ if it is satisfactorily demonstrated to affect bene-
ficially one or more target functions in the body, beyond adequate nutritional effects, in a
way that is relevant to either an improved state of health and well-being and/or reduction
of risk of disease. Functional foods must remain foods and they must demonstrate their
effect in amounts that can be normally consumed in the diet….” (working definition, Sci-
entific Concepts of Functional Foods in Europe, Consensus Document 1999,6)
“ a food category in which the products are either a) modified or b) fortified with sub-
stances that have a preventive or therapeutic effect beyond their original nutritional
value.” (Jonas and Beckmann 1998, 2)
What is common to all these definitions is that functional foods are considered as exten-
sions to traditional foods. Not only the positive nutrient content of foods is taken into
consideration, but that there are also other positive factors in foods. However, as it was
seen when the health-functionality was evaluated, traditional foods contain typically
positive and negative factors. Reference only to the positive factors gives an impression
that only new positive factors are added to a neutral basis, whereas in reality many posi-
tive characteristics are added in order to overcome the negative factors in current foods.
Japan is considered to be a pioneer when it comes to functional foods. Japanese foods are
seen to have three functions (Ichikawa 1994, 453). The primary function is the food’s
nutritive value. The secondary function is the food’s sensory appeal, or organoleptic
properties. The tertiary function refers to the food’s physiological aspects such as
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neutralising harmful substrates, regulation of body functions and physical conditions,
preventing diseases, and promoting recovery and general good health. It is this third
function that is considered to be typical for functional foods.
As this functionality of foods is compared to that used in this study, there is an obvious
difference in perspective. Whereas the above foods are taken as given and it is the con-
tent of the foods that is of interest, in this study foods are seen in a broader context. It is
assumed that there is a relationship between the body and certain goals. The body as such
is not a goal. For example, a body can be used to improve performance in a task, which
then sets specific demands for foods. In a similar fashion health is not a naturally occur-
ring condition that simply exists but there has to be an aim for health. Foods then become
functional from that point of view.
Functional foods are not the only concept that is being used in this context. There are also
other concepts that refer to the same product area, for example nutraceuticals, designer
foods, pharmafoods, medical foods. Nutraceuticals is a commonly used concept, espe-
cially in Northern America: “ Foods or bioactive ingredients in foods that protect or pro-
mote health whether they are delivered in raw agricultural commodities, processed foods,
dietary supplements, extracts, beverages, or other products” (Childs 1999,74).  It is evi-
dent that nutraceuticals is a broader category and not restricted only to foods in the tradi-
tional sense. Nutraceutical products can range from isolated nutrients, dietary supple-
ments and diets to genetically engineered designer foods, herbal products, and processed
foods (Murthy.1997, 76).
Functional foods or the above mentioned respective categories do not usually have spe-
cific legal status in food legislation. Medical foods are an exception. Medical foods are a
special category within US legislation: “A medical food is a food which is formulated to
be consumed or administered enterally under the supervision of a physician and which is
intended for the specific dietary management of a disease or condition for which distinc-
tive nutritional requirements, based on recognised scientific principles are established by
medical evaluation “ 8. In the US context the difference between the medical foods and
foods for special dietary use is that medical foods must meet all the nutritional require-
ments arising from a particular disease or a medical condition (Murthy 1997,87). Thus a
product formulated to meet only part of the specific demands in a medical condition
would be a food for a particular dietary use. Medical foods are actually close to being
called prescription foods.
The official categories into which functional foods fall often concern the needs of the
not-so-healthy individuals. In Finnish legislation there is, besides traditional foods, a
category of special dietary products (special foods) that consists of foods that either be-
cause of their composition or production method, differ significantly from ordinary
foods. These foods are aimed at individuals having metabolic or malabsorption disorders
or which due to their special physiological state benefit from a controlled intake of ingre-
dients that these specific food products contain 9
Within the legislation of European Union there are nine separate categories under Foods
for Particular Nutritional Uses 10 which though are not all actively used.  These product
                                                
8
 Section 5b of the Orphan Drug Act (21 U.S.C.360ee.
9
 Ministry of Trade and Industry decision on special foods 937/95
10
 89/398/EEC
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categories consist of different purposes for which foods are aimed and of the consumer
groups to whom these products are targeted. There are for example categories of baby
foods, sport nutrition and foods for diabetics. Basically this reflects the continuum that
exists behind the idea of functionality.  There are no ideal foods that would suit all but
there are special needs that are not only linked to a state of unhealthiness.  It is not very
common for example to classify a child unhealthy if he/she uses specially optimised baby
foods. In the USA a relevant category from the functional foods perspective besides
medical foods are dietary supplements. They include also those products that are not usu-
ally classified as nutrients (including phytochemicals, hormones).
When the empirical situation is compared with the categorisation in the previous section,
it seems that usually functional foods are considered within a broader area than simply
health-functional foods but usually not in such a broad area as that is a covered under in
functional area of this study. Typically, instead of a pleasure function a concept of mood
foods is used which seems to unite performance and pleasure aspects. The esthetics type
of function is not usually mentioned in the context of functional foods.
There is a question concerning limits to the health-functional foods. Do only the changes
that are being made to foodstuffs in order to promote health make them functional foods?
Implicitly it is usually thought that unless very obvious changes are made to a foodstuff
or something untraditional is being added, it is not a functional food. However, if the
above definitions are taken as a starting point it is not required that significant physical
changes are made to foods. Above all it is a matter of information concerning the health-
promoting effects they have. Based on scientific research a traditional food could also
become a health-functional food.
2.2.3. Validation of health-functional foods
Validation of functional foods consists of many phases and there are different parties that
are involved. In the following the subject is examined from four perspectives: research,
manufacturing, public regulation and consumption.
When it comes to validation of health effects the scientific research methods are consid-
ered of key importance. Sometimes there is an underlying tone that scientific validation
and clinical tests were previously unknown in the food context. This is, however, not
quite right. Nutrition and role of nutrients has always based on the use of scientific meth-
ods. What has especially changed is that this does not only concern traditional nutrients.
Earlier positive relationship between foods and health were to a large extent same as nu-
trient related considerations, now the perspective is broadening to cover other factors as
well.
If there is an immediate body reaction towards a specific goal (e.g. performance or pleas-
ure) the validation of foods is relatively straightforward. In the case of health-functional
foods, especially when it comes to the preventive properties of foods, the validation is
more complicated. Often it means that the goal is to prevent certain body reactions taking
place in the future (e.g. a body reaction in a form of an outbreak of a disease). In that
case specific markers (e.g. cholesterol and its level) are needed that can be used to antici-
pate future body responses. It is then the effect of foods to these markers that is of im-
portance when the products are being validated. A proposal has been made concerning
the scientific concepts behind functional foods in which also the theme of markers has
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been elaborated (Scientific concepts …1999). These markers are assumed to be of crucial
significance when the future development of functional foods is concerned.
From the manufacturers point of view it is the profitability of the product that validates it.
In that sense health-functional foods do not differ from other food products. What is now
different is that a manufacturer needs to consider questions that were previously mainly
the domain of the public sector. The old situation was that in most cases the results of
research concerning the relationship between foods and health were more or less given
from the point of view of a food manufacturer. Now it is necessary also for a manufac-
ture to decide how much to be involved in this area.  What used to be an area where only
certain minimum product requirements had to be fulfilled is becoming of strategic sig-
nificance for many food manufacturers.
From the public regulation perspective validation means that new health-functional foods
should improve public health. The minimum requirement is that the new products should
be tested in order to assure that they do not bring with them new negative health factors.
That is not a new requirement in the food context. There has been such demands even
before concerning new ingredients and major food modifications. What these new foods
may bring with them is increased demands concerning the health aspects. It could be
thought of as a separate question not concerning old foods. However, there is a link be-
tween old and new products. It is probable that the more that is demanded of new foods
the more negative characteristics will be found also in traditional foods. This in turn puts
more pressure to changes in old foods. In the long run it is not a very sustainable situa-
tion if there are different requirements concerning products in the same legal category.
The more there are special health optimised foods the more different will also be the ba-
sis that will affect public health. Market dependency will increase. The dependency from
market products then replaces the dependency from generic food products. Changes in
the market share of specific products or change in the content of a dominant product on
markets may have more significance from health point of view than changes in tradi-
tional food habits.
When it comes to functional foods there are specific questions linked to consumption.
Information that is based on sensoric characteristics was considered typical for traditional
foods. In the case of health-functional foods indirect information has probably a more
important role to play. Decisions are made on the cognitive level. This means that ques-
tions such as what is a consumer’s general attitude on information concerning foods will
become crucial. It can especially be asked what is the attitude of a consumer towards sci-
entific validation. If scientific information is not given specific value in general it is not
very probable that it would be of value in this context.
When an individual consumer validates products the subjective nature of health comes
into picture. A key question concerns the extent to which health properties are valued in
foods? As it was previously noticed an individual is normally very powerful when it
comes to food choices. If he/she can even decide not to eat at all, it is much easier not to
eat properly in a health supporting sense. The situation is more complicated as individu-
als are often not very aware what is the starting point: how healthy are the foods they
actually eating.
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What is important to remember is that an individual even if he is eating alone, is not do-
ing so when it comes to food choices. Social influence is important. What are the atti-
tudes of reference groups or other influential groups like health professionals toward
these new foods, is of major significance. In a social context also other questions arise.
For example to what extent should special foods for special needs be available in social
occasions?  And how do general attitudes develop? Will it be possible in the future that
dinner guests consider it quite normal that the healthiness of their dinner is based on
health-functional foods?
3. Foodwebs – a framework for studying the product develop-
    ment
In this part of the study there is first a brief introduction to the general background of in-
dustrial networks. After that the main structure and processes of the industrial networks,
or more specifically of the so-called Uppsala School of networks (Tikkanen 1997,14),
will be presented. In the second section the focus is on foodwebs. The modifications,
which must be made to meet the purpose of this study, are examined and the initial basic
assumptions concerning foodwebs are presented.
3.1. Industrial Networks
3.1.1. The background of the industrial networks
Network analysis has been a common approach in the social sciences. A network in a
social context is typically defined as a specific type of relation linking a defined set of
persons, objects or events (see Mitchell 1969). Different types of relations identify dif-
ferent networks. As the actor perspective is emphasised there are many kinds of social
relations between them. Knoke and Kuklinski (1991,177) list some examples of rela-
tions: transaction, communication, boundary penetration, instrumental, sentiment,
authority/power, kinship and descent relations.
Network analysis has gained popularity also in industry and business related studies
(some examples: interorganisational studies, see Oliver and Ebers 1998, Ebers 1997, Os-
born and Hagedoorn 1997, Araujo and Easton 1996; strategic networks, see Jarillo 1988;
marketing networks see Anchrol 1997; Möller and Wilson 1995; small business net-
works, see Johannisson and Mønsted 1998, and internationalisation, see Johanson and
Mattson 1988). The network approach in industry and business studies is primarily in-
stitutional even though there are also more formal approaches to the subject (e.g. Easton
et al. 1997, Jones et. all. 1997). The perspective is usually at the business strategy level
(see e.g. Håkansson and Snehota 1989). Relationships within networks are emphasised in
many approaches. The perspective on networks is however not only restricted to relation-
ships. According to Easton (1992, 8-27) networks can be studied based on relationships,
structures, positions and processes.
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The background of the industrial network approach, the Uppsala School of networks ap-
proach, can be linked to the studies during the 70s emphasising industrial marketing. The
Industrial Marketing and Purchasing Group (IMP) in which research centres in Sweden,
Great Britain, Germany and Italy co-operated, was organised out of these efforts. The
reason for the new approach was based on the finding that industrial marketing differed
significantly from the consumer marketing (Mattsson 1997, 451). Network research has
however a broader functional perspective and background than simply marketing. Re-
search is linked to macro-organisational studies, economic sociology, and theories of
technological change and economic history (ibid. 452).
According to Håkansson and Johanson (1992, 28) the main aim of the model of industrial
networks is to make possible an integrated analysis of stability and development in in-
dustry. A second aim of the model is to provide a basis for studies of the roles of actors
and sets of actors in industrial development processes. According to Möller and Wilson
(1995, 605) the intellectual aims of the networks approach are primarily descriptive. It
tries to understand systems of relationships from the positional- focal firm’s perspective,
and the network perspective angle.
It can be asked what differentiates industrial networks from social networks in general?
The difference between social and industrial networks according to Håkansson and Jo-
hanson (1993, 35) is that social networks are dominated by actors and their social ex-
change relations. In industrial networks activities and resources are of equal importance.
The difference is not necessary very dramatic. If the above definition of social networks
consisting of persons, objects and events are taken as starting points and adapted to an
organisation context, the difference is not in principle very significant.
If industrial networks are to be differentiated from social networks in general there has to
be other reasons. Is it industry? What then is industry? In the business-to-business con-
text industry has been defined based on the actor basis:  “ industry being an aggregated
system of participating organisations in a time-and space bound techno-social system”(
Möller and Wilson 1995, 588).  However, industrial networks based on organisations is
not the only alternative. Traditionally industry has been defined based on products 11. It
could also be the basis for networks. However, the industrial network has typically no
direct links to products.
Could industrial networks be separated from other social networks based on specific re-
lationships? Could exchange relationship form a proper basis? It is common to link the
industrial network basis to the Cook and Emerson (1978.725) definition of networks as
“sets of two or more connected exchange relations”. Theories of social exchange are
primarily interested in explaining the emergence of various forms of social structures,
including networks and corporate groups (Cook and Emerson 1984).  Cook and Emer-
son’s (1978, 725) definition points to social network on a general level and not specifi-
cally to that on an industrial level.
What would then differentiate industrial exchanges from any social exchanges or from
pure market (or economic) exchanges? The distinction between the context of industrial
network and economic context has received some attention (see e.g. Easton and Araujo
1992.). There have also been attempts to find common denominators on a relational
                                                
11
 Industry consisting of homogeneous products or products that are in close susbtitute positions (see e.g.
Tirole 1989,13 and Bain.1966,6.).
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basis. Olkkonen (1998) has developed a concept of relational exchange to emphasise the
long-term features of exchanges within networks.
It has also been suggested that networks could be considered as such a common govern-
ance structure in a similar way as the market and hierarchy forms have traditionally been
(see e.g. Håkansson and Johansson 1993; Powell 1990, Thorelli 1986, 37-51.). Axelsson
(1992, 237-251,) was critical in this respect when evaluating the basis of industrial net-
works. On the whole, there seems to be weaknesses in the theoretical basis of industrial
networks. However, these questions have not prevented the model of industrial networks
becoming widely used. Citation based analysis of the impact of IMP literature on schol-
arly research showed that particularly since 1994 the approach12 has been gaining wider
acceptance (Horan et. all. 1998).
3.1.2. Structure and processes of industrial networks
In the beginning of the 1980’s the IMP approach was still very much based on dyadic
relationships. The emphasis on analysis was on the interaction of firms that buy and sell
(Håkansson 1982,15).  The network model of the late 1980´s (Håkansson 1987, 17) al-
ready contained the elements that have since been attached to the industrial network
model (Figure 8). By that time the network model was specially linked to technological
development.
Actors control resources; Actors perform activities.
some alone and others jointly. Actors have certain knowledge
Actors have a certain knowledge of activities
of resources
  NETWORK
  Activities link resources
  to each other.
  Activities change or exchange
  resources through use of
  other resources
Figure 8.  Network Model (Håkansson 1987,17)
Actors can be individuals, a group of persons, and a part of a company or group of com-
panies. Each actor can be described in three dimensions: which activities the actor per-
forms or controls, which resources the actor controls, the knowledge the actor has about
activities, resources and other actors in the network The actors’ main aim is supposed to
                                                
12It has to be pointed out that IMP does not only consist of industrial network approach.
ACTORS
- at different levels
- from individuals to
   groups of companies
- aim to increase the
   control of the network
RESOURCES
- heterogenous
- human and physical
- dependant on each
  other
ACTIVITIES
- transformation act.
- transaction act.
- activity cycles
- transaction chains
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be to increase their control in the network using their experience and knowledge of the
network as well as their relationships with others (Håkansson 1987,14). Later on the
development of relationships and goal orientation (increase of control) was raised beside
the three main dimensions to characterise the actors (Håkansson and Johanson 1992, 28).
Activities are performed by the actors, which means that resources are combined, devel-
oped, exchanged or created by using other resources. There are two main categories of
transaction activities: transformation and transaction activities. Transformation activities
are always carried out within the control of one actor, and are characterised by one re-
source being improved by the use of other resources. Transaction activities link transfor-
mation activities, forming chains of activities, and creating relationships with other ac-
tors. Activities are linked to each other in various ways and they constitute parts of more
or less repetitive activity cycles, where a number of interdependent activities are re-
peated. (Håkansson 1987,14).
Resources consist of physical assets (machinery, material, etc.), financial assets, and hu-
man assets (labour, knowledge and relationships). Transformation and transaction re-
sources are mutually dependent. The use and the value of a specific transformation re-
source are always dependent on how it is combined with transaction resources and vice
versa. Knowledge and experience of resources are important. New insights in the han-
dling of resources can change or break old activity cycles and therefore contain the seeds
of development and change in the network. Resources can be characterised by the actors
controlling the resource, by the utilisation of the resources in activities and by the versa-
tility of the resources. (Håkansson and Johanson 1992, 33)
The elements within each of the three basic classes of variables form within them a net-
work structure. They are interwoven in a total network. There are specific forces that
bind the three networks together (Håkansson and Johanson 1992, 34):
1. Functional interdepence: actors, activities and resources together form a system
where heterogenous demands are satisfied with heterogeneous resources. They are
functionally related to each other.
2. Power structure: on the basis of control of activities and resources there are
important power relations between the actors. The performance of the activities is to
some extent organised on the basis of those power relations.
3. Knowledge structure: the design of the activities as well as the use of the resources
    are bound together by the knowledge of the previous and earlier actors. And the
    knowledge of those actors is related to one to another
4. Intertemporal dependence: the network is a product of its history in terms of all
    memories, investments in relationships, knowledge, routine, etc. . Changes of the
network must be accepted by at least large parts of it. Therefore all changes will be
marginal and closely related to the past.
The intertemporal dependence suggests that stability and development within the net-
work are closely related. Development in certain areas needs stability in others, and vice
versa. The actors can act and therefore the model is voluntaristic. The relations between
actors, activities, and resources though circumscribe the action possibilities. In brief
the network model suggests mechanisms whereby stability and change in industrial sys-
tems not only co-exist but also are actually dependent on each other. The change of the
network can also be considered as an evolutionary process Håkansson (1992, 129-143).
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What have also been emphasised are the relationships within three basic elements
(Håkansson and Snehota 1995). There are actor bonds, activity links and resource ties
that bind the elements together. This was extended to a view where it is actually a ques-
tion of a network on networks situations as the three elements are also considered as net-
works.  In respective sub-networks it was expected that activity patterns, webs of actors
and resource constellations could be identified that correspond to certain specific indus-
trial network.
 The industrial network paradigm has inspired a large number of studies in which the
above-described model has been in a more or less dominant position13. Whereas in the
beginning technological development and related subjects where emphasised, later on the
relationship theme in business relationships in general has become more dominant (see
Håkansson and Snehota 1995).
There have also been proposals to modify the basic network structure.  Johanson and
Mattson (1992, 206) suggested that the network governance and production should be
separated from each other.  This can be seen as an analogical development to that which
has taken place in the institutional economics where the paradigm of a firm as a produc-
tion unit has been replaced by the paradigm where the governance and production func-
tions are separated. If this is commonly accepted there will also probably be more of a
focus on network agreements.
3.2. From industrial networks to a foodweb
3.2.1. Change to food product perspective
It can be asked what is the role of the product in industrial networks. The origin of a net-
work is linked very much to the studies of technological development. Studies have also
been made concerning the development of products in industrial networks (Håkansson
1987, 84). In those studies development of a product has been a central goal that the net-
work is striving for. In general the role of products has however not been very signifi-
cant. This is demonstrated by the fact that products are not part of the explicit network
structure.
In the market context products are key intermediates between the actors in the markets
but in network context this is not the case. Market products are objects, which form the
basis of value formation. In the network context it can be thought that it is the relation-
ships itself, which are being valued and not the products that are results from these rela-
tionships. When food area is approached the lack of products in an explicit sense be-
comes a weakness. In industrial network analysis the starting point is usually certain spe-
cific actors, which form the network. The product area is of less central significance. In
case of foods the opposite is true. Product area (foods) is of primary significance and ac-
tors are dependent on this. This means that there is a need to shift the emphasis to stress
the role of a product because products are so important from the identity point of view of
foods.
                                                
13
 see e.g. IMP Annual Conference Proceedings 1999.
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Product emphasis can also be considered to bring more purpose to the existence of net-
works. It can be questioned whether networks would exist at all if they do not aim to cre-
ate products. A network without a purpose would be just any social network. Even the
forces that Håkansson and Johanson (1992, 34) mention are not related to any purpose.
This is not to say that networks always aim for specific products, which could be called
managed products. This is the perspective of traditional product development (typical in
marketing, see e.g. Urban et. al. 1987). The product-network relation is typically less
managed. Within networks opportunities emerge that can lead to different kinds of de-
velopments concerning products.
The product basis brings networks also closer to the traditional industrial approach where
products are the basis of differentiating industries. Within the industrial network ap-
proach this would mean a change of emphasis from governance on an actor basis to gov-
ernance on a product basis. In the case of industrial networks it would be the products
that differentiate networks. A different question is the actual actor-product relation. Net-
work products could be compared with other types of products (Figure 9). In the tradi-
tional approach the relationship between a firm and a customer is emphasised. The serv-
ice approach brought out the importance of interaction between a firm and a customer. In
the network approach the actor basis is especially broadened. Network products would
differ from others in that there are actually more than two actors that more or less simul-
taneously create a product (Figure 9c).
=   = product
        firm            customer
a) traditional markets          b) service markets             c) networks
Figure 9.  A product within different actor-product relationships
The food context could be described as an industrial context, especially if industry is de-
fined based on substitute products. It is, however, unclear what is the basis of substitut-
ability. In order to differentiate between market products and industrial products it would
be tempting to define industrial products as supplier products, if market products in turn
are producer-consumer or supplier-customer products.  It is though too simplistic because
consumers and customers also influence industrial products. In the industrial network
context the actor basis is even broader and the influence of different actors on products
can vary.
Industry has also another typical feature. Even though industry by above-mentioned defi-
nitions does not necessary have requirements for high product volumes it is common to
consider industries and massmarkets as a similar types of phenomena. However, in the-
ory it is also valid to consider industries that consist of a few product types with very low
product volumes. The use of the concept of an “industry” can be even misleading. For
example on a general level it is common to use the umbrella concept of the food industry
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even though there are many food products which are not truly substitutes in the real mar-
ket context.
That leads to the question of the difference between technological similarity and substi-
tutability. In the case of health-promoting foodstuffs the difference becomes evident. A
health-promoting yoghurt although in many respects similar to other yoghurts is not nec-
essarily a substitute for traditional yoghurt products.  It could be as well be part of a spe-
cific health industry than the dairy industry in which it is traditionally located.
3.2.2. Properties of a foodweb
Basic assumptions
Some basic assumptions are made concerning the behaviour of the actors in a foodweb.
They are thought to be rational actors. Rationality is however not given technological
boundaries (like limitations in brain capacity) but it is thought to be institutionally de-
pendent. It is assumed that actors in foodwebs are bounded by institutional14 rationality.
This means that their preferences and decisions are very much based on customs and
habits.
Interaction is thought to be a key elementary process within a foodweb. As it is assumed
that a foodweb is an open system, the interaction process also links a foodweb to its envi-
ronment. Interaction has a relation with exchange phenomena. An exchange is like a de-
rivative of an interaction process. Interaction therefore refers to the continuity of a proc-
ess whereas an exchange is more like a cross-section in time.  Even if it can be thought
that ideally all the interactions in a foodweb are known, a more realistic approach is, that
in any specific context only some of them are known. In order to emphasise this fact the
concept of revealed interactions is adopted. This refers to the fact that for an outsider or
even for an insider in a foodweb the entire interaction that takes place is not visible but
remains at least partly unknown.
Foodwebs can only in special conditions be considered as managed or controlled. At
certain phases or under certain conditions a single actor or small coalition can be so
dominant that they actually seem to control the foodweb. It is assumed that the open na-
ture of foodwebs usually makes this is a temporary situation.
Structure of a foodweb
The structure of the foodweb is based on the Nordic model of industrial networks (see
chapter 3.1.1). The model is specially modified to take into consideration product per-
spective. For that reason product development is given an explicit role in the structure of
the foodweb (Figure 10). Product development is not only considered as a single activity
in the web but as a key integrating mechanism.
                                                
14
 The content given to concept of institution is not uniform (see e.g. Mäki 1993, 13). ”Institution” usually
refers  to social rules and regularities that are based on common beliefs.
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Activities
                    Product Development
Actors                      Resources
Figure 10. The structure of a foodweb
Activities
Activities are those elementary operations of a foodweb that usually take place repeat-
edly and more or less regularly. They are relevance for the development of products in a
foodweb. In industrial networks transformation and transaction activities were considered
as actors performed the elementary activities which linked resources. Activities can form
different types of configurations. In foodwebs market like activities are the starting point
for describing the activities. It is assumed that in minimum case there are there are two
types of activities in a foodweb: production and consumption activities. Production refers
to industrial scale transformation activities that result in tangible and intangible products.
Consumption refers to the use of products that is ultimately dominated by the interests of
individuals.
Actors
Actors define the operative units that are of importance in a foodweb. Such actors are of
special influence when it comes to the development of products.  They are not necessary
the same as formal organisations because usually organisations contain many parts that
are not of direct significance for specific products. On the other hand within certain or-
ganisation different parts of the organisation can together form an actor that is of rele-
vance in the product development context. The separation of actors and activities is as-
sumed to take place in foodwebs. It is for example possible that within a single actor both
production and consumption type of activities take place. It is also possible that e.g. pro-
duction activity is divided between several actors. A one-activity-one- actor situation is
considered to be an exception.
Industrial networks were thought to consist mainly of industrial actors. Individuals can
also be actors but it is usually assumed that they act on behalf of industrial organisations.
If they were assumed to be motivated based on their own advantage, they would be act-
ing like consumers.  The starting point on foodwebs is that actors are united with product
related interests. Behind this product interest there can then be very different kinds of
motives.
It can also be argued that there are situations where the gap between actors on industrial
networks and foodwebs is not any more very clear. A global industry with tens of thou-
sands of customers with localised markets can not act at a similar personal relationship
level as a network where there are dozens of actors. It can also be claimed that today
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many consumers are in their attitudes very much like professional buyers as they make
food purchases, for example, for their families.
Resources
The third element that can be assumed to be necessary for product development is re-
sources. A foodweb without any links to resources would hardly be recognisable as a
foodweb. Resources on foodwebs are initially assumed to consist of two types of re-
sources: natural endowments and technology.  In industrial networks different types of
resources are assumed to exist, but here the starting point is simpler. It resembles that of
the market approach in which typically technology is considered a key resource factor.
From traditional food context stems from the assumption that natural endowments are of
significance as a resource base.
Development of products in a foodweb
Product development is here considered in a different sense than in network context in
general (see e.g. Håkansson1987, 84). It is a continuing process that is linked to the very
existence of networks. The creation of products is also different from product develop-
ment in a single organisation context. The actor, activity and resource basis contains
more possible development trajectories than are typical in single organisation context.
Generally, it can be assumed that there are many more uncertainties due to the uncon-
trolled nature of networks.
Development in single organisation context could easily be labelled a supply based de-
velopment. Even in supply based development demand is always present in some form.
A product could be assumed to consist minimally of supply and demand ideas. What is
typical in the supply approach is that the demand idea will get less attention than the sup-
ply side idea. Even though both sides start from an idea level most development efforts
are on the development of supply side concepts. In a foodweb context the situation is
more complex because there are usually several concepts that all direct the development
process to greater or lesser extent.
Product development can be considered as a tertiary level in foodwebs. Interaction being
the most elementary process. Actors, activities and resources combined with the interac-
tion between them form the secondary level (Figure 11).
            Product development
                Actors, Activities, Resources
                          Elementary interaction
Figure 11. Process levels in foodwebs
44
Change in foodwebs
In the Nordic industrial network an assumption is made that the networks are stable. No
such initial assumptions are made concerning foodwebs. A foodweb can be retained or
either a long or short period of time. What is here of importance is the role of a product.
To what extent it is dependent on a specific foodweb? It is very likely that there will be
changes in a foodweb as the development process continues.
If actor perspective is being emphasised it can be assumed that normally there are two
general dimensions in the changes in a foodweb. One of these is an expansion that means
that the number of actors that interact with the foodweb increases. This may mean only
quantitative changes in which case the new actors that join a foodweb are a relatively
homogenous group or it may mean also qualitative changes as the new actors differ from
each other. An opposite dimension to expansion is contraction that can also be of a quan-
titative or/and qualitative nature.
When besides actors also resources and activities are being considered the change of the
foodweb can have two dimensions. One is integration that means an increase in the integ-
rity of a foodweb. It can mean more personalised interaction, more activities that depend
on one another, and a resource basis that is less distinguishable. An opposite direction to
this would be dispersion of the foodweb.
The dynamics of change in a foodweb can be divided into two broad classes. There can
be incremental changes. This means that a change in any foodweb elements or its envi-
ronments causes changes that takes place gradually even if the final outcome is very dif-
ferent from that at the starting point. Another type of a change is radical change where a
foodweb alters remarkably in a short period of time.
Foodwebs can also be considered from the learning point of view. An actor point of view
is emphasised when the learning process of the foodwebs is examined. It can be assumed
that foodwebs are constantly learning and this will affect the ways it operates. A foodweb
can be called a learning foodweb, if significant changes take place in the ways it operates
based on experiences from the past.
4. Empirical part of the study
4.1. Case study method
According to Stake (1994, 237) case studies can be classified based on the purpose of the
research. There are three general types of cases: intrinsic case study, here a study is un-
dertaken because one wants a better understanding of the particular case; instrumental
case, a particular case is examined to provide insight into an issue or refinement of a the-
ory; collective case study, it is not a study of a collective but an instrumental study ex-
tended to several cases.
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Another approach is to classify case studies based on the number of cases in the study.
Yin (1989) differentiates between single and multiple case studies. If multiple cases are
being examined there are various possibilities. Yin (1989) differentiates between holistic
and embedded types of approaches when multiple case approach is chosen. In holistic
type one unit of analysis per case is chosen whereas an embedded type consists of several
units of analysis per case.
In this study the phenomenon under study was the development of health-functional
foods. It was therefore not a matter of development of any specific health-functional
foodstuff, which ruled out the intrinsic case study approach. Then there was the possibil-
ity to select a single case that would have been considered as an instrumental case to pr o-
vide insight into the development phenomena. What favoured the single case method was
the limited resources available. With limited resources a single case study would have
made it possible to go deeper into the details of that specific case. However, it could have
meant that certain important features of the phenomenon would have been by-passed if
they were not of significance in that special case. On the other hand with limited research
resources available in a multiple case approach there is always the risk that the cases will
be approached too superficially and the underlying phenomenon will not be understood.
In this study the collective case study approach was chosen. The phenomenon that was of
interest was the development of health-functional foods and the cases were examined in
order to provide insight into it. The choice was based on the fact that the phenomenon
had not previously been much studied.  It was thought that despite the risk that in multi-
ple cases it would not be possible to go deeper in details, it would give a more holistic
picture of the phenomenon.
In multiple case analysis it is also possible to make cross-case analysis in addition to the
basic within-case analysis. As the phenomenon under study was examined using qualita-
tive approach, it was not necessary in advance to decide to what extent there would be
cross-case evaluations, but such decisions would  evolve as the study was carried out.
Cross- case analysis was not an aim itself, but it was thought that it could give new in-
sights.
4.2. Selection of the cases and broadening the information basis
When selecting the cases it was hoped that they would reveal different aspects of the
phenomenon.  The universality of these aspects were of less interest. Certain selection
criteria were set. What united all the cases was that they all should involve health-
functional food products.  Other selection criteria were that they had to be commercially
successful and that they had to have already had some history behind them.
When we looked at the availability of such cases we found out that there were not very
many such products on Finnish markets in 1997. The uncertainty concerning the true ex-
tent of this product area made the choice of cases even more difficult.  There were opin-
ions according to which all foods are health-functional. There were also opinions ac-
cording to which only products with substantial modifications should be included to this
category. The examination concerning the background of this product group, which led
to some characterisations of health-functional foods, was of significant help at this stage.
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From the study point of the view it seemed that actually it would be advantageous if there
were some cases that lie on the borderline between being health-functional and non
health-functional. This would make it possible to examine the problem further and to
gain new insights in addition to those already gained. Based on the above considerations
the following product cases were initially chosen (identified by the respective trademark
if the products had them):
Benecol, was a recent product of the Raisio Group, which many experts in the field con-
sidered as the most typical example of the modern health-promotional foods when this
group of foods are evaluated on the food-medicine dimension.
Hyla, was a product of the Valio Group. There opinions were divided as to whether it
was really a health-functional product. The question of health-functionality would be an
issue. It was also interesting because it was an older generation product by the same
company as was producing LGG based Gefilus. It would mean that some aspects in-
volving differences in time could be dealt with.
LGG, produced also by Valio, was also considered as a typical example of what was
meant by a modern health-functional food. The Benecol and LGG cases seemed to create
a pair that had both common and differentiating elements and they would therefore be
especially interesting in-between-case analysis.
Xylitol (also a generic name of a substance), was a product by Cultor. Xylitol is often
considered in the Finnish context as the first health-promotional food already before this
category had been widely recognised. This case was expected to bring also some per-
spective to the development of foodwebs in general.
Yosa, was a product from Bioferme. Initially some experts raised concerns whether it was
a true health-functional food. It differed from the other products because it was a product
made by a small company. It was expected that the foodweb would therefore be different
from the others.
After the products were chosen, contacts were made to respective firms that produced
and owned the trademarks of the products in order to establish whether they were posi-
tive towards giving information for the purposes of this study. Their attitudes were posi-
tive in all case and the study process could continue as planned.
At this stage of the research there were already indications that some factors (e.g. the ac-
tor basis and differences in public regulation), even though they are of significance from
the development point of view, might not become a significant issue in the Finnish con-
text.  This meant that as a general hypothesis concerning the foodwebs was going to be
made, some important aspects would not be represented. Therefore it was decided that
after the case study in the Finnish context was undertaken, additional information con-
cerning development in the international context would be required.  This meant that the
study actually was going to be more comprehensive than the initially planned specific
product based case study.
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4.3. Data collection and analysis
Data collection
Data collection started with a preliminary familiarisation with the cases. Prior relation-
ships that the researcher had with professionals in the empirical field of study made it
possible to make inquiries and short interviews first on an informal basis. The idea of a
foodweb contains an assumption that there are usually different types of actors in a
foodweb, so it was necessary to incorporate different viewpoints in the study.
One difficulty concerned the fact that some cases had a history reaching back to the
1970´s. A typical situation was that in the respective organisations changes had taken
place and some of those persons involved in the development in the first place, could no
longer be reached for different reasons. It was also found out in the early stage that se-
lection of informants could not only be based on their position in the organisational hier-
archy.  It seemed that in the cases for example the role of the top management seemed to
differ. In some cases they were more involved than in others.
As far as the development process is concerned one problem is how far back should the
processes be traced. In practice it is possible to follow different development paths to dif-
ferent extents. In this study a key starting point was the time when the first idea for the
product was expressed.
A major problem concerning the data collection was that there were few sources in writ-
ten form other than product specifications or other technical data. There were even less
written data available concerning the development of the product. Given the resources it
would not have even been possible to go through all the internal memos of all the actors
involved even if they had been available. Therefore it was necessary to rely mainly on
information received from those people actually involved in the development processes.
In the first phase experts were interviewed who were not linked to any specific cases but
who were at least in principle part of all the food webs. One of the experts represented
major retail chain in Finland (Kesko Oy), two others were representatives of public
authorities (The Ministry of Trade and Industry and Finnish Food Authority) and one
represented consumers (The Finnish Consumer Association). In the second phase infor-
mants were chosen who had been closely involved in the product development process.
The following structure of informants/case was the result (more details concerning inter-
viewees are given in appendix 1):
Benecol: two interviews
LGG:    three interviews within a company
Hyla:     two interviews within company
Xylitol: three interviews
Yosa:     two interviews
Each interviewee were sent in advance a list of topics that were going to be discussed
(see also appendix  2). As the interviews were made, a foodweb based framework was
not presented to the interviewees and no references were made to the general
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functionality of foods. The interviewing took place using the traditional conceptualisa-
tions that the respondents were familiar with. Most of the interviews were carried out in
autumn 1997.
Interviews were not made in any specific order. The reason for this was that it was as-
sumed that because it was a matter of heterogeneous cases there was no special reason to
start from one specific case. It was assumed that a learning process would take place and
affect the following interviews whatever the order may have been. This would make the
approach in practice close to the replicative order (see e.g. Miles and Huberman 1994) in
which the understanding of previous cases is the basis for studying other cases.
All the interviews were recorded and notes were taken during the interviews in order to
help to organise the data. After the interviews transcriptions of the tapes were made. A
case narrative was written for each of the cases based on the material available.  The nar-
ratives were then sent to the interviewees who were asked to comment on possible incor-
rectness and misunderstandings.  Changes were made based on these comments.
After the Finnish cases have been analysed another gathering of information took place.
It was not any more restricted to information concerning the case products. The aim was
to find out themes and problem areas that did not come up at all in cases or which were
not of significance in a Finnish context. Some experts in the field were contacted con-
cerning possible information sources. Such sources consisted of secondary sources such
as books, journal articles, market reports, and information published on the Internet.
Time horizon in the cases was from the beginning of the development to the end of year
1997, the time period for data gathered for the purpose of considering health-promotional
foods on a more general level extended to the end of 1999.
Data analysis
The case narratives formed the basis for further analysis of cases. The case narratives
could be characterised as stories of the product development based on consensus among
respondents. The role of the researcher for this part of the research was as much as possi-
ble that of an information collector and editor.
According to Miles and Huberman (1994) data analysis consists of the following phases:
1) intertwining of data collection and analysis 2) formulating of classes of phenomena 3)
identifying of themes, and 4) provisional testing of hypothesis.  Intertwining of data col-
lection means that data collection is not separate from analysis. This meant that data that
was obtained from cases could not be treated as pure objective data, which would then
later on be simply analysed.
As data was collected, analysis took place that increased knowledge concerning the phe-
nomenon , which in turn affected further data collection. When it comes to formulating
classes of phenomena and identifying themes, in this study the starting point was not
typical for a qualitative study, because based on the previous framework constructing
done at the beginning of the study, there were already some initial classifications made.
The purpose was, however, not to test these frameworks, but they were expected to guide
the analysis and improve the identification of the development relevant themes. In the
study the aim was to produce initial generalisations and not clear-cut hypothesis.
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When it comes to analysis phase no formal codification procedures were followed and no
computerised data analysis methods were used. Taking into consideration the purpose of
this study such procedures were not considered critical. Especially if the emphasis in the
study had been more in the cross-case comparisons, the situation would have been differ-
ent and probably the analysis would have benefited from the use of such analytical tools.
The analysis procedure could be called “process thinking” as for example the narratives
and the initial framework were repeatedly gone through on a mental level in order to gain
insights concerning the relationships. This meant a strong reliance on an inductive proc-
ess.
4.4. Questions of validity and reliability
Qualitative researchers have no consensus on addressing such traditional topics as valid-
ity and reliability. Although researchers felt first compelled to relate to traditional notions
of validity and reliability, later they developed their own language to distance themselves
from the positivist paradigms (Creswell 1994, 157). Despite this development the issues
of validity and reliability are still of key concern also in qualitative research.
Validity
Creswell (1994,158) brings out two themes concerning validity: 1) Describe how the
study will address the issue of internal validity, the accuracy of information and whether
it matches reality. 2) Discuss the limited generalisability of findings from the study – the
external validity. There are also other ways classifying validity. Yin (1989) divides va-
lidity into three categories: construct validity, internal validity and external validity (see
Yin 1989). Construct validity refers to the operationalisations of the concepts being
studied whereas internal validity then relates more to the internal causal relationships
within the case. Especially the internal validity in the latter approach reflects the influ-
ence of the positivist and quantitative traditions.
It can be asked about the validity of the empirical study. What was the significance of the
case selection?  It is obvious that selection of cases will affect validity. In this study it
was considered that there were not very many alternatives when it comes to the selection
of cases. If there would have been more cases available probably it would have been pos-
sible to use different criteria in case selection, thus matching the study better with the
overall phenomenon. However, it is probable that the cases represented quite well the
phenomenon in a Finnish context at a certain period.
When it comes to within case research processes, the main procedures to improve inter-
nal validity was careful selection of the interviewees, the choice of more than one infor-
mant per case and compilation of case narratives, which the interviewees then reviewed.
As it is a matter of a qualitative research the personal role and behaviour of a researcher
is also important.  What probably helped in the orientation was the background that the
researcher has in the field. There were also no value conflicts because the researcher has
a general positive attitude towards the phenomenon under study.  To lower the barrier
between the researcher and interviewees the atmosphere during the interviews was kept
as informal as possible and in the language that was used theoretical concepts not well
known were avoided.
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In the study the external validity was specially emphasised as the generalisability of
findings is often considered to be the main weaknesses of case studies. Generalisation
then usually refers to the statistical generalisation. In case studies generalisation more
often refers to the analytical generalisation (Yin 1989).  In an attempt to improve the ex-
ternal validity of the empirical part of the study, the decision to expand the information
basis beyond the specific cases has to be mentioned.
Reliability
Reliability is linked to the replicativeness of a study (Creswell 1994, 159). Sometimes it
is said that good reliability means that other researchers following exactly the same pro-
cedures as the one who has undertaken the study will arrive at the same findings and
conclusions. In qualitative study such a demand causes problems. The question of the
difference between the transparency and replicability of a study becomes of importance.
It is one question whether a research is so well documented that an outsider can follow
the process of a research and the decisions that are made in it and another question to
what extent a study is truly replicable.  The more the inductive process, evolving deci-
sions and the personal role of the researcher are emphasised, the more the replication
would actually require that the person reproducing the study would have to have same
mental set-up as the original researcher.
Yin (1989) suggested that a detailed protocol of data collection should be reported so that
the procedure of a qualitative case study might be replicated in another setting. In fact the
grounded theory of Straus and Gorbin(1990) relies very much on such specific proce-
dures to be taken. When the purpose of this research was taken into consideration it was,
however, decided that a detailed protocol of data collection that goes beyond the usual
notes like facts concerning interviews, was not of crucial significance.
In a study where data collection is based on interviews, there are special reliability con-
cerns. Interviewees are not impersonal sources of information.  There are differences in
how they remember and interpret occasions in the past. In case of special types of data,
like dates, there can be expected to be always problems of reliability. There are also other
concerns. Many factors are not under the control of a researcher or a researcher may not
even be aware of them, even though they can be crucial from the reliability point of view.
For example an interviewee may have an especially busy schedule on the day of the
interview and therefore can not concentrate on the interview. This may result in some
important topics not coming up during an interview. A similar interview at some other
time could give different results.
Triangulation means procedures that reduce the likelihood of misinterpretation (Stake
1994, 241). This is also of significance as far as reliability is concerned. The selection of
more than one interviewee per case can especially be thought to improve reliability. If the
views seemed to differ it was always possibly to clarify them.  Also the compilation of
the case narratives improved reliability. Once the development process was presented in
written form and examined by interviewees, the reliability of the study probably im-
proved.
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5. Health-functional foodstuffs – five cases
In this chapter the purpose is to describe the development process and respective food-
webs in order to increase understanding of the empirical problem and question that are
confronted as health-functional  foods are developed.  In order to obtain a more holistic
picture especially those aspects are emphasised that are special in every case.  Cases are
presented in the order in which products were launched to markets.
5.1. The case of Xylitol
5.1.1. Background of the health-functionality
As a chemical substance xylitol has been known for over a hundred years. The first ap-
plications in foods are from the 1950s. In the former Soviet Union and also in China it
has been used as a sweetener for diabetic patients. For medical purposes xylitol is used in
Japan and especially in West Germany, where it was given intravenously for patients
even before the dental applications in Finland began.
The high consumption of sugar (saccharose) was considered to be a major health problem
during the 1970s. Background of this was the well-known role of sugar as a promoter of
caries. In order to prevent caries it was recommended that the use of sugar should be
minimised. Consumption of sweets and chewing gums was considered especially harm-
ful. These developments gave opportunities for sweeteners that did not cause the same
kind of harmful health effects as saccharose. The health related background of the prod-
uct is therefore based on a search for means to prevent dental caries.
5.1.2. Periods in the development of the xylitol products
In this section product development and events that had a major impact on that are on a
forefront. Five different periods were recognised in the development of xylitol products.
They are: 1. Complementing triad 2. Push by experts 3. Loss of safety image 4. Con-
sumer commitment 5. Global orientation
5.1.2.1. Complementing triad
This was a period during which the initial foodweb emerged and a basis was laid for co n-
sumer products. The previous medical applications meant that toxicological studies had
already been made on 1950s. In 1963 xylitol was approved in the USA as a sweetener in
special diets. At that stage there were no large-scale commercial applications. The back-
ground of xylitol however made it possible not to start from the very beginning as it
would have been with a previously unknown substance.
Cultor Ltd (by that time Finnsugar Co) had developed technology that was suited for the
production of special sweeteners such as sorbitol and fructose, which were already estab-
lished products on markets. New products were also looked for that could be produced
using the same technology basis. This directed interest to xylitol. As production of xylitol
seemed possible a search was made to find possible applications for xylitol products. The
Institute of Dentistry at the University of Turku was contacted at the end of the 1960s.
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At the Institute of Dentistry there was already an interest in prevention of caries. Prelimi-
nary tests were then made. The initial good results gave Cultor an incentive to support a
two year long clinical research project, Turku Sugar studies, in which xylitol was com-
pared with saccharose in a normal diet. The results were even more positive than the re-
searchers had expected. Total substitution of saccharose was not needed to achieve the
positive effects and a remineralisation effect was noticed. What was now needed was a
producer of xylitol containing products to continue tests using consumer products.
The confectionery factory Leaf Hellas Co (by that time Hellas Oy) was at that time part
of the Huhtamäki concern also located in Turku. The health policy aimed to reduce the
consumption of sugar was intensified and culminated to a campaign against sugar in
1975-76. The sales of sugar containing chewing gums and sweets were declining. Prod-
ucts containing sorbitol had already entered Finnish markets and Hellas was lagging be-
hind in this development. It was actively looking for products where alternative sweeten-
ers to saccharose were used. The company had already examined the possibility to use
fluorine in sweets before xylitol appeared.
Lozenges and chewing gums were especially suitable products for xylitol products be-
cause in both cases there is a mouth-lag. That means that products are not swallowed
immediately, but they stay in mouth for a period of time. This was a necessity for xylitol
to be effective. No sacrifices were made in the organoleptical properties of products.
Some considered xylitol being organoleptically even better than saccharose because of its
cooling effect, when it dissolves in the mouth.
After the Turku sugar studies a short follow-up research was done using chewing gum as
a test product. That research gave similar results as the original study. The positive re-
sults meant that development could be continued on several fronts. At Hellas the devel-
opment of xylitol products was started by Mr Sakari Taskinen who was hired to become
product development manager and who then later on provided continuity to the develop-
ment of xylitol products. After several years of research Cultor patented the industrial
production method for xylitol in 1974. Hellas Leaf did not at that time consider it neces-
sary to patent its development achievements.
Cultor contacted public authorities in order to get permission for xylitol in foods. First,
the medical authorities and then the food authorities were contacted. Permission was
granted first for chewing gums, lozenges and later a special permission was obtained for
chocolate products.
5.1.2.2. Push by experts
Leaf Hellas launched Xylitol chewing gum –Xylitol Jenkki - both in Finland and in the
USA year 1975, after the results of the Turku Sugar studies were published. During the
first spring Leiras Oy15 distributed the products through pharmacies. Later on in the same
year Leaf Hellas entered the retail markets. In Finland the sales of xylitol products started
to increase slowly. In the USA the product was not commercially successful. The com-
pany had not the resources and willingness to invest in a large scale to support the mar-
keting of the product in the USA.
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 a pharmaceutical company part of the Huhtamäki concern
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Xylitol was more expensive than sugar. Accordingly xylitol based products were more
expensive than sugar based products. To compensate this difference in most products be-
sides xylitol other sweeteners such as maltitol and sorbitol were used. Consumers, how-
ever, accepted the higher price of xylitol products. In 1975 several new lozenge and
chocolate products were introduced. The chocolate products were made based on the
wishes received from the consumers and not so much on the wishes of the development
personnel within the company. The dental health advantages of xylitol in chocolate are
not as obvious as in other products. At the same time also other producers in Finland
started to launch products that were sweetened using xylitol.
Already at the beginning the informing of specialists of the research results was an im-
portant part of the development.  Specifically dentists and dental nurseries were informed
of the research results and of the significance of xylitol. It was noticed at the beginning
that in medicine other branches than dentistry understood the advantages provided by
xylitol more readily. In the dental profession the older generation of doctors had not
studied much chemistry, biochemistry and microbiology. This had an impact in the be-
ginning. In Finland there is, however, a good system of medical further education, which
spread the information of the advantages of xylitol to specialists.
Cultor was already in the early stages of development aiming for international markets as
a producer of xylitol. At the same time as Cultor had developed and patented the produc-
tion process for xylitol, the Swiss based company Roche Group (at that time Hoffman-la-
Roche Ltd.) was investigating xylitol processes in its laboratories. Because of the patent
protection gained by Cultor, they could not continue work to industrial scale. Therefore
they contacted Cultor which was then looking for a partner that would be experienced in
international marketing of such special products, and who could also manage the proce-
dures that were needed to get permission for food use in different countries.
In 1976 the companies founded a joint-venture company the stocks of which were owned
on a 50/50 basis. The mission of the company, called Xyrofin Ag, was to market interna-
tionally the special sweeteners produced by Cultor. Roche hired most of the sales and
marketing personnel whereas Cultor was responsible for product support and technology
development. The company was located in Zug, a small town in Switzerland. At the same
time also a big chewing gum producer in the USA – Wrigley Co - had become interested
in xylitol and as early as 1977 had bought considerable amounts of xylitol.
5.1.2.3. Loss of safety image
There was an intention to obtain a GRAS (Generally Recognised As Safe) status for
xylitol in the USA, because it would not have been possible to enter general food markets
in the USA without it. The permission obtained in 1963 for specific use was not suffi-
cient in this respect. On the request of the US authorities, Xyrofin had research done at
Huntingdon Laboratories in UK concerning the long-term toxicological effects of xylitol.
The aim of the tests was to confirm the safety of xylitol.  The test animals were rats, mice
and dogs. In the beginning the test results were as expected but at the end of the research
there were signs that xylitol causes cancer. These results were spread rapidly by the me-
dia.
Afterwards these tests have been very much criticised. The test animals were given ex-
tremely high amounts of sweeteners. The respective amounts would have meant that a
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person weighing 70 kg should eat 0.6-1.3 kg of sweeteners in a day. The high doses
meant that the normal metabolism of the animals changed. The high amount of saccha-
rose and sorbitol that were used in the tests caused similar cancer promoting effects.
Later on it has been observed that in corresponding tests also lactose has similar effects.
Of major importance are also the differences in metabolism that exist between humans
and that in the test used animals. The metabolism of rats, mice and dogs differ signifi-
cantly from that of humans and they cannot, for example, use carbohydrates in a similar
fashion as humans. A pig as a test animal would have been closest to a human physiol-
ogy in many respects.
The results caused the research project in the USA being stopped. Wrigley also withdrew
from the project. The results did not have major consequences in professional circles es-
pecially outside the USA and they did not cause changes to the official permissions al-
ready obtained. In year 1983, the joint committee of the WHO and the FAO (JECFA)
concluded that a reasonable use of xylitol does not cause any health problems for hu-
mans.  There is no ADI value (maximum Acceptable Daily Intake) for any sugar alcohol
including xylitol. Especially in the USA authorities were unwilling to confirm the safety
of xylitol.  Not until 1986 the US authorities gave xylitol a GRAS position (Generally
Recognised As Safe in food use).
The interest of Roche Group in xylitol was also diminishing. This in turn meant that the
operational preconditions for Xyrofin were weakening. This combined with difficulties in
the fructose markets resulted that Cultor raised its share of ownership in Xyrofin first to
70% and later on to 100% in order to get a better control of the business area. Key mar-
keting and service activities were relocated to Redhill in UK that became a centre for Xy-
rofin operations.
5.1.2.4.  Consumer commitment
In Finland the sales of xylitol sweets and chewing gums increased steadily even after the
results from the Huntingdon research had been publicised by the media.  A turning point
was reached after the so-called Ylivieska studies. There were two research periods in that
study. The first period was between 1982-85 and the second period between 1987-89.
When the first results of the Ylivieska studies became public sales of the xylitol products
started to increase significantly. The sales of xylitol products that Leaf Hellas was mar-
keting increased by 30% in each consecutive year. In 1989 a chewing gum brand Xylitol-
Jenkki was the most sold candy in Finland. At the end of the research period xylitol con-
taining products dominated especially the chewing gum markets in Finland (Figure 12)
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Figure 12. Market shares of xylitol chewing gums in Finland 1997
(Source: AC Nielsen Scantract; incl. grocery shops)
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Xylitol containing chewing gums became an important part of oral hygiene not only of
individuals. For example in many nursery schools, xylitol containing chewing gums were
replacing the traditional use of toothbrushes, because of the difficulty of controlling the
hygienic use of the latter. Xylitol was considered to be a convenient alternative.
Consumers have not been active only as buyers of the product. In Finland there was a
special tax on products high in sweeteners. A school class (the 4th class in a primary
school in Vatiala) made a proposal to exclude the xylitol containing products from this
taxation. In 1994 they were successful after a three year campaign. The tax was no more
levied on xylitol containing sweets.
5.1.2.5. Global orientation
Global orientation in the research started early on. During the 1970s xylitol was used in
cariological research in the former Soviet Union. The WHO also became interested in
xylitol research at an early stage and research was done in Thailand and Polynesia. At the
beginning of 1980s just before the Ylivieska studies there was research concerning xyli-
tol in Hungary and Canada. While the Ylivieska studies were under way, plans were
made concerning long term clinical studies in which saccharose, sorbitol and xylitol were
compared. This led to the Michigan program during 1988-95. Part of this was a major
research project that took place in Belize in Central-America. In Belize there were over
1000 children that took part in research where different sweeteners were compared. The
study concluded that xylitol is useful in programs aiming for the prevention of caries.
The budget of Belize project was over FIM 10 million. For Leaf Hellas, who was a major
supporter in that study, it was the biggest single investment in xylitol research. It was es-
timated that the clinical tests of xylitol have altogether cost tens of millions of marks.
There were also other reasons why the research was becoming international. The use of
xylitol in Finland had become so common that it was more and more difficult to find test
subjects who had not used xylitol. This made comparisons with other sweeteners diffi-
cult. Also the ethical rules concerning research were tightening. It was not permitted to
ask test subjects to use saccharose in comparative tests because saccharose was known to
have a caries promoting effect.
In Finland the growth in use of xylitol, especially in chewing gums, slowed down during
the 1990s because xylitol was already so extensively used. Therefore international mar-
kets became more and more important both for Leaf Hellas as well as for Cultor. Within
the Huhtamäki concern a major change took place when the confectionery business was
chosen to become one of the concern’s strategic business areas. Several confectionery
companies especially in the USA were bought and a new unit Leaf Group was estab-
lished in 1983. The former Hellas then became part of the new unit and was renamed
Leaf Hellas. Xylitol products did not have any specific role in these changes even though
it brought new opportunities for the products.
There were differences between European countries especially in consumption of xylitol
based chewing gums. In Sweden, Norway, Holland, Switzerland, and Italy more xylitol
based chewing gums were consumed whereas for example in the UK the overall per cap-
ita consumption of chewing gums was lower. The use of specialists in marketing of
xylitol products to increase the credibility of the products has been of crucial importance
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in all the countries.  There are official endorsements by dental associations besides Fin-
land also in Sweden, Norway, Iceland, Estonia, Belgium, Holland, Canada and Ireland.
For Cultor xylitol has been one of the most important products, the growth of which was
over 15% during many years in 90’s. The worldwide market share of Xyrofin was over
70%. The capacity for the production of xylitol was always slightly lower than the actual
demand even though Xyrofin has continuously increased the capacity. Cultor invested
over 500 million marks in xylitol between 1992-97. The return on the investment was
higher than in other investments within Cultor. In 1996-97 Xyrofin build a xylose factory
in connection with the viscose production of an Austrian wood processing company
Lenzing AG. Beech is almost as good a source of xylose as birch that had previously
been exclusively used. Crystalline xylose was still shipped to Kotka factory to be refined
into xylitol.
At the end of 1997 xylitol was approved for use in foods in over 40 countries. After Ja-
pan permitted xylitol in spring 1997 xylitol is being approved to differing extents on all
the major markets. Also US foods firms, including Wrigley, have taken xylitol-
containing products into their product assortment. Besides sweets and chewing gums
there are also other applications for xylitol in many other product groups like in oral hy-
gienic products and medicines.
When international markets are considered besides the basic approval of xylitol products
also other regulatory questions are important. Concerning the use of results of research in
marketing, the attitudes of the Finnish authorities has been very pragmatic. Health claims
in the food context were principally not allowed. However, the authorities did not inter-
vene until a later stage when there were claims made concerning other than the dental
health effects of xylitol. Internationally there were differences in that what kind of claims
could be used. For example in the USA there was a claim approved for all polyols: does
not promote tooth decay.
As Finland has entered the EU it is no longer possible to give xylitol containing products
a tax advantage over such products where other sweeteners are used. Behind this there is
the EU policy that aims at the enhancement of competition.  It was not denied that xylitol
had caries preventing effects. However, it was assessed that the advantage of xylitol was
not so much that it would justify a tax difference based on national health considerations.
5.1.3 Identification of the respective foodweb
In the following emphasis is on the identification of the structure and dynamism of the
foodweb that lies behind the product development process. This is expected to give more
background to the development process that was described above and that was seen more
from a product point of view.
5.1.3.1. Actors
In the following the main actors are briefly described. The basis here is the official type
or form of an actor. Parts of the organisations or individuals are being mentioned as ac-
tors to the extent that their roles came up as the cases were studied.
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Cultor Ltd (at the beginning of the period Finnish Sugar Co, annual sales in 1997 US$
1.8 billion) had been a dominant producer of sugar and sugar based raw materials on
Finnish markets. Especially under the leadership of general director Gustav Herzen it
had gradually diversified also to other business areas like feeds, biochemicals and food
ingredients. The former director of the research centre professor Melaja was in a key role
as technology was developed. Roche Group (at the beginning Hoffman-la-Roche Inc,
turnover 1997 US$ 11 billion) a Swiss based pharmaceutical and diagnostics company
was an actor especially in the beginning as it founded a joint venture company Xyrofin
Ltd with Cultor.
Leaf Group (at the beginning of the period Hellas Co, annual sales in 1997 US$ 400 mil-
lion) was formed in 1983 as the Huhtamäki concern acquired confectionery producers
mainly in the USA. Hellas was then merged into a new company and named Leaf Hellas
Co. Within Leaf Hellas research director Sakari Taskinen and marketing manager Erkki
Leskinen provided continuity in the development of xylitol products. Later on several
other chewing gum and confectionery producers have also had xylitol-containing prod-
ucts.
Turku University, Institute of Dentistry under the leadership of Professor Arje Scheinin
was an important partner especially in the beginning. Professor Kauko K. Mäkinen who
also worked at the same institute has been a leading figure in xylitol research since the
beginning of dental applications. Dental associations in different countries played also an
important role by giving official endorsements concerning the products. The WHO
(World Health Organisation; a UN organisation) was also interested in xylitol to prevent
caries and supported research linked to it. Dental caries is a problem all over the world.
5.1.3.2. Activities
The importance of scientific research as a whole was well demonstrated in this case.  It
gave the foundation for the development of the products but it also brought results that
nearly made the foodweb to collapse. The results that were obtained already at the very
beginning, concerning the caries preventing effects of xylitol were of major significance.
Later on research mainly verified and brought more understanding to the results obtained
at the beginning. It was not until at the end of the period under research that researches
brought up results that were not any more linked to the original findings in dentistry.
When it comes to the research what was also noticeable was the contribution of a single
researcher, Professor Kauko K. Mäkinen, to the development of xylitol products.
He seemed to be during the period under research the leading figure in the research con-
cerning dental applications of xylitol. Not only in research done at the University of
Turku but also as far as international research is concerned.
As far as production is concerned there was a certain technology already available and
new products were looked for that could be produced by it. As xylitol production seemed
possible what happened was that the existing technology had to be adapted to the pro-
duction of xylitol. What was special here was the need to change to a new raw material
source, which originated from wood processing. There were special development needs
mainly concerning the primary process stage. What actually happened was that a forest
product chain and a food chain merged in the early processing stage.
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In marketing the role of health specialists in the field was noticeable. When the relation-
ship between producers of xylitol products and consumers is considered the role of pro-
fessional associations, dental associations became important. Dental associations were
middle actors in a dimension where at one end are personal relationships between a doc-
tor and a customer and at the other end there are direct media relationships between a
producer and a customer. The credibility of products are obviously higher if they were
recommended by specialists than if it is based only on information provided by a pro-
ducer.
By the time of xylitol came to markets product approval was taking place on a national
level. No major additional safety tests were required. It was obvious that the previously
made safety tests in a medical context were considered sufficient. In case of communica-
tion concerning products there was a special situation before new food legislation came
into force in 1995. At that time legislation concerning pharmaceuticals was extended the
food area and based on that usually health claims were not allowed to be made. The do-
main of foods was subordinate to that of pharmaceuticals in that respect.
In consumption activity a change in attitudes and use of chewing gum was noticed. There
was a difference between consumption of traditional chewing gums and chewing gums
containing xylitol. Xylitol made the chewing gums more acceptable also to adults that
had previously been negative concerning the use of chewing gums.
5.1.3.3. Resources
In this case the existence of a specific natural resource was partly a starting point.  How-
ever, xylitol and its sources did not become valuable until an application area was found.
In Finland forest products and especially birch trees are a source of raw materials that can
be obtained in industrial quantities. Other possible raw material sources were beech and
corn. Until the end of the 1990s birch was also the main source for xylose. In 1997, a
new factory was built in Lenzing, Austria where a sidestream of a wood pulp production
was utilised for making xylose, the raw material for xylitol production.
The technological development that led to the xylitol production within Cultor did not
take place by chance. During the 1960s professor Melaja headed the Research Centre of
the Finnish Sugar Company. At that time a chromatographic separation method was de-
veloped that was first used to improve the yield of saccharose from molasses. At the
same time the technology of crystallisation was under research. At the end of the 1960s
and at the beginning of the 1970s the production of saccharose was no longer considered
as a growth area for Cultor. With support from the Director General Gustav von Herzen,
a lot of resources were allocated to research and development activities.  Special sweet-
eners were seen as a future growth area and new personnel were hired by the research
centre and new facilities were build. The competence acquired in chromatographic sepa-
ration made possible the production of fructose and glucose at an industrial scale at the
end of the 1960s and it was used also in the production of xylitol.
The Institute of Dentistry at the University of Turku had already during 1960s chosen
development of preventive measures in cariology as one of its strategic areas. The Pro-
fessor in Cariology,  Arje Scheinin who was also the director of the Institute, was already
looking for alternatives to sugar. At that time Kauko K. Mäkinen was Associate
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Professor in Dental Biochemistry. The background information needed for xylitol re-
search had already been acquired by previous research done at the institute.
There had been overcapacity in the confectionery branch that led to rationalisation where
different producers concentrated on the areas where they were strongest. Leaf Hellas be-
came especially strong on chewing gum markets in Finland. More resources was, how-
ever, needed as the development of xylitol based products began. The production of
xylitol containing confectionery products was technologically more demanding than the
production of traditional confectionery products.  For Leaf Hellas the development of
xylitol products became a key development process requiring two to three persons con-
tinuous work input. Some production related problems could only be solved after a long
research and development period. For example it was not until 1991 that Leaf succeeded
to produce a xylitol based hard sweet on an industrial scale.
5.1.3.4. Development dynamics
The key events in the development of xylitol products are presented in Figure 13. The
events presented on a time scale reveal that there are times when development takes
place at a faster  pace and times when it is more gradual. Xylitol was first used in foods
for special purposes. From those experiments it took over ten years before the applica-
tions in main stream foods were considered. There were no direct contacts between these
different research approaches for people or even countries. What was common was that
both the early and later applications have their origins within medicine. It was not a typi-
cal start for food product development.
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Figure 13.  Key events in the development of xylitol products
From the initial contacts that took place between Cultor and University of Turku, it took
about five years until Leaf Hellas launched the products on various markets. The rather
fast development was  possible because there were not very many factors that retarded its
advancement. The positive effects of xylitol were so obvious that only one long-term
study was needed before the first products were launched. Technologically, there was no
insurmountable problems concerning the production of xylitol and xylitol containing
products.  No long term toxicological tests were required because obviously the back-
ground that xylitol had was considered to be sufficient.
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Then there was the negative development. At the end of 1970s it was thought that the re-
search studies that were to be done were just a formality which would confirm previous
knowledge. After the alarming results that were received from toxicological tests made at
Huntingdon the development drastically slowed down. For example it took almost ten
years in the USA before xylitol was finally given the GRAS. What was however notice-
able was that the core of the foodweb survived over this period.
In Finland a more dynamic period was encountered as sales of xylitol products began to
increase after the first results of theYlivieska studies were published in the middle of the
1980s. The results of those studies as such were not radically new compared with results
from previous studies. Within a few years time xylitol became a dominant sweetener es-
pecially in chewing gums.
5.1.4. Conclusions drawn from the case
The initial development of xylitol products took place during the time when no such
category as health-functional foods was generally known.  It simply was a step by step
process that eventually led to the development of health-functional foods in a very mod-
ern sense. There was even the foods-medicine dimension represented. Xylitol based
products had not only preventative but also therapeutic significance.
Applying the framework of functional foods that was introduced at the beginning of this
study a change between categories could be identified. Although Falk (1992) identified a
general change where the role of the pleasure function for foods is increasing, the case of
xylitol showed that there are also opposite developments taking place. A product group
that used to be clearly pleasure-functional changed significantly in the direction of
health-functionality.
If it is assumed that foods in general are a product area which is tradition orientation  and
conservative. Then there has to be special reasons that ease the way to even more radical
changes. In this case there seemed to be such factors. Firstly, Finland is often considered
as a country where health matters in food context have a high priority and also legiti-
mates significant changes in foods. Secondly, there was already very strong pressure
against saccharose based on the health concerns, which eased the acceptance of even
non-traditional solutions. Thirdly, the product groups: chewing gums and sweets, al-
though foods, were not in a very central role within foods and there were for example no
active interest groups trying to protect the traditional products.
What the case pointed out is that for new radical food products there can be many sepa-
rate uncoordinated developments, leading  to situations where certain opportunities arise.
It is then a question of either taking advantage of them or not. The development of pro-
duction technology by Cultor, the willingness of  Leaf Hellas to find new products and
the orientation of Department of Dental  in University of Turku were all on a short per-
spective factors  that were given. At the stage as the new product was created no funda-
mental changes were possible.
During the globalisation phase one interesting feature is that as the international markets
were approached there was a systematic approach. In every country the aim was to first
approach regulators and  health professionals, which required that for example additional
new research has to done in that country. What it actually meant was that the aim was to
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accomplish networks that would start to operate within that country. The aim of the Fin-
nish actor (both in case of Cultor and Leaf) was to sell its products, but before it was po s-
sible it was necessary to create a network (e.g. research- government officials-health pro-
fessionals- retailers) that could support the product before or at the time consumers were
linked to the network.
The later development indicated that cultural differences matter even if the same mar-
keting approach is being used in different cultures. In the case of xylitol it could however
be that besides the health-functional dimension other factors are dominant. It can be that
in some cultures the chewing gum is not accepted no matter what it contains because
there are other reasons (e.g. ’chewing’ as a not proper conduct, the litter caused by
chewing gum etc.).
5.2. The case of Hyla
5.2.1. Background of the health-functionality
Unfermented milk products contain lactose. In the small intestine lactose is hydrolysed
by lactase enzyme into glucose and galactose which are then absorbed from the intestinal
tract. Hypolactasia means the lack of this enzyme in general and lactose intolerance re-
fers to an enzyme deficiency that results in symptoms of intolerance. In lactose intoler-
ance lactose is transported into the colon, where it is fermented by intestinal bacteria. The
fermentation results in gas formation and water retention causing discomfort in the stom-
ach.
Primary lactose-intolerance means that production of lactase in the body ceases at a cer-
tain age. The phenomenon was noticed at the beginning of the 1960’s. In the global per-
spective lactose intolerance is a common phenomenon whereas the tolerance of lactose is
a dominant hereditary trait. When there is a change from lactose tolerance to primary in-
tolerance, it usually takes place between the ages  2-15 depending on the cultural and ra-
cial traits. In international perspective hypolactasia and  lactose-intolerance are least
common in Central and Northern Europe. By Nordic standards in Finland a relatively
large portion of the population suffers from hypolactasia. According to modern estimates
about 17% of the population has hypolactasia whereas in Sweden and Denmark the re-
spective portion is 3-4%. About 3% of the population in Finland have lactose intolerance.
A secondary lactose intolerance that is also called acquired lactose-intolerance, is a tran-
sition phase and it is not dependent on age or race.  The reduced activity of lactase has
been noticed  in most illnesses of the gastric system as well with the poor nutritional
condition. The use of alcohol and certain drugs may also reduce lactase enzyme. In Fin-
land, secondary lactose intolerance is not thought to be very common.
5.2.2. Periods in the development of Hyla products
In the case of Hyla four major periods were identified in the development of products.
Those periods were: 1. Technological choices, 2. Internal uncertainty, 3. Generic brand,
4. New technology.
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5.2.2.1.  Technological choices
The research concerning the hydrolysis of lactose was one of the key research areas at
Valio’s R&D at the beginning of the 1970s. The technological development in the hy-
drolysis of lactose led to a situation that at the pilot plant in Lapinlahti a semi industrial
state was reached. There were tests made using both immobilised and soluble enzymes in
the process. The process using immobilised enzymes was a new and more demanding
way to hydrolyse lactose. The reason for it being developed was that enzymes are quite
expensive and the immobilised system aimed for a continuous process were the enzyme
to product ratio would be as low as possible. At that stage the new system was however
not utilised, but  it was decided that the soluble enzyme system would be used for the
production of the first Hyla product - a milk powder.
The price of the product was an important factor as the choice of production process was
made. Low lactose products were not unique on global scale. It was known that for ex-
ample in Milan in Italy a dairy company Central Del Latte had started to produce lactose
hydrolysed milk, which was guaranteed to contain less than 1.3% of lactose. Due to the
specific process the price of the product was more than 30% higher than that of ordinary
milk. Also in Holland low-lactose milk based products came on the markets. Valio was
not in contact with these actors and there were no imports to Finnish markets. At Valio,
however it was thought that a major price difference compared to standard products was
not tolerable. If Valio had used the new immobilised production system the price of the
product would have been too high due to small product volumes.
There were production systems available on the markets using the soluble enzyme alter-
native. Such a  system was acquired from the Tetra Pak International located in Sweden.
In the production of such Hyla products the beta-galactosidase enzyme is added to milk
that is heated to a high temperature for a very short time period (UHT-milk) before asep-
tic packaging. The enzyme hydrolyses the lactose during storage. The same process has
been used to produce low lactose spiced milk products, ice-cream mixes and whipping
cream
The faster the hydrolysis the more expensive is the production process. As UHT-milk
goes through the distribution chain slower than pasteurised milk it was possible that the
hydrolysis could take place in the storage and distribution chain. Based on experience the
guaranteed level of hydrolysis is 80% even though if, for example, the UHT milk is
stored at room temperature, hydrolysis reaches almost 100%. In products stored in cool
temperatures (like yoghurts) the lactose is hydrolysed using a batch type of a process
prior fermentation.
5.2.2.2. Internal uncertainty
In 1970s the per capita consumption of fresh milk in Finland was the highest in the
world. Valio was a dairy company owned by the farmers and they also sold their milk
production to Valio. In Finland Valio had a dominant position when it came to milk
based products. On the other hand by that time hypolactasia and lactose-intolerance were
not very well known phenomena by ordinary consumers. All these factors meant that ac-
ceptance of Hyla products to the product range were not self-evident.
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The reason for the doubt was only partly based on the uncertainty whether consumers
would buy the products or that they would compete with the company’s own products. It
was feared that the new products would be detrimental from the viewpoint of the reputa-
tion of the traditional milk products. It was thought that if Valio launched products indi-
cating a weakness in milk products it would affect the sales of milk products in general.
By that time the key integrating mechanism in R&D questions within the company was
the product development committee which consisted both of specialists and top manage-
ment. The top management of the company was very much involved in the decisions
concerning new products. Hyla products caused controversies and serious discussions
until they were finally accepted in the product range. It was understandable that after
such a process they were for a long time low-profile products which were not considered
as a business opportunity but more as a necessity that has to be produced for those that
suffered from lactose intolerance.
5.2.2.3. Generic brand
The first Hyla product, low-lactose milk powder, was test marketed in 1978 and it estab-
lished its position at the beginning of the 1980s. In 1983 the production of the first low
lactose UHT product; Hyla milk; started. The first fermented Hyla products were intro-
duced in 1986. Since then the product range has gradually expanded to cover almost
every dairy product group and there are over 30 different Hyla products.
For a long time Hyla products were practically the only low lactose milk based products
on Finnish markets. It was not until 1990s that the domestic competitors, especially Ing-
man Foods and Aito Maito, entered these markets. Hyla became almost synonymous for
low-lactose milk products. Later on Valio used this in its marketing to enhance a brand-
in-brand type approach. Producers of ready-made foods were given rights to use the Hyla
–trademark in their products made with Hyla-products.
Organoleptically Hyla products differ from the corresponding basic products to some
extent. As lactose is hydrolysed to glucose and galactose the products become sweeter.
This difference is most obvious in UHT-milk, which tastes clearly sweeter than the ordi-
nary UHT-milk. In other products the difference is not as remarkable.
Sales of Hyla-products have grown gradually. No rapid growth periods have been experi-
enced. There has been a correlation between the sales and the number of people who
have been diagnosed as being lactose-intolerant. Market shares vary very much depend-
ing on the product type (Table 1).
Table 1.    Market shares of Hyla products in 1997 in respective product groups (Source
AC Nielsen Scantrack, includes grocery shops)
______________________________________________________________________
Product  type                                        Market share %
Yoghurts  3
Milk                        5
Creams                        22
Ice-cream                  1
_______________________________________________________________________
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Hyla-products were from the very beginning aimed only at domestic markets. At no stage
had Valio plans to enter international markets on a major scale with Hyla-products.
However, at the end of the research period exports to Sweden with selected products
were under consideration.
5.2.2.4. New technology
It was not until 1990 that the technology using immobilised enzymes developed and pat-
ented by Valio could be utilised in commercial scale to hydrolyse the lactose. This took
place in the production of Gefilus drinks (see LGG), as the cheese whey is hydrolysed by
immobilised lactase. By that process it was possible to reach a hydrolysis degree of up to
95%.
Hyla was not linked only to the traditional products, which were based on the use of milk
as such. In Gefilus drinks Hyla was used as a brand-in-brand. Even though the drink did
not contain whole milk as such but a special fraction of it, the Hyla brand on the package
told consumers of the low-lactose characteristics of the product.
Hyla products typically contain a certain amount of lactose. Even these small amounts
cause symptoms for some lactose-intolerant people. The next step was to remove lactose
altogether from milk. This means that a solution of milk proteins and salts is obtained.
Valio developed a chromatographic separation method in order to does that. In the mid-
dle of the 1990s a series of ice creams was launched that were based on lactose free milk
and sweetened with special sweeteners. It was also expected that there would be interna-
tional markets for these new technologies.
5.2.3.  Identification of the respective foodweb
5.2.3.1. Actors
When it comes to research of lactose-intolerance there were no specific actors, which
would have been especially influential as far as the development of Hyla products is con-
cerned. The situation was different for the research into the hydrolysis of lactose.  Inside
Valio, especially the role of Ph.D. Matti Heikonen was significant. Valio co-operated
with the Department of Biochemistry at the Technical Research Center of Finland (VTT)
and with the Department of Chemistry in University of Technology in Helsinki.
The Hyla based foodweb was in commercial sense very much centred on a single food
company Valio Group (turnover in 1997 FIM 8 billion). It was initially founded by the
milk co-operatives to export their products at the beginning of the last century. In the
1970s and 1980s Valio was a dominant player in Finnish milk based product markets
with a high market share.
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A key partner in the supply and development of the technological equipment and pro-
duction systems was a Swedish company Tetra Pak International located in southern
Sweden. Valio had good working relationships with the company already from the past.
Also within the Valio Group there was a specialist engineering company Valio Engi-
neering Ltd which was involved in the process developments.
Inside Valio a key role in the development of the products was given to a product devel-
opment committee which consisted of both specialists as well as of the top directors of
the company.  The marketing of the Hyla products was the responsibility of the same or-
ganisational units that were responsible of the marketing of respective traditional prod-
ucts.
5.2.3.2. Activities
What was known about the lactose-intolerance phenomenon was very much based on
articles in scientific publications. By that time the research concerning the body-related
phenomena was not linked to the activities that directed the development of milk based
products. Research results concerning lactose-intolerance were taken as a general back-
ground that directed the development.
By the time Hyla products appeared the role of the milk as a basis for foods was chang-
ing. It was already typical that certain modifications in milk (e.g. concerning the amount
of fat) had been made. Technological development made it possible to take this process
even further. Attempts were made to make most of the Hyla-products to resemble the
traditional products as much as possible. Therefore also production processes were to
large extent traditional ones. Hyla process could be considered as a new subprocess in
those processes. In this respect the Gefilus product was an exception because in it the ba-
sic product itself and the respective production technology were different from the tradi-
tional major products and technologies used by Valio.
The marketing of the Hyla products could be called low profile marketing. One indica-
tion of this was that HYLA (HY=Hydrolysed, LA=Lactose) was actually a working
name that was simply registered as a trade name. Although the leaflets and brochures of
Hyla products were spread to health centres and maternity clinics no major marketing
campaigns took place at the beginning of the process. The use of the support of nutrition
specialists in marketing was not intentionally planned.  There was a slow and continuous
growth of the awareness of the products as the phenomena of lactose intolerance became
more known.
Consumption of the product was mainly by lactose intolerant people that bought the
products. There was also a price difference towards standard products that probably de-
terred some people using products even if they had benefited from that. What added to
consumption was the fact that in institutional kitchens and also partly in restaurants a
change took place later on where low-lactose products were being used as standard prod-
ucts in order to avoid the need to produce low-lactose products separately. Partly this
same phenomenon was noticeable in domestic usage as there are families where some
members are lactose intolerant or when lactose intolerant visitors were expected.
In the beginning there were no special regulatory procedures concerning Hyla products.
Under the recent legislation Hyla products were registered as special dietary products.
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This meant that besides standard food labelling requirements a special labelling is used:
dietary product or diet product, which indicates that the product is meant for special
groups. Otherwise these products are sold under the same regulation as other food prod-
ucts. This means that for example health claims are not allowed unless otherwise speci-
fied.
5.2.3.3. Resources
Valio has traditionally allocated resources to research and development. It has long tradi-
tions that go back to the time of the Nobel prize researcher, A.I.Virtanen, who was also
head of the Valio Laboratory. The research in the Laboratory at the beginning was very
much oriented to problems in primary production even though there was also a research
specially concerning cheese and also a link between nutrition and milk.
A key research area in the beginning of the 1970s was the hydrolysis of lactose initiated
by Matti Heikonen, Ph.D. The research had no direct connection to the lactose intoler-
ance phenomenon but the interest was on whey. Whey is a side product from the dairy
processes. There was a search for ways to utilise whey and also to improve the yield of
lactose from it. This development resulted in growing knowledge on technology of hy-
drolysis that was later on needed in order to produce low-lactose milk products.
Especially as the technology used involved immobilised enzymes the research done in
the Technology Center of Finland was an important basic resource.
Being a dominant player already in milk product markets meant also that Valio had no
major difficulties to get the new products through the very concentrated Finnish food
distribution system. Valio and its products had a good image among the Finnish consum-
ers which was a positive asset when the new Hyla products were launched.
5.2.3.4. Development dynamics
The key development events are presented in Figure 14.  It took almost twenty years
from understanding the phenomenon to the first products in Finland to appear on mar-
kets. However, it was not until the beginning of 1970s that experts in Finland became
aware of the lactose-intolerance.
-98-90-80-60 -70 -75 -85 -95-65
Lactose intolerance
was found
Studies of 
hydrolysis
Launch of
Hyla milk
powder
Light 
milk
Yoghurt,
Viili
Sour
milk
Rahka
Hyla-
Gefilus
Pastörized,
UHT milks
Internal
conflict
Figure 14. Key events in the development of Hyla products
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What has been typical for Hyla-products is a steady and incremental growth in scope of
the products. Information concerning detailed long-term volume growth was not avail-
able. However there seems to be no periods when more drastic changes have taken place.
It seems that products grew very much in an evolutionary fashion following the growth
of the natural lactose-intolerance phenomenon.
5.2.4. Conclusions drawn from the case
The Hyla case can be considered as a within a company case, which therefore is close to
the traditional view on product development, in which a single organisation dominates
the development. However, even here the foodweb framework was applicable. Basically
the situation is the same whether it is a single organisation case or multiple organisations
because the organisational boundaries as such are not the main subject of interest.
In the case of Hyla there were reasons to examine the starting points for products. What
is special in case of lactose intolerance is that it is not a disease in the traditional sense. In
primarily lactose intolerance it is a matter of a genetically determined change, that ac-
cording to what is currently known, is not reversible. In this sense it can be anticipating
future. It is probable that there are more genetically determined changes that are of sig-
nificance even though they may not lead to such obvious symptoms as lactose intoler-
ance.
The health-functionality of Hyla products involve a controversial situation. If it is as-
sumed that a lactose intolerant individual prefers to eat milk products in every case it is
evident that the products are health-functional, if thereby the negative body reaction can
be avoided. However, if such a link to preferences is not made, it can be argued that this
is not sufficient for health-functionality, unless the product has some specific properties.
For example if it is a matter of a traditional milk based product in which no other changes
than hydrolysis of lactose are made, it can be argued that such a product is nutrition-
functional as the change makes it possible to utilise the nutritive content of the milk
product. It is a different situation if it can also be shown that such a product has some
other health-promoting effects.
What was noteworthy in this case was the lack of extensive clinical research concerning
the actual effects of the product at the time products was launched. It was simply as-
sumed that a reduction in the amount of lactose was all that was needed. The company
itself was not involved in the research concerning lactose intolerance. Even the standards
of low-lactosity seemed to be based more on production technological factors than on
research on what are the critical amounts of lactose from the consumer point of view.
As to the technology what was also evident that the latest technology could not always be
used. In the Hyla case it was necessary to return to old technological processes for hy-
drolysing lactose. The situation could have been different if there had been a simultane-
ously strategy to enter international markets with Hyla products as then the product vol-
umes would have also been higher and the advantages of the new process more evident.
What this case also brought out was the difficulty within a one organisation context to
bring out the different aspects that drive product development in a balanced way. It is
very probable that every single organisation is biased toward some interest group. In the
case of Valio it was towards the primary producers of milk. The company was very much
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tied to the use of specific raw materials and this meant it was difficult for them to attempt
to enter certain development paths that seemed to be in conflict with this basic bias.
Instead of marketing the respective activity could better be characterised as informing
from a modern perspective. There were no major marketing efforts at the beginning. It
seemed also that the introduction period was very critical. Even later on when marketing
in general was more advanced Hyla products were still marketed very much based on the
old approach of informing customers. What was especially noticeable was that there was
no attempt to broaden the customer basis even though secondary lactose intolerance
could have given a proper basis to obtain a broader customer base.
Despite the low profile marketing because Valio was the first and for a long time the only
producer of low- lactose containing milk products it gained a very strong position among
both professional customers and individual consumers. In that respect Hyla became actu-
ally stronger than a brand because it is typical that brands are in competitive positions
whereas Hyla was almost synonymous for a certain generic product group. When Hyla
emerged, branding was not a well-advanced activity at least in Finland.
What was also typical to case of Hyla products, is that they did not get any special sup-
port from health professionals. This can partly be based on the fact that lactose intoler-
ance was not considered to be a major health problem and later on probably partly based
on the fact that milk products were not favoured because of the saturated fats they con-
tain and which were considered to pose a health risk.
5.3 The case of LGG
5.3.1 Background of the health-functionality
Probiots are defined as living microbe products that promote health by supporting the
natural microbial balance in the colon. The term probiotic was first used in domestic
animal research and later on it came to be used also in a food context. A specific term
colonic foods has also been suggested to characterise this food category.
The health promoting properties of lactic-acid bacteria has been studied since the begin-
ning of the 20th century. The first studies were made at the Pasteur Institute. From the
modern perspective the problem was that the effects could not be properly verified. To-
day it is known that many microbes that have been thought to be beneficial are not, as
they do not influence the intestinal milieu.
The differences in strains of harmful bacteria have been known for a long time. There has
not been so much knowledge about the differences in strains of useful bacteria. Often in
studies in this area only the collection is mentioned from which the used microbe stems,
and not the specific strain. As an example there are differences in the properties of Lac-
tobacillus acidophilus strains.  It has also been suggested that such microbes should only
be considered as probiots, which are part of the existing microbial flora of human gut.
69
5.3.2. Periods in the development of LGG products
There were four different periods identified in the development of LGG products: 1. Pur-
poseful research and expert involvement 2. A slow start 3. Aggressive marketing  4.
Business-to business internationally
5.3.2.1. Purposeful research and expert involvement
At the beginning of the 1980s doctors Sherwood l. Gorbach and Barry Goldin at Tuft
University in the USA come to the conclusion that none of the Lactobacillus strains that
they have studied and which were used in dairy industry had the necessary ability to im-
plant the human gut. They did not simply start to search for a best possible new microbe
but first defined the qualities that would be required from a strain that would improve the
health and could also be used in dairy industry.
In 1983 they started a new research project in order to find a proper strain of Lactobacil-
lus. After a two year research in 1985 a microbe was found that existed in human gut and
which met the previously set requirements. It was given the common name Lactobacillus
GG. Researchers then applied for a patent, which was granted in the USA in 1987, and
internationally in the middle of the 1990s.
By the same time as the researchers made their findings, the Valio Group was looking for
new microbes that were health promoting and could be used in dairy products. By a con-
nection established by professor Adlercreutz at the University of Helsinki the then re-
search director of Valio, Kari Salminen, contacted the researchers and soon after that
Valio signed a licensing agreement with the researchers for international rights for the
strain. The commercial product is known by its trademark LGG.
When the project began it was not known very much which factors affect the colonisa-
tion of gut by microbes. There was first a need to do some basic research work to under-
stand the phenomena. A lot of resources were used and efforts made to secure the back-
ground. The early research was mainly done in Finland but later on many research insti-
tutes and laboratories requested LGG for their own work. As a result of these efforts
Lactobacillus GG gained the most extensive safety assessment record of the probiotic
strains. LGG became also one of the most studied probiots internationally. The more its
characteristics became documented the more LGG became an important part of the
knowledge building process for probiots.
This meant that a lot of effort and resources were already committed before there was a
single consumer product on the market. In 1989 an information campaign was directed at
health professionals in Finland even though the products were not yet ready but under
development. Valio decided to start marketing all the LGG containing products under the
Gefilus brand. The aim was to launch two different types of products: a drink and a
spoon food product.
5.3.2.2. A slow start
First the Gefilus drink was introduced in 1990. It was a new type of fruit drink based on
whey from which the lactose was partly hydrolysed. The spoon food product was a yo-
ghurt product. It was developed in order to maximise the amount of LGG in products and
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therefore only LGG microbes were added. The yoghurt had a lot of production problems
and consumers did not like the consistency of the product, and therefore production was
stopped after a short period of time. Improved yoghurts were introduced five years later.
Meanwhile a LGG sour milk was introduced that was intended to modernise the image of
sour milks products.
It was then noticed that the key results that were obtained concerned children even
though there were no products that were specifically intended for children. Even the yo-
ghurt was of a type that children did not like. A result of this was the introduction of milk
products. The next product introduction was also based on the research results and con-
sumer aspects. All the previous products had milk based raw materials. However, it was
found that LGG was helpful in alleviating gut and skin symptoms of those children who
were allergic to milk. A pineapple-banana fruit drink was then introduced.
A difficult year for Gefilus brand was in 1994 for despite major investments sales had not
grown as expected. Marketing the product only internationally was not considered to be
viable option. In order to be successful on the international markets a good reference
from domestic markets was also needed. There were discussions concerning withdrawal
from the markets. However in 1995 a slight increasing trend in sales was noticed.
5.3.2.3. Aggressive marketing
What Valio had noticed was that although health claims concerning foods were explicitly
forbidden by the new food law in practise claims were being made to an increasing ex-
tent. A specific campaign was planned to introduce Gefilus-milk in 1996 where the bac-
teria LGG was introduced as a ”rescuer bacteria” and claims were made which were
directly based on the research results. Specifically it was for example mentioned that
LGG is effective in cases of diarrhoea and protects the stomach from the irritation of an-
tibiotic treatment. As the campaign was running the authorities approached Valio and
requested them to change the above-mentioned claims when they changed their market-
ing materials. After the campaign the sales of the LGG products started to increase and
the awareness of LGG brand was 89% by 1996. It was not known to which extent the
specific claims contributed to this.
For LGG products it was learned that in contrary to foods in general the so called
moment of truth was difficult to establish. This is usually for foods the first time the
product is tasted, the flavour of the product etc. In the case of the LGG products it was
linked to the experience of usefulness either to a  user or her/his family. LGG products
were bought mainly by the mothers of a family. Who is the user of the product depended
on the type of product.  Mainly it was adults that were using the products. In case of
families with children the products were usually linked to a cure that lasted a certain
time.
It was also not known very well to what extent they were used as substitutes to standard
products and to which extent they expanded consumption. The difficulty here was that in
most cases the sensoric qualities of products differed from basic products also in other
respects than just the inclusion of LGG.  The sour milk was not as sour tasting as tradi-
tional products, the yoghurt was of a more full-bodied and thick gourmet type than basic
products. The only one that differed from basic product with regard to LGG was the
milk.  The only reason to buy LGG milk was for health reasons.
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The better profitability of LGG products compared to ordinary products was an advan-
tage seen from all the commercial actors’ point of view. However there is a problem that
if all parties increase their margins, the end result is that product becomes too expensive
from the consumer point of view. It was also found out that there was a link between tra-
ditional products and LGG products. As the prices of basic milk products were typically
going down this caused a similar trend to LGG products. LGG products were thus very
much linked to the corresponding traditional products.
Table 2. Market shares of Gefilus products in Finland 1997 (source: AC Nielsen
Scantrac; incl. grocery shops)
_______________________________________________________________________
Market share %
_____________________________________
Gefilus drinks (within juices and juice drinks)   4.4 %
Gefilus milk   0.7 %
_______________________________________________________________________
5.3.2.4. Business-to-business internationally
From the very beginning it was not only the domestic markets that were aimed at. The
agreement made with the inventors of LGG obliged them to take an international ap-
proach. International markets were approached more in a business-to-business fashion
and there was no attempt to make direct consumer contacts abroad. It was LGG what was
the basis of licensing activities and it was more like an ingredient brand in contrast to Ge-
filus that was a food brand on domestic markets. The awareness of LGG within research
community however made it possible to broaden the product base further away from the
traditional milk products.
The licensees were granted a right to certain products within a certain territory for a lim-
ited period of time.  In Japan, a product containing LGG was a first probiotic product that
was approved  within the FOSHU system16. LGG is not the only probiotic on the mar-
kets. Internationally the most important competing probiots are LC1 produced by Nestle,
which is based on the strains owned by the company and Yakult, which is produced by a
Japanese company. What was evident was that probiotics were becoming an established
category also known by health-conscious consumers.  However there were no binding
rules concerning probiotics and it seemed that in many cases also microbes that did not
have scientifically valid basis were called probiotics.
5.3.3.  Identification of the respective foodweb
5.3.3.1. Actors
The key actors at the early phase were two researchers: Drs. Gorbach and Goldin at the
University of Tuft in the USA and the research organisation of Valio represented spe-
cially by its director Dr Kari Salminen and Dr. Maija Saxelin. Influential actors already
                                                
16
 FOSHU= Foods for Specific Health Use; a specific approval system that seeks to specify health claims
that can be made only on approved products in Japan
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at the beginning were also Dr Seppo Salminen at the University of Turku then employed
by Valio, and Dr. Erika Isolauri at the University Hospital of Tampere.
The actor basis gradually expanded among research institutes and laboratories all over
the world as the research results concerning LGG were published in scientific journals
and as they were presented at scientific conferences and other occasions. The
interest of  such respected institutions like John Hopkins Hospital in the USA was accel-
erating the expansion of the actor basis. In 1997 it was estimated that LGG had been used
for research purposes in over 40 research institutes and laboratories in 14 different
countries.
In Finland, the Valio Group was the key commercial partner. Within Valio the Fresh
Product Division became responsible of the Gefilus products on Finnish markets. The
Research Division was responsible for the international LGG business. There was no
separate organisation set around Gefilus or LGG neither domestically or internationally.
Valio had been in international markets very much on an export basis and was by that
time scaling down its own international presence. The licensing activity was handled di-
rectly from Finland and licences were granted on a territorial basis. In 1997 there were
licensees in 17 different countries.
As far as food regulation was concerned, the National Food Authority in Finland played
a key role as a general food authority not only as far as product contents were concerned
but also as the content of product specific information was concerned.
5.3.3.2. Activities
Basic research activities played a key role because the research took place during a time
when a clear change in the knowledge base was taking place. The traditional knowledge
concerning the microbes proved partly to be insufficient. Many of the microbes that were
previously considered useful actually did not turn out to be beneficial in the gastric sys-
tem. The research had to take a new start first considering whether and which of the mi-
crobes would have an positive affect.
From the food perspective the production of LGG actually meant that a food ingredient is
being produced. Valio and specifically its R&D Division thus became an ingredient pro-
ducer. What makes the production of microbes special is that the added amounts to foods
(e.g. 20 g/t) are typically not the same as the amounts that are needed in the food. This is
due to the growth of the bacteria in foods. What this means is that the actual amounts of
ingredients that have to be produced in the first place are smaller and therefore all the
logistics linked aspects took place on a small scale. This in turn means that the change
from laboratory scale to industrial production scale was not as significant volume wise as
in case of many other ingredients.
In marketing there were several layers even though it is not certain to what extent there
were explicit strategies on all the levels. Firstly, there was the researcher level. The aim
was to establish a good position for LGG among researchers. This required that LGG was
exposed on conferences and that there were publications about it in respected journals.
Secondly, there was a need to approach the health professionals who were influential in
matters concerning LGG. The consumers were involved only on a tertiary level in the
process.
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In regulation of the respective foodweb the role of Valio was noticeable. For example it
initiated the setting of specific safety requirements and contributed to the setting of ge-
neric standards for probiots. There were no specific requirements concerning the safety
of probiots although there were guidelines for testing of safety of microbes in general.
Valio was also trying to set its own norms concerning communication with consumers as
it deliberately exceeded official norms.
5.3.3.3. Resources
In this case natural resources did not play any significant role. The microbe as such was
of human origin and the products that were then produced were based on quite ordinary
sources that are used in the dairy industry. The only different aspect was the use of whey
as a raw material but even here there was nothing special about the sources of whey used.
Valio had long history in the development of souring agents for the needs of the dairies
that belong to the Group. For special microbe based souring agents it was considered that
its capabilities were in some respects even more advanced than firms that specialised in
the field. Valio had made products that contain Lactobacillus acidophilus bacteria since
1980s. The claimed advantages of these product were based on published sources and
international research. Valio did not do its clinical research at that time. What were the
specifically new and required new capabilities was the involvement in clinical studies.
The first Gefilus drink was also based on the results of the technological developments in
the hydrolysis of lactose. In that special product the technology and capabilities which
were considered in the development of Hyla products could be fully exploited for the
first time and this meant that the development of Hyla products was integrated with a de-
velopment that had started in order to find new beneficial microbes to be used in dairy
products.
5.3.3.4. Development dynamics
The key events in the development of LGG based products are presented in the Figure
15. It took five years from the finding of the Lactobacillus GG bacteria to the first prod-
ucts appearing on the markets. Especially the initial research period both before Valio
was involved and as it was co-ordinating the research were an intensive period. What is
significant is the subsequently long stable period, which lasted for five years, before the
sales of the products began to increase.  The increase was so slow that withdrawal of the
brand was already considered.  As sales in 1996  started to increase the brand achieved a
critical mass and expansion to different traditional product categories became possible.
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Figure 15. Key events in the development of LGG products
5.3.4. Conclusions drawn from the case
The health-functional background of LGG does not involve life-threatening diseases or
diseases in general that were especially on focus when the products appeared. This is not
to say that the health problems that the products were addressing were of no significance.
On the contrary they are often of major significance both from the individual and public
point of view. For example if the absenteeism of children from schools and kindergartens
due to diarrhoea can be reduced it will have positive indirect consequences both socially
and economically.  Such issues are though not very often raised.
What was special in the beginning was the goal-oriented research where both the needs
of the body and requirements set by the production was set prior to research. A more
common approach would have been either to start with a specific microbe that has been
found and find some use for it, or to start looking for new microbes and stop as soon as a
microbe was found that in some respects seemed promising. In the latter case the end re-
sult could be that it in some respects the microbe could be excellent but in other critical
respects it might not fulfil the requirements.
What makes this case special is that the key natural resource in this study was the human
body. The human body was not only the consumer of the new products but it was the ini-
tial source of the specific microbes that were then added to new products. This does not
mean that microbes were produced in the body for industrial purposes. However, this
brought a new dimension to the question of what are natural resources. Key natural
resources are not necessarily those that are needed directly for production but they can as
well be more informational resources. In this case a microbe was found that already had
the characteristics that were needed. No direct manipulation of the characteristics of the
microbes were needed as nature had provided a microbe with the right characteristics.
In case of LGG the background for safety and health-promoting characteristics of LGG
was specially emphasised. At no stage were there noticeable doubts raised concerning
this. Also internationally the microbe was well exposed within the research community.
This was probably made easier because there was an international approach from the
very beginning, an emphasis on openness for the research results and that LGG appeared
as the subject area was new and therefore especially interes ting.
In LGG case no internal conflicts within Valio between old and new products were ob-
served. LGG was actually not a natural part of milk, even though the products it was ap-
plied were based on the tradition of making milk based products. Within Valio brand
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based thinking was in a stronger position than in the case of Hyla. The raw material was
not a critical issue. Under the Gefilus brand there were side-by-side products based on
milk with products a non-milk base.
In the international business dimension there are specific characteristics in Valio ap-
proach. It was very much a business-to business orientation. It was evident that the pur-
pose of Valio was not to reach international consumers in any deliberate manner.
It was up to the licensees how much they emphasised the role of LGG as such in their
marketing. However, not even Valio on domestic markets emphasised LGG as the mar-
keting of products took place under the Gefilus brand. Probably not many consumers
were even very familiar with LGG other than it was a “rescuer bacteria”. What was also
special in this case was that the R&D department remained responsible for LGG business
even when the  strategic and financial significance of the project were increasing.
On the regulatory side, the legislation that prohibits the use of health claims become an
apparent impediment in this case. There were not such well-known markers like choles-
terol that could have been referred to and therefore the consumers were left to make the
final link to health. However, it is difficult to know to what extent the specific advertising
claims contributed to the success of the products. Considering the whole spectrum of
marketing operations covering groups from researchers to consumers it can be questioned
what was ultimately the significance of the specific wordings in the claims.
5.4. The case of Yosa
5.4.1. Background of the health-functionality
There were two factors combined in Yosa products that formed the basis of health-
functional properties. One factor was the use of oatbran to lower the cholesterol level of
blood serum. High cholesterol levels pose a health risk. It has been shown that there is a
connection between high cholesterol levels and cardiovascular diseases. It is not only
high levels of total cholesterol that are a risk factor but it is the proportions of different
types of cholesterol that is important. Especially a high level of LDL cholesterol is
considered to increase the risk. Another factor was the use of probiots based on their
health promoting effects (probiots: see LGG case)
The effect that oatbran and oatflakes have on cholesterol level was discovered during the
1980s. It lowers both the totals as well as the LDL-cholesterol levels in blood serum. It is
thought that the effective ingredient is beta-glucan that is located in the aleuronic and
subaleuronic layers of kernel of oat. There are several mechanisms by which it affects
cholesterol levels. According to the FDA (Food and Drug Administration in the USA)
the total scientific evidence shows that both total cholesterol level as well as the level of
LDL-cholesterol are lowered by about 5% if the intake of soluble nutritional fibre of oat-
bran exceeds 3g/day. The result is based on 37 clinical studies made on human beings.
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5.4.2. Periods in the development of Yosa products
Five different periods was identified in the development of Yosa products: 1. Develop-
ment of the product idea 2. The search for an industrial partner 3. Emphasis on process
development 4. Distribution barriers and media push 5. Learning about consumers
5.4.2.1. Development of the product idea
Professor Hannu Salovaara, professor in cereal technology at the University of Helsinki,
invented the idea that led to Yosa. The starting point for the method of making Yosa was
the procedure used to make the traditional cereal oat pudding called kiesa. The product
had been typical in the former southeast part of the Finland called Karelia, but it was no
longer very well known.  Grounded whole oat corn was used to produce it from which
part of the husk and the fibrous parts were removed using a piece of canvass. Souring the
oat with sourdough and then cooking the pudding made Kiesa. However, the product
obtained by this process did not contain those health-promoting factors that had emerged
in research concerning the health-promotion of oat. Also the microbes that were naturally
in the product died as the products were cooked.
Initial funds were obtained from different research funding institutions. First small scale
experiments were done to see whether the product idea worked and what kind of charac-
teristics the product had. The choice of main raw material was coarse oatbran obtained by
dry milling. It gave the highest fibre content and best structure to the product.
The experimentation resulted in a process that takes place in reverse order compared to
the traditional kiesa. First the pudding is made then the microbes are added which sour
the product. By this it guaranteed that the microbes will remain alive. The intention was
to produce a snack type of product to which fruits and berries were added. In the begin-
ning the yoghurts were considered as a reference point. The brand nameYosa is actually
based on words yoghurt and kiesa.
5.4.2.2. The search for an industrial partner
In 1990 the production method was ready to be patented. At that time some food compa-
nies were approached in order to commercialise the product. However the product idea
was not yet finalised. Professor Salovaara considered that the product might be of
international interest. An international patent needed significant financial resources and
outside support was needed. The Alko Group was at that time developing a fractionating
process of oat and they were interested in oat based applications. A co-operation agree-
ment with the company was signed and an application for an international patent became
possible. Later on the Alko Group stopped its process development. The agreement with
Salovaara concerning Yosa remained valid. There was now a need to search for a new
industrial partner. All the major food firms in Finland were not interested and the search
was directed towards smaller firms. Also some international contacts were made but the
lack of reference in Finland was a major barrier. Interest in oat bran was also temporarily
declining.
Bioferme Oy, a company owned by Scharlin´s family, was looking for new products.
Due to the economic downturn at the beginning of the 1990 the outlook for organic
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products was not very good. Also the problems concerning the availability of raw materi-
als for organic foods meant it did not seem possible that new products could be devel-
oped for that sector. Merja Scharlin was at that time interested in the possible use of pro-
biots in the products and contacted Professor Seppo Salminen at the University of Turku.
He told her of the product that Salovaara had developed at the University of Helsinki.
After that she contacted Salovaara who was then negotiating with another firm. The ac-
tivity and interest shown by Merja Scharlin finally resulted in Bioferme entering into a
licensing contract with the inventor and Primalco (previously the Alko Group). A sched-
ule was established according to which products should be on the markets.
The patent concerned the method of production and laid the foundation for an industrial
process. To start planning and developing the industrial process funding from Tekes (the
National Technology Agency)  was applied and the application was successful. A devel-
opment process involving Universities of  Helsinki, Kuopio and Turku began. The pur-
pose was to develop technology for industrial scale production, to generate product vari-
ants and to make initial clinical tests.
5.4.2.3.  Emphasis on process development
The development of a new industrial scale process in a limited period of time was a de-
manding task for a small enterprise with limited resources. There was no production
system that was directly applicable. The machines and equipment closest to this applica-
tion area were for use in the production of sourdough’s or yoghurts. It was necessary to
invest significantly in  the technological development and building of production facili-
ties There were also problems in guaranteeing the raw material supplies as Primalco
stopped its oat related developments and could not supply oat bran. There was only lim-
ited availability of oatbran without husk.
Another critical area was the selection of proper strains, which would act properly on a
large scale. Oat as a raw material creates special demands in this respect. Many strains
and combinations of them had to be tried until a proper combination was found. Devel-
opment in this respect was considered as one of the most important competitive advan-
tages that the company gained in the development process.
Discovering ingredients that create the desired flavours with oat was more difficult than
expected. For the sake of flavour it was necessary to use flavour additions.  A develop-
ment group had been established at the University of Helsinki, consisting of members
from the cereal technology research with Professor Hely Tuorila from sensoric food sci-
ence. The group suggested one taste variant and Bioferme selected another variant.
Initial tests were made among school children and elderly people to study attitudes to-
wards products. The results were promising. Clinical tests made in Kuopio also showed
that the use of Yosa had positive effect on the functioning of stomach as far as elderly
people are concerned. It had also been established that oat bran can promote the growth
of some probiotic bacteria in human gut.
The technological problems linked to products and processes were solved in the specified
time. This took place partly at the expense of the commercialisation process.  A small
enterprise has not much resources for such activities as the design of packages and
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promotional materials. It was also to large extent an open question what would be the
retail chains attitudes towards the products.
5.4.2.4. Distribution barriers and media push
The launch of the first products to markets took place on the 17th of November 1995 (a
month before Benecol was launched). The place was the historic milieu of Koskipirtti
near Turku. All the major food journalists were invited and a busing was arranged from
Helsinki.  Merja Scharlin was known for her work as a pioneer in promoting the use and
production of organic products. Shortly before the launch she was rewarded for this work
by one major women’s magazine in  Finland.  After the occasion there were several arti-
cles about Yosa in many journals which spread the awareness of the product.
There was a distribution agreement with Reformikeskus, which was a wholesaler spe-
cialised in marketing of health and natural products. Bioferme had used the same whole-
saler before. The problem was that it mainly distributed to specialist shops and the goal
of Bioferme was to reach a more broad customer base than only those who use specialist
shops.
Retail chains were not interested in the beginning. The buyers of the chains advised that
individual retailers should be contacted directly. This meant that distribution needed to be
handled by the company itself. There were direct deliveries to areas nearby. To other
parts of Finland a contract concerning logistics was made with a general transport com-
pany, Transpoint Oy. When retailers ordered products, Transpoint handled the deliveries.
That was not a very common distribution channel in Finland as far as foods are con-
cerned.
The product gained a lot of publicity in the media and Salovaara wrote many articles to
the trade press. Especially after one article had appeared in a major Finnish evening pa-
per in late autumn 1995 one of the major retail chains contacted Bioferme and asked
whether they could start selling the product. In spring 1996 also the other major retail
chains accepted the product to their product sortiment. Yosa was frequently in the public
eye and in 1997 it received a special prize in the Food of the Year competition.
Within shops the placement of the product was problematic. It was a new product and it
had not established its position within stores. Typically the product was in the beginning
besides the yoghurts. However it turned out that yoghurts were not a proper reference
group. In many cases consumers were disappointed because they were expecting the
product to have loose structure, which is typical for yoghurts, sold in Finland. The prod-
uct was later on typically located near the low lactose special products.
The position of the product within foods caused some concern. According to Salovaara
the closest counterparts to English product types are vellie or flummery.  The generic
type used on labels and accepted by food authorities is a soured oat-fruit product. Based
on the type of use the product is referred to in advertising as a snack, which has not been
very common for these kinds of products.
Bioferme contacted the National Food Administration before the product launch. It was
asked of the possibility to add calcium to the product. As the product did not contain
milk products it did not either contain calcium which is a necessary ingredient from a
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body point of view. This was considered to be a disadvantage. The Administration re-
plied that the application should be made not until the product was already on the market.
Later on the permission was granted and the new taste variety launched in 1997 con-
tained the same amount of calcium as yoghurts. Otherwise there was no contacts with the
food authorities.
A concern that was always present as Bioferme made development and investment deci-
sions were their role as a licensee. Yosa was becoming a major product for the company
and they were becoming more and more dependent on that. The trademark and the patent
were however owned by the licensors and there was always a fear that they would lose
the rights when the renewal of the contract was negotiated.  It would have been difficult
to find a replacement product at least at short notice.
5.4.2.5. Learning about consumers
As it is typical for a small business it was not possible to make large investments in
large-scale media campaigns. Spreading product information and in-store presentations
by sales promoters were ways to bring the product to the consumer’s attention. A lot of
positive feedback was received from the consumers especially on occasions like food
fairs. These were the ways how understanding the desires of the consumers increased.
It was found out that there were many special groups that preferred Yosa. One such
group were vegetarians and people looking for a vegetable based diet. Another important
group were families with children who had milk allergy. In general consumers who had
milk allergy, lactose intolerance or celiac used Yosa products. Feedback from consumers
directed many development activities. For example at the beginning there were com-
plaints that level of sweetness was too high and consequently it was reduced. It was also
considered whether organic raw materials could be used. However, celiac set require-
ments that no wheat should be in the raw materials. No organic oat bran was available
that was guaranteed to be wheat free.
The fibre content of the product was raised to the levels that were required by FDA in US
in order to make health claims. In Finland it was however not permitted to use similar
claims. From the consumer point of view the availability of the product was still a prob-
lem. It was still a relatively small product (yearly total sales about FIM 10 million) for
retailers and it was not necessary included in the product range of smaller shops.
5.4.3. Identification of the respective foodweb
5.4.3.1. Actors
Professor Salovaara, professor in cereal technology at the Department of Food technol-
ogy in University of Helsinki was a key actor in early development of Yosa products. In
the precommersial phase as the method was patented the Alko Group (later known as
Primalco, a group that had monopoly rights for retail sales of alcoholic drinks and pro-
duced besides alcoholic drinks also feeds and biotechnology products) was also of sig-
nificance.
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A key actor in the development of product as the technology development and commer-
cialisation phase was reached was Merja Scharlin, managing director and co-owner of
Bioferme Oy. Bioferme Oy is a family run company, with three family members involved
and five employees. The company was founded twenty years ago and is located near
Turku. It produced fermented vegetable products and organic products, most important
products being sauerkraut and vegetable juices.
Other influential actors were Tekes, the National Technology Agency, which is the main
financing organisation for applied and industrial R&D in Finland. Other significant ac-
tors were the media, especially the food editors in different media, as well as the retail
chains, which controlled the main distribution channels to consumers.
5.4.3.2. Activities
Research in health issues in this case can be characterised as applied research. The
health-functional features were very much based on existing research. A knowledge of
health-promotional aspects of oatbran and probiots were taken as given. In the case of
cholesterol lowering the reference point was the instructions given by food authorities in
the USA. What was unique was the development of a new foodstuff.  It differed signifi-
cantly from the current food products on the markets even though it had predecessors
among traditional foods.
What is special in this case is that two entrepreneurial activity periods can be associated
with it. One is the period from incubation of product idea to the signing of a licensee
agreement with Bioferme. Salovaara had clearly an entrepreneurial role although there
was no formal enterprise or concrete products involved. There was however a base for
concrete products and expectations concerning their value to consumers. This activity
took place very much in a business to business type of a context. The second period, led
by Scharlin, is the one, which is typically considered as a normal entrepreneurial activity
because it resulted in concrete products for consumers.
5.4.3.3. Resources
There is a link to the natural resource base in a sense that in Finland the consumption of
oat products had been on a relatively high , which in turn had supported the maintaining
and developing of cultivation and production of oats. However, in this case there were
no special reasons why oats specifically grown in Finland would be of higher value.
The Department of Food Technology at University of Helsinki, with a professorship in
cereal technology, was a key resource at the beginning because it was a major centre in
Finland concerning oat products. There were facilities and equipment that made possible
experimentation and the small-scale production of the products. At the department there
was also the section with deals with the sensoric food science which also forms a link to
consumer sciences. These resources were used in developing the consumer related char-
acteristics of the products. Food Chemistry Department at the University of Turku was a
partner in microbe related developments.
The technological adaptation and process modifications took place by trial and error. Lo-
cal resources and knowledge in process technology were utilised. Financially Tekes
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supported this development. Tekes funds R&D work by grants (25-50% of developing
costs) and risk loans. Later on clinical tests were carried out also at the University of
Kuopio.
Professor Salovaara’s key role was to modify the old traditional food process to form a
base that could be used to produce a heath-functional food, which  responded the re-
quirements of modern markets. The starting point in the technological respect was actu-
ally very close to that part of food technology, which could be called traditional home
food technology. This was then adapted and modified to make an industrial product that
was no longer linked to home food technology as it was a ready-made food. At that stage
also financial resources were needed,. this was provided by several funds and founda-
tions.
Bioferme had already a relatively long history in small scale vegetable processing and
also in organic products. As Mrs Scharlin is as an entrepreneur she was well aware of the
market developments and was actively responding to changes in them. She had already
established positive relationships with members in the media who specialised in food,
which formed a significant resource in the case. Her energy and capabilities to integrate
many different kinds of demands finally to a successful new food product were of crucial
importance in this case.
5.4.3.4. Development dynamics
Professor Hannu Salovaara was the source of the idea led to the development of Yosa at
the University of Helsinki. The actual research and development work started round 1987
(see Figure 16 ). After three years the development was at a stage where a patent appli-
cation could be made.  Then a five-year period of slower development started. During
that period the aim was to find an interested industrial partner.
After a licensing agreement was made with Bioferme Oy, a period of accelerated devel-
opment followed. Within a year the product was commercialised.  Even the distribution
related problems were sorted out in a relatively short period of time and the sales of the
product began to increase as consumers joined the foodweb. This was followed by a
more stable period when new taste variants of the product was introduced.
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5.4.4. Conclusions drawn from the case
What was special in the Yosa case was that the food product itself was a new product. In
contrast to other cases there was not a well-established traditional food to which a new
bundle of health characteristics was added.  This newness of the food brought with it new
possibilities but also some difficulties because it was not only the health attributes that
were of concern.
In fact if the health-functionality is considered in its strictest sense there were concerns
about the health-functionality of the product especially in its initial form. Initially the oat
bran levels were not high enough, which was later on requested by FDA to validate
health claims. It was also uncertain to which extent the product contained truly tested
probiots (see Gefilus) and to which extent certain microbes were needed because the
fermentation of oats have special requirements. The tests performed at University of
Kuopio showed the product had positive health effects. However, they were of a general
nature and did not concern cholesterol levels or the significance of certain specific pro-
biots.
A small business entrepreneur does not have the resources to do detailed market surveys.
The direction of their development processes are very much based on the fragmented
feedback from different sources. When the products reached the consumers it seemed
that the traditional health related factors had a more important role to play than the new
factors. The cholesterol lowering effect and the probiots were not very strongly expressed
in the feedback. The absence of milk and wheat proved to be even more significant fac-
tors.
In the case of Yosa there were several single development options: the scientific based
healthy characteristics, the lack of milk and wheat based ingredients, the new-
ness/tradition of the product as such, or appeal to developed tastes (high quality ingredi-
ents). What actually took place was that a certain balance between different factors was
attained. The product still preserved its image as a natural product even though there
were elements related to scientific/technological products.
The difficulties small business have with retail chains are a well-known phenomenon.
What added to the difficulty here was that it was a matter of a new product concept. The
difficulty was not only the general acceptance at the chain level. The proper place
within a store was also of concern. The traditional division of a food store is very much
based on an ingredient or raw material basis (milk, meat etc) and the basis of the use
context (main dishes, desserts, snacks) or customer characteristics is still developing.
What is evident here was the key role of individuals and their personal contacts Professor
Salovaara gave credibility to the product and could promote the product among food pro-
fessionals . Mrs Scharlin had a good knowledge of the media and previous contacts.
What probably played at least some role here was her university education that made it
easier to operate in the new science based food environment.
It was also an advantage that during the early development of Yosa health-functionality
in foods in general (especially in relation to Benecol and Gefilus) became a largely dis-
cussed theme. Along the products of the bigger companies there was a also a place for
small business products. Yosa was introduced to the general public at a right time.
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One special controversy concerning the regulation of health related information of foods
came out in this case. In the marketing of Yosa there was reference to the health status
that certain oat products had received in the USA, which makes it possible to make spe-
cific health claims. However, it is not generally allowed to make specific health claims in
Finland.  Then it can be asked to which extent such references can be made without act u-
ally making a health claim.
5.5. The case of Benecol
5.5.1. Background of the health-functionality
The cholesterol level of blood serum can be affected by diet. Usually the decrease of
cholesterol by means of diet requires radical changes concerning foodstuffs that can be
included in a diet. This usually means a significant change in one’s food habits. Changes
in habits are, however, difficult to accomplish. Another approach to lower the cholesterol
level is to alter the composition or characteristics of foods.
Plant sterols correspond to the cholesterol of mammals. They are, like cholesterol in
mammals, necessary substances for the functioning of a living cell. Our normal diet con-
tains small amounts of plant sterols. Vegetarians get more of them than non vegetarians.
It has been noticed that plant sterols reduce the cholesterol levels in the blood serum.
This effect has been known for a long time. The first studies are from the beginning of
the 1950s.
In studies made in the USA it was shown that certain sitosterols significantly reduce the
cholesterol of blood serum. There is no certainty about the mechanism but based on
studies during the 1970s it was concluded that plant sterols displace cholesterol in the
digestive tract  and therefore prevent some of cholesterol being absorbed. The crystalline
and homogenised sterol products used by that time were however not very effective in
lowering cholesterol levels.
In the middle of 1980s interest among researchers started to focus on saturated plant ster-
ols (including sitostanol). In Germany clinical studies were carried out on humans and in
Japan on test animals. The results indicated that sitostanol could be more effective in
lowering cholesterol than its precursor sitosterol. Sitostanol had also the advantage that it
was not absorbed into blood serum. The disadvantage with all the plant sterols, including
sitostanol, is that they have a low solubility in fat, which restricted their use.
5.5.2. Periods in the development of Benecol products
Five different periods were identified in the development of Benecol products: 1. Search
for complementary partners, 2. A technological solution, 3. Path to product approval 4.
Launch without introductions launch, and 5. The product leading the company
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5.5.2.1. Search for complementary partners
Kaukas Oy  approached Åbo Akademi University in Turku in the middle of the 1980s
asking whether there would be applications for the plant sterols. Åbo Akademi advised to
contact the University Central Hospital in Helsinki(HYKS) where Professor Tatu Mietti-
nen was aware of the developments made in medical research and where small-scale ex-
periments had also been done.
The low solubility of sterols was however a major obstacle in the research and no good
solution to solve the problem had been found. Miettinen contacted Valio in 1987 but
there was not enough interest in the matter and no further progress took place. At the end
of 1988 Miettinen contacted development manager Tapio Palmu at Raisio. Raisio
showed interest and the development that lead to Benecol products started.
5.5.2.2. A technological solution
Finding a technological solution was of crucial importance to the development of a prod-
uct. There had been earlier attempts and it was known that already during the 1970s the
researchers of a US based company Procter and Gamble had esterified plant sterols. They
had not used sitostanol and they had not added the product to foods. Later on it was
found that also the researchers at Hoffman la Roche (see xylitol) had already esterified
sitostanol. They had used phosphoric acid, the use of which can be problematic in food
context.
Raisio´s R&D manager Ingmar Wester tried to find a solution first using different adju-
vants and utilising different temperatures that were possible in refining process. They
were not successful. It seemed that no solution could be found even as the clinical tests
were about to start. Esterification with the fatty acids of rapeseed oil emerged as a solu-
tion as soon as Wester considered what was the natural form for plant sterols in rapeseed
oil. Fatty acid ester is their natural form, which then breaks down when plant sterols are
extracted. The trans-esterification process brought the technological solution to the
problem and clinical tests could be started.
At the beginning tests were made in which stanol ester was in a mayonnaise type emul-
sion which was packed in tubes. Because the use of mayonnaise is not very common in
Finland a margarine that was enriched with stanol ester was developed. Margarine was a
proper product because it is being used regularly in association with meals. The absorp-
tion of cholesterol is reduced as stanol ester margarine is used at mealtimes and that leads
to lower cholesterol levels on a more permanent basis.
In small scale studies and experiments the cholesterol lowering effect was repeatedly ob-
served. It was concluded that  2-3 g/day of stanol ester lowers  the total cholesterol of
serum about 10% and LDL cholesterol about 15%. In order to reach this amount of si-
tostanol it was necessary to consume 20-25 g of margarine that contained 9% of esteri-
fied sitostanol. No negative side effects were observed.  Especially after the research car-
ried out by HYKS and KTL (Public Health Institute in Finland) involving 67 test sub-
jects, the researchers became convinced of the advantages of the product.
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However, without studies of long-term effects and possible side effects it was not possi-
ble to think of the commercialisation of the product. It was decided to conduct a study as
part of the North Carelian research project  It was going to last one and a half years and
there would be 150 test subjects. The results of the study confirmed what was already
known and finally results were published in 1995 in the New England Journal of Medi-
cine, which was a highly respected journal within medicinal science.
5.5.2.3.  Path to product approval
As the commercialisation of the product seemed more and more certain, interaction with
food authorities was increased. The food authorities were contacted two years before the
launch of the product. The more certain the launch seemed to become the more there was
interaction with the authorities. The authorities suggested a year before the launch that a
seminar should be organised where the different product related aspects would be exam-
ined. Company representatives, researchers and authorities attended the seminar. Official
application for the addition of stanol ester into the raw material of margarine was sent to
the Ministry of Trade and Industry. In the reply it was said that there was no need for
special permission but that it was necessary to indicate clearly the addition on the label of
the packaging. An other application was made for the use of stanol ester in vegetable oil.
Vegetable oil could not only be used in margarine but also in other products like mayon-
naise and salad dressings. At that time there were no plans to launch such products on the
markets. Permission was granted in May 1995.
5.5.2.4. Launch without introductions
A big concern was the price of the product. Due to the high costs of stanol ester produc-
tion the product price was going to be much higher the prices of ordinary margarine. Ac-
cording to the marketing people the maximum difference to other margarine products
should not have exceeded 1.5 FIM/package. The actual price was going to be 5-6 times
higher because a certain amount of sitostanol was needed. No research was done con-
cerning the acceptance of price among consumers. The risk remained whether the high
price would be accepted.
In other aspects the product was tested by small consumer groups in order to develop the
product concept. What made the development easier was the fact that consumers do not
organoleptically notice the difference between stanol ester and ordinary margarine.  The
Benecol trademark had been chosen already between 1992-93.  Finally, a smaller con-
sumer package than the packages of standard margarine’s was chosen in order to keep
the price per package lower.
The product was kept in secret so that only a small group of people was aware of the
product before its introduction to the market. The launch of the product took place on
November 16th 1995. At the same time as the results were published in the New England
Journal of Medicine there was a press conference held in Finland for the media and in the
USA the results were reported at an occasion arranged by the American Heart Associa-
tion. It was not until this that the deliveries to wholesalers and retailers started.
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The high price of the product was tolerable. The market share of Benecol rose faster than
was expected. The availability of the raw material was soon to become a bottleneck and
the product could not be produced to meet the demand.  At the beginning it was only
Kaukas that could supply the plant sterols and the saturation of sitostanol were made
partly by pharmaceutical companies before a new factory to produce esterified sitostanol
was built. Later on plant sterols could also be acquired from a French company DRT(
Les Dérivés Résiniques et Terpéniques) which had specialised in the production of wood
based chemicals and which had forty years experience in extraction of plant sterols.
The sales of Benecol rose in two years to FIM 80million which meant an eight percent
share of the total margarine markets in Finland (see Figure 17)  Benecol was received
favourably also by retailers because its sales margins were higher than those of standard
margarine’s. In case of consumers it was found out that typical consumers were over 50
years old and there were even more regular consumers in the group over 60 years old. It
seemed that it was those people who already had high cholesterol levels or who were the
risk group that were typical consumers of the products
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Figure 17.  Development of sales and market share of Benecol margarine in Finland
(source: AC Nielsen Scantrack; incl. grocery shops)
In autumn 1996 the National Food Administration was informed that Benecol margarine
was considered as a special diet product. The intention was to position the product clearly
differently from other margarine. At the same time it was wanted to make sure that the
claims that were going to be used would be acceptable.  The food authorities requested
several changes to the suggested claims.
As preparations were made for entering the international markets more research was
needed. Many experts were approach and their opinions asked to direct the research to
key areas. The problem was that it was not possible to base the next research on the re-
sults of the previous one but it was necessary to start simultaneously research in many
areas in order to fill the possible research gaps. Even though research in Finland is well
respected there was also a need to repeat the studies abroad for the sake of international
recognition. Also such safety studies were made to secure the background that experts
considered as not anymore necessary at that stage of the development. The differing re-
quirements for official permissions in different countries however demanded them to be
done. By the end of 1997 there were about 15 clinical intervention studies and about ten
studies toxicological studies that had been carried out, which  resulted in over 20 scien-
tific publications.
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5.5.2.5. The product leading the company
As Benecol gained an established position on the markets there was organisational re-
sponses within the company. A separate brand based business unit was formed in 1996.
The importance of the brand was further emphasised as a Benecol division was founded
in 1997 beside the other divisions of the group. At the end part of 1997 there were about
50 employees including one in England and one in the USA. Benecol Division was re-
sponsible for the business operations concerning Benecol products: marketing, licensing,
R&D, and also production of stanol ester. In Finland the Benecol Division sells the stanol
ester internally to the Margarine division.
Based on the success in Finland a search for an international partner began. It was unde r-
stood that Raisio alone did not have resources to enter international markets. In May
1997 a contract was made with McNeill Consumer Products. McNeil was granted sole
rights to patent and trademark within North-American markets. Raisio in turn had exclu-
sive rights to supply McNeill and was committed to build a factory to produce stanol es-
ter. In November the contract was expanded to cover world markets excluding only Fin-
land and the neighbouring regions. Raisio received a lump payment and were going to
receive remunerations based on the development of operations and royalties based on the
sales of the products.
The role of the Raisio was then mainly to secure the availability of the raw material and
to build new processing capacity for stanol ester. In order to reach that goal Raisio and
UPM-Kymmene made a initial contract in 1997 to establish a joint venture company to
which both companies would transfer their know-how and which would develop the ex-
traction method of plant sterols and sell them to wood processing industries. Also Raisio
supported the capacity expansion that took place in DRT factories reserving the extra ca-
pacity for its own use. In the USA a joint company Westerol LLC was founded in co-
operation with Westvaco Corporation to build a plant sterol recovery unit. Also with a
Chilean company Härting S.A a joint venture was established to extract plant sterols.
It was calculated that when all these investments were made, Raisio would have an an-
nual capacity of 4000 tons of plant sterols. If the consumption per person level would be
the same as it were in Finland it was estimated that this capacity would be sufficient to
meet the needs of a 200-million people market.
There was a lot of international interest in Benecol already at the beginning. It gained a
lot of publicity from the trade press. It became one of the most well-known Finnish food
brands even before there was any concrete product on international markets. The expec-
tations were also influencing the value of the stocks of the company. Initially there were
estimates that the value of the Benecol patent could be even FIM 12 billion and there
were expectations among investors that Benecol could achieve a share of 3-5% of the
margarine markets in developed countries.
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5.5.3. Identification of the respective foodweb
5.5.3.1. Actors
The University Central Hospital in Helsinki (HYKS) was an actor in the web. It had been
a Raisio partner already during the 1980s in the so-called fat studies in which one aim
was to study the effects of rapeseed oil on cholesterol levels. The head of the Clinic of
Internal Diseases Professor Tatu Miettinen was also a cholesterol metabolism researcher
and was familiar with the research on plant sterols in medical science.
Another actor was The Public Health Institute in Finland (KTL). It had been active in
investigations of the role of diets in national health. The Institute was strongly involved
in the North Carelia project, which had been a major public funded project established
already during the 1970s to reduce the high occurrence of cardiovascular mortality in the
North Carelia region. One aim of the project was to improve the food habits of people
living on that area and to investigate the consequent effect of that change in their health.
One key actor was the Raisio Group, an enterprise with an annual turnover of FIM 4.9
billion in 1997. It was mainly active in the food and chemical businesses where products
where mainly derived from potato- and wheat starch. Its international turnover was about
50% of its total turnover and it had production plants in 16 countries. Raisio Margarine
division had an annual turnover of FIM 1.7 billion in 1997. About 10% of its output were
sold on Finnish markets. Raisio had about 50% share of the Finnish margarine markets,
the other half being controlled by Paasivaara Oy (a 100% Unilever owned company).
Within Raisio the influence of the previous director of Raisio Margarine Folke
Gustafsson should be mentioned. In important roles were also development manager
Tapio Palmu who brought the idea to Raisio and R&D manager Ingmar Wester, who in-
vented the key technological solution.
One commercial actor in the web was Kaukas Oy (later on part of the UPM-Kymmene
Group). It was a wood processing company, which also produced pine oil. Kaukas had
developed together with researchers at Åbo Akademi in Turku a process to improve the
quality of pine oil. An other actor was McNeill Consumer Products, a company that be-
longs to the US based Johnson and Johnson Corporation(turnover about USD 22 billion)
which in turn was one of the biggest producers in the world of health related products.
McNeill was not a food but a healthcare company with a product range, which consisted
mainly of non-prescription pharmaceuticals, e.g. lactose-intolerance products. Tekes (see
Yosa) was also an actor in the technological development.
There were two food authorities involved. One was the National Food Administration, a
public authority controlled by the Ministry of Trade and Industry (see Gefilus). It had the
main responsibility for the control of the Finnish food product markets. Parts of the re-
sponsibilities (especially for animal based products) were divided with the authorities
that operated under the Ministry of Agriculture and Forestry.
5.5.3.2. Activities
On a food medicine-dimension the area of activity in this case is obviously closer to
medicines than foods. A specific indication of this is that Benecol products were fre-
quently compared with medicines (even though this is typically not permitted in
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consumer contacts). It was not only long-term effects as in many cases with foods but
also short-term effects that were of importance. This is typical for medicines. Sitostanol
has also a specific influence, which is typical for medicines. On the other hand what
points in the direction of foods was the aim for uncontrolled intake. It is assumed that the
required amounts of sitostanol ester would be taken without special attention given to the
intake. The amounts and the intervals of product intake of medicines has to be the con-
trolled more carefully at least by the user her/himself.
The activities in general were a combination of practises from the food and medical con-
text. The clinical research was more than is usually done in food context but less than is
typical done for new drugs. As the products were already on the markets there were criti-
cism, saying that there should have been a more extensive research basis, specially con-
cerning the different safety aspects of the product.
As the technology was developed food production was a reference point. The key ad-
vantage in the new technological invention (esterification of sitostanol) was that it was
based on the processes already common in the industry processing edible fats and there
was no need for example to use chemicals foreign to the food industry. In marketing even
though there were different messages to professionals and consumers, both groups were
approached simultaneously which is a typical food marketing approach.
Regulation activity was a special issue in this case. At the time the Benecol product en-
tered the markets there was not special regulation concerning new foods on the EU level.
The legislation and respective norms of every EU country were effective. In Finland it
was not self-evident what was the position of sitostanol in food context. At that time the
ingredients of margarine were mainly regulated under the Ministry of Agriculture and
Forestry, whereas National Food Authority located under the Ministry of Trade and In-
dustry, gave directions concerning product labels . Authorities then considered sitostanol
to be a nutritional supplement like vitamins and minerals.
A specific activity was the valuation of the product. As international markets were ap-
proached a significant interest arose within capital markets even before there was prod-
ucts or certainty of product approvals on international markets. The expectation of inter-
national success multiplied the value of the stocks of the Raisio Group in a short period
of  Time even though later on there were fluctuations in this value. It was not as if they
technology stocks, which are usually linked to high-technology companies. In this case
the company was more traditional but it was the product that was radical in nature. To
bring about that effect there was no need for Raisio to go even beyond the relative small
Helsinki Stock Exchange. However, even the valuation was linked to Benecol
products it was not only the product itself that was considered. Every act, like the choice
of a partner, affected the stock value. Therefore it can be said that even though the valua-
tion changes were seen in the value of the stocks of a company it was to very large extent
the whole network that was valued.
5.5.3.3. Resources
The raw material and its availability were of significance in the case. Even though plant
sterols are common in plants there has been no industrial use for them. Kaukas had to-
gether with researchers in Åbo Akademi in Turku developed a process to improve the
quality of pine oil. In that process plant sterols were extracted from the oil. That resulted
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in a sterol powder that contained 15% of stanols. This was still a useless sideproduct.
What it meant from the further development point of view was that a raw material supply
at least up to certain industrial scale was secured.
The finding of a technological solution played a key role in this case because in the very
early phase it was known what kind of characteristics were required from the product but
the technological solution had not been found. In case of Raisio even though there was a
separate chemical division within group, there was no significant interaction and the de-
velopment that led to the technological innovation took place independently. It was not
only a matter of a purely technological solution but it was also necessary that it should be
suitable for a food context.
The development of Raisio’s capabilities had historical roots. During the 1980s there
were still five factories in Finland producing margarine. The director of Raisio Margarine
at that time Folke Gustafsson understood that if Raisio was going to stay on this business
area, it was necessary to acquire more knowledge and improve the company’s capabili-
ties. At the beginning of the 1980s a research laboratory was founded besides the already
existing product development laboratory. New research personnel were hired, among
them was the research chemist, Ingmar Wester. Also a pilot-plant was built that covered
the whole margarine process. As a result of these investments to increase knowledge and
capability basis, it was later on possible for Raisio to participate in fat r esearch.
During 1986-88 clinical studies were made to test the effects of rapeseed oil on choles-
terol levels. Raisio’s partners were the Department of Pharmacy at the University of Hel-
sinki and Helsinki and Turku University Central Hospitals.  The favourable results of the
research were key factors in the commercial success of  rape oil. This meant that the
company had already a positive example of the significance of health related factors in
food context.
The earlier scientific research and knowledge can also be considered as a resource.
Coronary heart diseases have been a major health problem in Finnish society. Research
knowledge and capabilities on that area were well esteemed internationally. It was not
only the treatments of the diseases but their prevention that had been highly prioritised.
As foods and diet were already considered important factors and as medicines to treat the
diseases were already common it can be thought that from the public health point of view
a positive attitude would be taken to the exploration of overlapping areas. This is also
what happened. What was also significant was Professor Tatu Miettinen’s experience and
knowledge of the previous research that had been done in the area. He could direct the
development efforts to the most critical and promising factors.
5.5.3.4. Development dynamics
The development (see Figure 18) of Benecol started when a wood processing company
Kaukas Oy produced plant sterols as a by-product and was interested in finding applica-
tions for them. At the same time there had been interest in sterols as possible substances
to be used to lower cholesterol. There had been a slow development towards the product
idea. At the end it was more of a matter of a solution to be found to a technical problem.
A more intensive period started as the contact between Professor Tatu Miettinen at the
University Central Hospital in Helsinki and Raisio was established. This led in about two
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years time to a technical solution. The technological basis of the product was established.
Then a more stable and slower development five-year period followed during which the
clinical tests were made and regulatory approval was obtained.
An intensive period started again in 1995 as the product was successfully launched on the
markets. Domestic sales increased rapidly, international markets showed significant in-
terest on the product, and then there were many kinds of informational needs that has to
be responded to. Benecol received publicity on many fronts.
-96-92-88-84 -86-80 -94
Raisio
involvement
Patent
applications
Product
launch
in Finland
Benecol
business unit
established
Product 
   idea
Co-operation with
McNeil
Consumer
Products
begins
-97-90-82
Sitostanol is
a by-product
Effectiveness
of plant
sterols
known
First
stanol ester
factory
North-Karelia
research
Food 
authority
approval
USA patent
granted
Technological
solution
Figure 18. Key events in the development of Benecol products
5.5.4. Conclusions drawn from the case
What was new concerning stanol ester was that it found applicability in a food context.
However, what is especially significant in here is that it introduced a new element to
foods.  Previously it has not been very usual to focus on the borderline between foods
and the body. No matter what the foods originally contain, there are possibilities to con-
trol what ingredients of a food will be incorporated into the body. It could be thought that
there are many phases in the food flow where this control may be of significance.
On a food- medicine level Benecol and Yosa can be compared because they partly aimed
at the same purpose: the lowering of cholesterol. In case of Benecol the quick effect, the
clearer mechanism of influence and the isolated key ingredient (stanol ester) made it
more of a medicine type whereas for Yosa the long term effect, the more obscure mecha-
nism of influence and the low level of isolation of key ingredients (oat bran, not any spe-
cific part of it) made it more like a food. These differences are not necessarily linked to
the actual effectiveness of products to lower cholesterol levels.
In the case of Benecol the official food (food laws and other official instructions) regula-
tion was clearly not prepared for such a new food product like Benecol to appear. The
consequence of this was that there was a need to rely on an internal regulation that was
based more on the expertise and knowledge of the people involved than on official regu-
lation. The deficiencies of this approach became evident when the international markets
were entered.  There was a big step from the domestic context where less was demanded
to international context where in every country there were different requirements. On the
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other hand it is very probable that if there had been very extensive (like in case of medi-
cines) and formal requirements, the product would not have entered Finnish markets.
On a foodweb level it is interesting to compare the Benecol and Xylitol cases. There are
many similarities. Both have strong medicine related backgrounds which are linked to the
main health concerns of their times. There are also similarities in the geographical actor
constellations. In both cases the activity of the raw material producer was a significant
development trigger. The raw materials, at least at the beginning, are from wood proc-
essing industry. In both cases there were also concerns for product safety in the early de-
velopment phase. Both had as their major international partners companies that are actu-
ally not food companies.
There are also differences concerning the development. In the case of Benecol the key
ingredient and consumer products are produced within the same enterprise. There was a
more direct foods-to-consumers approach. There were no sitostanol capsules or concen-
trates available and also the international partner sold products directly to consumers.
However, what makes this comparison difficult is that in case of xylitol the period under
observation was two decades and in case of Benecol about two years.
Comparison with LGG reveals that development is possible with different emphasis.  In
LGG there was a goal-oriented research to find an ingredient (a microbe) that met the
requirements set in advance. In the Benecol case the product was more or less known
whereas technological solutions were of more importance. In the LGG case safety issues
were given more attention initially and there was also attempts at standardisation within
the field. For their marketing and partners Valio used double branding and international
customers were approached directly whereas Raisio had only one brand and one major
international partner.
It is obvious that if Valio had become the industrial partner and technological problems
had been solved the foodweb around ”Benecol” would have become very different. On a
product level it could have meant a more defensive approach. If stanol ester or some
other corresponding plant sterol were added to butterfat it would have meant that part of
the negative effects that butterfat have would be eliminated. It would have defended the
position of butterfat as a food even though it would probably also brought up more
clearly the tensions between the good and bad characteristics in a food.
The development process behind Benecol, at least to the point as Finnish markets were
entered, could be characterised as a development process at its limits. There were no ex-
tra resources to do much more than what was necessary. This is evident whether it is
matter of the research basis, production capacity or the marketing approaches.  However
it is understandable that the initial aim was to make a niche product for Finnish markets
with only some export potential, no extra resources were allocated to the development.
The Benecol case also showed how health-functional food markets are in many aspects
tied to global markets. The knowledge of the Benecol product spread rapidly among pro-
fessionals. However, not necessary only food professionals.  It could be asked at some
point whether Benecol was better known among professionals in capital markets than
among professionals among foods and nutrition?
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6. Foodweb of the health-functional foods – a broader perspec-
    tive
The aim of this part of the study is to broaden the perspective. In the previous section the
focus has been mostly on single cases. The purpose was to describe and to understand the
processes that empirically take place in a foodweb of health-functional foods. Broaden-
ing the perspective means above all two things. Firstly, based on the findings from the
individual cases steps will be taken to make initial generalisations concerning the factors
that need to be taken into consideration in a foodweb of health-functional foods. Sec-
ondly, even though the single cases brought up many different issues they all had a Fin-
nish context as a common basis. This meant that in all the cases there were many com-
mon elements. In the following also topics that were not especially on the forefront in the
cases are also considered. In what follows, for the sake of brevity a foodweb means the
same as a foodweb of health-functional foods unless otherwise mentioned.
6.1. Structural properties of the foodweb
Structural properties of foodwebs are analysed using the framework developed in section
3.2.2. Product development is a structural part of a foodweb but because it is of impor-
tance in this study, it will be evaluated separately.
6.1.1. Foodweb activities and activity patterns
Activities
It was assumed that in a foodweb there are at least two kinds of activities: production and
consumption. Based on the cases it seems that such a division is too simple. There are
other activities that also have a significant importance. Based on the cases three addi-
tional activities were identified which were of significance in all the cases: research,
marketing, and regulation (Figure 19). Research is used here in a broad sense to refer to
an activity that produces new knowledge. Marketing is thought to consist of a positive
and intentional relation formation in a web. Regulation in turn is an activity that gives
directions to operations in a web. In a foodweb the relation of activities to products are of
special interest. Therefore it is the new knowledge of products, the relationships that have
a product dimension, and the regulation that concerns products that are of primary con-
cern.
research   production     marketing
consumption  regulation
Figure 19. Basic activities on foodwebs of health-functional foods
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In the following activity features are described that were found to be typical in a food-
web. They are not meant to be tested generalisations but they are more like initial hy-
pothesis based mainly on the cases and other information that was available.
Research was in a key role because it was the prerequisite for the emergence of the new
products. Especially scientific research was emphasised. It was typically demanded that
the basic validation of health-functional foods would have to take place using scientific
methods (of natural sciences). However it was not the scientific basis as such which
made the difference towards foods in general. What was different was the broadness of
substances that were considered. Also the post-oral influence of products in the body
went beyond that what has been typical in food context. This all meant that the scope of
research was broader than in case of traditional foods.
It was found that the production of health-functional foods has a diverse basis. Produc-
tion of health-functional foods is often an end process where different transformation
chains are integrated. The individual transformation chains often have no initial links to
food products but their main emphasis is on other product areas (e.g. wood processing
products, pharmaceutical products). There were also indications that in a foodweb the
outcome of the production, a product, and its qualities were more emphasised than the
process itself. This takes place if the safety aspects have been secured. Situation would
probably have been different if technologies were used towards which consumers are
more sensitive (e.g. gene modification technologies). This to some extent is in contrast to
the traditional food context where in many cases the way a product is made has more
significance for the consumers.
In marketing in a foodweb there were typically features of both business-to- business
marketing and service marketing.  The relationships were not only short-term exchange
relationships. There were long term relationships between commercial partners. On the
other hand there were also short-term exchange types of relationships for example be-
tween a research partner and a producer or a producer and a food authority. What makes
these interactions service type is that typically several actors were simultaneously in-
volved in a foodweb.
A difference to traditional foods in consumption was the importance of the informational
content of a product compared to the dominance of the hedonistic characteristics in foods
in general.  However, in the study there were no cases where the trade-off between he-
donistic characters and health-promoting content of foods could have been studied.  No
major compromises were made in traditional food characteristics. It could be assumed
that in cases where the health-promoting effect is of very remarkable value, even a senso-
rically inferior product could be accepted.
What was typical as far as regulation is concerned was that there were few specific for-
mal regulations specifically concerning functional foods. General food regulations were
applied to this product area. In many areas there were clearly self- regulation taking
place. The special properties of functional foods however meant that they located on the
boundaries of foods in the regulatory sense and small differences in interpretation of
norms could have significant implications on the product point of view.
In  regulatory approaches there seems to be a basic difference between eastern and west-
ern societies in attitudes in dividing the line between foods and medicine. In the west
there is a more apparent tendency to separate foods and medicines whereas in east foods
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and medicines are closer to each other (see e.g. Weng and Chen 1996, Kojima 1996).
Part of this difference could be explained by the differences in current medical systems.
The development taken place especially in Japan though indicates that the differences
may have a deeper cultural origin.
Activity patterns
Even though the above mentioned activities can be positioned to form a linear chain
where each activity is carried out only once, it seems that such a situation is an exception.
A more typical situation was that the same kind of activity occurred many times. As an
example it was typical that research was carried out before and after production activi-
ties. A typical pattern was that firstly there was relationship that was formed between re-
search and production, secondly between production and marketing, and thirdly between
marketing and consumption. At every such stage product development had a different
emphasis.
It seemed also typical that it is not matter of one-time contact between activities. There
was a tendency for relationship formation, which also seemed to change the content of
the links. For example, at the beginning there seemed to be informal contacts which then
turned into more formal ones. This was true especially for activities taking place between
organisations. To which extent this is also true for activities, which take place within sin-
gle organisations, was not clear because such aspects did not get much emphasis in the
study.
An attempt was made to differentiate cases based on what activity was most emphasised
at the early stages of the development (Figure 20).  There were five cases and five activi-
ties, which meant that one case was allocated to one activity. This was very subjective
procedure and does not mean that in specific cases other activities were not emphasised.
Research emphasis  LGG
Production emphasis  Benecol
Marketing  Xylitol
Consumption  Yosa
Regulation  Hyla
Figure 20. Cases classified based on dominant activity
In the LGG case what was special was the broad international basis of the research. In the
Benecol case the key to the product formation was technological innovation that was
made in the beginning. In the Xylitol case the strong approach to include health special-
ists to foodweb meant that marketing activity was specially emphasised. In the Yosa case
it was the feedback from consumers that directed the product development. In the Hyla
case self-regulation was at the forefront as Hyla defined to large extent standards for low
lactose milk products in Finland.
A special activity pattern was noticed that took place in the case of Xylitol. It relates to
the internationalisation process. Here the commercial actors were in the leading role. As
a product was on the markets in Finland and international markets were approach there
was a tendency for a certain activity pattern that is here called network marketing. It
meant that there was an attempt to produce a similar process of network formation that
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had already taken place in Finland. It was more than just traditional marketing of services
or more tangible products. Typically there was an attempt to initiate relationships be-
tween research institutes, health professionals, food authorities, wholesalers and retailers
before or by the time the consumers were approached.  This same pattern was implicit in
all the cases to some extent but it was most evident in the Xylitol case.
6.1.2. Foodweb actors and actor coalitions
Actors
As was initially assumed different kinds of actors were found in different cases. It was
also observed that one-activity-one-actor type of an approach would have required analy-
sis on a micro level. In a higher analysis level actors typically appear within the institu-
tional settings that give them more permanency. As an example of the former it is possi-
ble to assume a temporary actor without permanent relations to any specific organisa-
tions. An actor would then be a temporary construction within or between organisations.
In this study the level of analysis was on a higher level and the institutional setting that
gave them permanency became more apparent.
Based on the findings from the cases four main types of actors were identified: scientific
research actors, commercial actors, authorities and consumers. Even though there are
links to the different types of activities described above, there is a clear difference. In
case of actors it is the permanency and dominance of certain activities that plays a deci-
sive role. For example commercial actors in the food industry also do scientific research
and also regulate their own activities but it is not their primary role.
Scientific research actors
In the cases there was no independent research actors specialised only to this area of re-
search. Research concerning health-functional foods was made in other research areas
and in forms of research programmes. In the Finnish context the importance of the area
has grown and it was for example a major part in a technology programme, Innovation in
Foods 1997-200017. However not all activities within that programme can be defined as
scientific research. Participants were food companies and research units and it was partly
the developments that were already described in the cases that continued.
In the cases the start of the development was often based on opportunities coupled with
good preparedness to react when they appeared. It is probable that many developments
still start similarly but as the field matures and more resources are directed to the area, it
is probable that the scientific basis broadens. This means that a more goal oriented ap-
proach will become possible.
Also at the international level, a typical situation was that research were made along
some other areas and that research on health-functional is based mainly on research proj-
ects. There were though examples of more permanent settings. An example of this is
Functional Foods for Health (FFH) programme18 at the University of Illinois in the USA.
What is important is to notice that there are a lot of research taking place that is not
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taking place as foods or even nutrition as the common denominator but that can actually
become of direct relevance to these areas. Example of such disciplines could be those
that are specially orientating to preventative measures in different medical fields and
those that study different biological phenomena.
Commercial actors
In the studied cases all the industrial actors were traditional food or food ingredient com-
panies. The business area that was related to health-functional foods was part of their
overall business portfolio. As the companies started to internationalise in this area, spe-
cific units were established. In the case of Cultor this meant an affiliation (Xyrofin) and
in the case of Raisio that a separate division (Benecol Division) was established. Among
the small businesses there are already specialised operators. In the Finnish context exam-
ples of such actors are Multibene Oy (salt replacers) and Omecol Oy (meat products).
Internationally it is much more difficult to assess the situation. There are big industrial
companies that are mainly active in the manufacture of foods, health products or pharma-
ceuticals, which are also interested in the area of health-functional foods (see Childs
1999). What attracts food companies are better profit margins. Pharmaceutical companies
used to consider this as a low profit area but as margins in drugs have become lower they
consider this a lucrative market as nutraceuticals can be brought to markets for a fraction
of the cost and less time than drugs (Brower 1998, 728).
If also the supply side of these industries is taken into consideration (e.g. agricultural
products, food ingredients, technology producers) there are many more actors already in
the business area. There is also a growing number of small businesses that are specialised
in certain specific area. The only area where there seems to be much less interest in the
area is the food service industry. In that area mainly retail chains have shown interest in
these products.
Industrial actors are not the only types of commercial actors in a foodweb. As the size
and extent of foodwebs grow the more there will be need for special commercial opera-
tors that support and integrate the foodwebs. An example of the existing group of com-
mercial operators is the printed media19 that is concentrated in this area. Their orientation
is typically business-to-business or specialist-to-specialist but it is possible that also me-
dia that address to general public will appear if the field becomes a distinguishable area
for general audience.
Authorities
The permanent food authorities on the field have naturally an important role to play. In
the Finnish context it was only in the case of xylitol that direct contacts were made with
administrators that handle questions linked to medicines. However, it seems that often
administrations concerning medical affairs are influential in this context at least indi-
rectly. For example if a specific substance is classified as a medicine this alone may pre-
vent the use of that substance in foods. There are, though, examples of substances used
both for medical and food purposes (e.g. vitamins)
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In medicines there can be separated two different kinds of medicine types: hard and soft
medicines that are  different from a regulation point of view. Hard medicines are typi-
cally those that can be acquired through authorisation by medical experts. Then there are
soft medicines; including the so-called over-the-counter products. It is specially the latter
group that is of special interest in the context of health-functional foods.
Usually anyone can buy over-the-counter medicines. There is seldom even age limits for
the sale of these medicines.  Depending on the outlet there is more or less expert advice
available at the point of  sale. In many cases these products can be purchased from the
same shops as foods. However, often there is an underlying expectation that the same
individual buying over-the-counter medicines and foods from adjacent shelves in a shop
is actually a very different person when it comes to rationality of choices. It can be asked
how valid is such an assumption?  If it is not, why are there then typically separate public
authorities for both product groups?
There are international organisations (e.g. WHO, Codex Alimentarius) that have regula-
tory power over questions also concerning health-functional foods. Usually it is though
that national level that has been of most significant importance in food regulation (e.g.
USA, Japan). That has been true also in Europe. Now what seems to be taking place
within the European Union is an attempt to centralise at least part of the food authority.
What is typical also both at EU and national levels is that health-functional foods have no
specific status within legislation.
It is not only public bodies that have authoritative influence on foodwebs. In these cases,
for example, the role of professional associations is evident. There are other types of
authority possessing bodies for example in research (e.g. ILSI20) that have a permanent
influence on the field. It seems also that on a temporary basis it is possible to assemble
groupings that can contribute as an authoritative actor in a foodweb (see e.g. the group
behind the Keystone Report).
Consumers
The question concerns how consumers should be defined in relation to a foodweb. Basi-
cally it could be assumed that every consumer has a unique position towards a foodweb.
There are no formal organisations that would unite them and make official statements.
There are organisations that represent consumers at a general level. Typical examples are
consumer organisations that aim to represent the interests of consumers. However, there
is a difference in thinking of consumers as members of a foodweb and thinking how con-
sumer interests in a foodweb are represented. There are also other representatives, like
health professionals, who can say that they also represent consumer interests, but who are
not actually the same as consumers.
A typical approach is to consider consumers as a segment within a general population.
Consumers then form a true virtual organisation that is not necessary very aware of each
other in a concrete sense. There are suggestions how consumers should be categorised
when it comes to health relates subjects Wrick (1995) suggested that consumers should
be segmented along the lines of health consciousness. She made a distinction between
consumers and patients who have already been medically diagnosed to have a disease or
for which they are at risk. Those who were health conscious and those who were at a risk
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were considered as the most potential consumers. A different approach is to classify con-
sumers based on more permanent attitudes on food and health related matters. Consumer
segmentation obtained in the HealthFocus trend report (Gilbert 1998) included the fol-
lowing categories: Managers, Investors, Strugglers, Healers, Unmotivated, Disciplines,
Wizard Managers, Savvy Managers, Casual managers. The problem with these ap-
proaches is that they do not very well describe consumers as active members of a food-
web.
It could be thought that there is an average consumer. According to Childs(1999, 81) a
definable nutraceutical consumer exists in the USA who is generally female, middle
aged, affluent and educated. However there are problems in generalisations. The Finnish
cases showed that fore example consumers using Benecol and Gefilus type of products
are very different as a group.
It can be asked do consumers desire products that are more health promoting? A pan-
European survey revealed that 70% of EU subjects believe that they do not need to make
changes to their diet as it is already healthy enough (Kearney 1999, s136).  As a health is
to large extent a subjective matter this has to be taken as a starting point. However, very
broad generalisations can be misleading. Decisions concerning foods are made at the
product level and even if it is thought that there is no general need to make changes in
diets, still individual products can be chosen based on their health-promoting effects.
Actor coalitions
In the following actor coalitions are examined only based on the number of actors that
have a significant role in a foodweb.  Significance refers here mainly to the role in devel-
opment process. Based on this a dimension is assumed where at the other end is one actor
and at the other  many independent actors (Figure 21).
         one major actor--------------------------------------many independent actors
Figure 21. Actor dimension
If the initial basis of actors was as reference point a typical example of a foodweb where
is one major actor is Hyla-case where the industrial producer, Valio, was central in all
activities. An example where there were several actors already at the early beginning is
Xylitol case (Finnish Sugar Co., University of Turku and Leaf Hellas). In other cases a
start-up took place with two major actors in a respective foodweb.  There were no such
cases where, at least based on the information that was available, a start-up took place
among several independent actors. This could also be interpreted that in the formation of
a foodweb there is a certain stage where the role of a few actors is critical for the future
formation of commercial products. On a longer perspective there was a tendency that the
number of actors in a foodweb was increasing even though the original actors still re-
mained in a significant position.
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6.1.3. Foodweb resources and resource constellations
Initially two types of resources were assumed to exist: natural resources and technology.
As resources of foodwebs were examined based on empirical data, it was found neces-
sary to add a third type of resource that would reflect more the direct human contribution
in the foodwebs. It is called capabilities. Capabilities consist of those human related as-
pects that make product development activities possible. As such the role of capabilities
is not a new finding. Also human resources were explicitly part of the resources in the
industrial network model. The significance of these, however, was not initially appreci-
ated as the content of resources in health-functional foodwebs was defined.
Natural resources
Natural resources have historically been considered to be of major significance in food
context. Natural resources usually refer to nature’s capability to provide raw materials for
food production. Food production has been directly dependent on natural resources. This
is also true in the  case of functional foods even though there are features that make the
situation different from many other foods contexts. It is not so much a matter of absolute
scarcity of resources that guarantee short term bodily needs but they are linked to more
elaborate needs. It is often the matter of scarcity of specific resources for specific pro-
duction.
What seems to be typical for functional foods is that the value of different types of natu-
ral resources is changing. In these cases a typical situation was that a substance that was
not typical in old foods was added to them. This actually meant that the basis of foods
from the natural resources point of view was broadened. Even more significant was the
importance of these new substances to the value of a product. Even though functional
foods often contain traditional materials, its share of the value of the product can be
small. It could be hypothesised that if there is certain amount that consumers are willing
to pay of foods and if there are new characteristics that foods are expected to contain then
there will be significant pressure to lower the costs of that part of a food product that
consists of standard commodities.
Functional foods need not to be based on significant changes in the nature of foods in
chemical or biological sense. There seems to be, however, a phenomenon that could be
defined as a change from natural to non-natural products. Previously it was natural that
there was shortage of foods. This resulted in famine. From a natural perspective a situa-
tion without famine is not natural. In the case of nutrients this same trend is obvious. For
example, it could be thought that in a natural situation there is at least a temporary short-
age of vitamins. A situation where foods always contain certain level of vitamins is not
natural. From nutrition point of view this variation is problematic. In case of functional
foods the situation is basically same even though the substance base is even broader. It
can be claimed that it is not natural to have a high and consistent amount of xylitol or si-
tostanol in foods no matter how beneficial they are from health point of view.
One question concerning the raw materials is their relation to traditional food material
sources. What was observed in these cases was that links to traditional basic natural re-
sources are weakening. Natural resources (e.g. from a forest) were significant as soon as
they had been processed to certain extent (e.g. xylose and plant sterols). What was im-
portant in these cases was the proximity to specific existing processes (wood processing)
and not to the resources as such. This was noticed especially at the early phases of
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product development. At later phases the basis of raw materials was typically widening
(e.g. from woods to plants in general) as more raw material sources were exploited.
What were actually been seen here were two different types of phenomena. Natural re-
sources can be considered as the basis for raw materials for production and they can be
considered to be a material-forming basis for new knowledge. The former emphasises the
physical volume and the latter the qualitative aspects of resources.  For example for
Benecol it was actually plant sterols that were the natural resource. Plant sterols already
existed they were not invented. A different question was how and in which context they
were produced.
It has not been typical to consider the human body to be a natural resource but the more
natural resources are considered as source for increasing knowledge rather than produc-
tion, the more relevant it is also to include also the human body as a natural resource.
Specifically the LGG case showed that the human body could be a natural resource. LGG
was a bacteria strain that was found to exist in the human gut. The human body was a
natural resource base for it.
Technology
The role of technology in product development in a foodweb is different than in a single
organisation context. Here the emphasis is on product related matters. For example, the
ways that actors in foodwebs used technology in to order to communicate with each other
was not examined. It was more the relation of technology to products that was of interest.
Despite this it is obvious that in many cases the role of communication technology can be
crucial, especially as it seems that technological development often takes place in a
situation where several development groups are close to the same technological solution.
Technology played a role in all the cases. There is however differences in how important
its role was. If only the production technology is taken into consideration it seemed that
in the cases of Xylitol and Hyla it was very much a starting point. In the case of Benecol
technology gave a key advantage and in cases of Gefilus and Yosa it was a necessity.
New technology opened up new possibilities. A good example of the new relationship
between foods and the body revealed by the new technology was the lactose intolerance.
The availability of certain nutrients (lactose as a carbohydrate) was not sufficient as there
were more or less permanent changes taking place in the body. In the case of lactose in-
tolerance there were immediate body reactions which made it easier to define the cause
and affect relationship. Using modern technology it was possible to go behind the obvi-
ous symptoms.
Capabilities
What the cases made evident was actually the crucial role of capabilities as a resource in
foodwebs.  A typical starting point was that natural resources and basic technology were
already available but what makes the difference was the capability to use them in a spe-
cific product development context. What was also noticed was the need for very different
capabilities in different phases of development.
In the cases all industrial actors were traditional food industry firms. As these firms en-
tered the new area of health-functional foods new capabilities were needed. In that sense
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there were different strategies concerning capabilities. Basically there are two different
approaches. Capabilities can be developed internally or acquired from outside. Raisio
(Benecol) and especially Valio (Gefilus) were examples of firms that had developed in-
ternal capabilities to enter also the body related research field and even they needed new
capabilities as the development process proceed. In the Xylitol and Yosa cases the key
industrial actors Cultor, Leaf Hellas and Bioferme relied more to external expertise in
this respect.
From an industrial actor perspective another critical relation is the product and customer
relation. Special capabilities are needed in order to direct this relationship. Ideally it is a
learning process where all the actors learn from each other. The cases seemed to show
that the capabilities that were sufficient in a Finnish context were not adequate in an in-
ternational context. This is partly probably based on the fact that the Finnish food indus-
try is not very internationalised.  A typical approach seemed to be that capabilities were
acquired from international partners who did not very much deal directly with food con-
sumers (e.g. Roche in Xylitol case, McNeill in Benecol case). This left gaps concerning
the capabilities to operate within an international consumer base.
There are also capabilities linked to regulation. Depending on the level they have
achieved development can be retarded or promoted.  Here the balance between self-
regulation and outside control is of significance. It could be thought that if there are high
capabilities in self-regulation there is little need for outside control.  What seemed obvi-
ous based on the cases was that especially prior to the EU-regulation became effective in
Finland, regulation was very much based on scientific and industrial actors’ self-
regulation in the foodweb. The role of the domestic food authorities was not very signifi-
cant. When the EU regulations came into force the situation changed and official systems
became more influential and visible.
Consumption also needs specific capabilities. In these cases the capabilities were not
linked to subjects like the capability to prepare foods in technical sense. The products
were either ready-to-eat products or products in which the preparation of food is simple
(e.g. spreading fat on a sandwich). Capabilities are more needed to take advantage of the
health properties taking into consideration for example the individual values and prefer-
ences, other food choices and economic resources.
Resource constellations:
Resources can be thought to consist of all the above mentioned resource types. A re-
source constellation could then be a combination of natural resources, technologies and
capabilities (Figure 22). It could then be assumed that in different development
processes different types of resources could dominate.
Type 1. natural resource – technology - capability
Type 2. natural resource – technology - capability
Type 3. natural resource – technology - capability
Figure 22. Resource constellations with a single dominant resource
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An example of a constellation where natural resources dominate, could be a situation
where certain natural resources or a rich variety of them are more valued at the same time
as technology and capabilities are in a more stable state. In technology or capability
dominated constellations other resources are respectively in a more stable state.
Based on the cases it seems that natural resources and technology-based constellations
are dominant especially in the early phases of the product development. It seemed that as
the development proceeded they did not become unimportant but their weight diminished
as the significance of capabilities increased.  Foodwebs based on the dominance of natu-
ral resources or technology may therefore be more unstable than those based on capabili-
ties especially in a dynamic development environment, because capabilities open up
more development possibilities for both natural resources and technologies.
6.2. Product development in the foodweb
As the development of products on the foodwebs was examined, four subprocesses were
identified which describe the overall development of the products. These four processes
were (Figure 23): choice of initial product characteristics, formation of product barriers,
product-related communication, and progress of product design.
* Choice of initial product characteristics
* Formation of product barriers
* Product related communication
* Progress of product design
Figure 23. Four subprocesses in the development of health-functional foods
It was seen that the initially chosen product characteristics are of major significance
also in the later phases of the development. The formation of product barriers refers to
the fact that not all the characteristics are changeable but that often as the development
proceeds many of them become fixed. Product related communication is important be-
cause it forms the basis for relationships within a foodweb. The progress of product de-
sign emphasises that there is continuity in the development.
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6.2.1. Choice of initial product characteristics
It was assumed that within products there is a hierarchy of characteristics. This means
that there are some characteristics in the products that are more fundamental than other
characteristics from a product point of view. In this study the starting point was that it
was the health-functional characteristics that were of special importance in a product.
What kind of characteristics?
It seems that there are two basic strategies in the choice of health-functional characteris-
tics. One starts by looking at health aspects. There are health-related factors and prob-
lems that are not specific only to certain foods even though they may have a relation with
foods. In another strategy specific foods are the starting point. There are no clear-cut
boundaries but it seems that of the cases examined Benecol and LGG were the best ex-
amples of the former and Hyla of the latter.
As the first strategy is being followed, it means that the actual choice of foods does not
take place until the characteristic and its relation to health has been established. Even if a
food is actually involved from the very beginning, there is always a possibility that a dif-
ferent foodstuff will be chosen that will provide a better context for the specific health-
promoting characteristics.
In these cases it was typical that the health characteristics were linked to a single sub-
stance. Even in the case of Yosa, which contained several health characteristics, each of
them was related to a single substance. In principle it could be thought that in a food
there are several substances that are linked to certain health characteristic (e.g. to lower
cholesterol). The single substance approach means that there is a strong dependency on
the qualities of that specific substance. The health related aspects could be taken into
consideration only to the extent that these qualities make it possible.
The health characteristic level starts in principle from an immaterial level. First, there is
the general level where different factors have a relation, for example, with the health
condition described as cardiovascular disease. Secondly, there are certain markers (e.g.
cholesterol) that indicate whether the risk of the disease is growing or decreasing.
Thirdly, there is a substance level that has a relationship with the markers. It is not until
we are within this third level that also the food level becomes of significance either for
the importance of whole foods or parts of them.
Typically in the cases there was a relation with specific medical states. The relation was
though not a medicine-disease relation. It is probable that the substances, at least at the
levels that they were considered, would have been classified as non-effective as medi-
cines.. Still the development of products was very much dependent on that relation.
Benecol, Xylitol and Yosa were particularly linked to the diseases that were considered
of major significance at the national level at the time their development started.
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The other strategy starts with foods. It is assumed that foods are health promoting to a
different degree. A key question here is how a food can be made more health-promoting?
There are several alternatives: A food product can be made functional (or more health
promoting) by using five different approaches (Roberfroid 1998):
1. to eliminate a compound
2. to increase the concentration of natural component or to increase the concentration
    of non-nutritive component
3. to add a component not normally present in most foods
4. to replace a component
5. to improve the bioavailability of food components
Approach number three is the one that is least dependent of the actual existing foods. In
other cases there is a foodstuff that is modified to make it more health promoting. The
problem here is that there are actually no reference points. Any change towards the
health-promoting direction can make the foods health-functional.
Who makes the choices?
In the cases that were investigated, the choice process seemed to be rather straightfor-
ward. There were usually no alternatives at least in the short term when the initial char-
acteristics were chosen. In such a situation it is actually the research actor who makes the
initial decisions, which from an industrial actor point of view becomes a yes-or-no situa-
tion.
If the situation is considered in the long term there are several actors that are involved in
the choice processes.  There is typically some major health problems that are considered
as more important than other problems for example from a national health perspective.
Cardiovascular diseases are an example of these. Resources are then allocated to the re-
search. The results of researches then form the basis from which different characteristics
can be chosen. If these research results reach the consumers it can be thought that they
actually make the choice and then producers can respond to that.
At the time the research was carried out there were no strong pressures from the con-
sumer side to demand foods with specific health-characteristics. A more common situa-
tion was that consumers just reacted positively or negatively to foods being offered. The
choices of health related characteristics were therefore to a large extent made by experts
in different areas.
Health-promoting characteristics in relation to other food characteristics
The substances that form basis of health-functionality may also have other characteristics
that are important from a food point of view.  The Xylitol case was an example of this.  A
sweet taste was a food typical characteristic for chewing gums and sweets. There are dif-
ferent ways to include a sweet taste in a food. There are for example different kinds of
artificial sweeteners, which are even tooth friendly, and do not cause caries. In the case
of xylitol the advantage of the xylitol as a substance was its physical structure which
made it possible to produce food products that were physically similar to chewing gums
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and other sweets made using sugar. Xylitol therefore contained both health-functional
and other food relevant characteristics.
In the Benecol case another food relevant feature is displayed. Margarine is a food even
though it is not eaten alone but is used in combination with other foods. It is not a food
supplement because it is a food itself but it is not an independently edible food.
There will probably be more and more such components in the future. This will add a
new dimension to the question of health-functional foods. Who is adding health-
functional components and at what stage to those foods that are being eaten at certain oc-
casions. Will there be for example health-functional “spices” in the future?
6.2.2. Formation of product barriers
A health-functional food is not an open bundle of characteristics, but there are many
factors that lead to the formation of product barriers. Previously, when the different
functional areas were examined some differences towards other product groups (e.g.
medicines, pleasurables) were considered. In here the perspective is more within the
foods barriers. Some barriers are explicit and some of them are implicit in a sense that
there are no written rules concerning them. What also has to be remembered is that in the
long run most of the barriers will probably change but in the short run some of them can
be considered to be fixed.
Body related product barriers
Not all foods have a similar position in food flow. For example if the desired body reac-
tion requires that a certain substance is ingested within certain intervals, it limits the
choice of foods. A product barrier rises between those products that meet these require-
ments and those that do not. This was evident for example in the Benecol case. In order
to lower cholesterol level a certain regularity in way the foods were used was needed.
Spreadable fats satisfied this requirement.
In case of Xylitol another requirement appeared. The mouthlag of a product became of
significance, If xylitol was simply swallowed in a food product the desired health effect
would not have been reached. There are not many foods that stay naturally in the mouth
for a long period of time. Therefore the body related factor gave a natural product barrier
for chewing gum and lozenge types of foods.
Food specific barriers
Health-promoting characteristics are typically not organoleptically recognisable in the
physically eatable product.  This does not mean that they are not of significance. There
may be changes in organoleptical quality as something is added, removed or modified.
Even though such changes may be positive in isolation, the problem is that there can be
strong expectations concerning the sensoric qualities of these specific foods, which can
make any changes intolerable.
One source of a food specific barrier is based on the fact that there are foods whose con-
tents are officially protected without link to sensoric qualities. These foods typically have
a specific cultural background that has led to a situation where there are specific norms
concerning the origin and the characteristics of these products. Health-functional
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characteristics can be added to these foods to a limited extent and therefore in those rare
cases where this is possible a further protection is achieved.
Patents and trademarks
Patents and trademarks are significant sources of product barriers. Especially in the early
phases of the development patents seems to be of significance. If development results
had not been patentable it is very probable that in most of the examined cases, the devel-
opment up to consumer products would have not been taken place. During the examined
period it became possible in Finland also to patent new foods. However, in the examined
cases it was mainly the results of the technological development that were patented.
It was also common practice to register trademarks for products. Trademarks also give
legal protection for an activity called branding. What was noticeable was the change in
significance that was given to trademarks. In the products that originated from the 70s
(Xylitol, Hyla) trademarks were merely logos given to products whereas later on they
were considered as integrated parts of branding and more attention was given to them.
Brands
Branding was one of the major themes for product development in the cases that came to
markets during 1990s. What is special in branding is that it directs the product develop-
ment based on social-and psychological factors whereas earlier products were produced
more based on technological development. A brand defines a space in the social and psy-
chological space. What this means is that the technical similarities in the products do not
necessary make them substitutable. From a consumer perspective health-functional foods
are not necessary comparable with respective basic foods but with other health products.
The examined products contained different layers of brands.
For example in the LGG case LGG was branded for experts whereas Gefilus was a brand
for consumers. Different aspects were emphasised when they were marketed.  In the
LGG –Gefilus case what was special was that branding took place within same enter-
prise. This multiple branding was more obvious as there was more actors in the foodweb.
Xylitol, although also a generic substance, was a brand name whereas Xylitol-Jenkki was
a consumer brand, although very much linked to xylitol, by a different company.
In all of the cases the brands were very much attached to a certain substance basis. There
were no brands that would have been more generally linked to health-functional foods.
Based on the information that was available this was not even very  common in interna-
tional context.
Information barriers
Consumers have few means to validate health-functional characteristics in concrete
physical sense. This means that the information attached to the product is of major im-
portance. It is of more significance than in the case of traditional foods where health re-
lated information is based mainly on the basic nutritive content.
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Information barriers are based on the fact that either because of a lack of information in
the absolute sense or if information is available, because of the actor differences in capa-
bilities to interpret the information, not all the products are in the same position. A lack
of information can mean that certain aspects of the products have not been studied
even these products may contain specific health-promoting features. The problem here is
that research itself does not make the products more health promoting but without re-
search it is not possible to validate their health-functionality.  Not all foods are equally
researched due to differences to the interest that has been shown to them.
Differences in consumption capabilities mean that even if generic information is avail-
able it does not lead to proper conclusions. Product can be overvalued or undervalued
based on misinterpretation of the information that is available.  The problem is not only
that of consumers but concerns many other actors as well. The faster there are changes in
the ways that information is produced the more difficult it will be even for experts to
follow the developments in the field and interpret the results.
6.2.3. Product related communication
In the foodweb there are as many communication links as there are actors in the web. In
every link there are special features. For example some have a formal basis (e.g. pro-
ducer-public authority) some are more informal. In some more interaction is needed
whereas others are more of a one-way type. In the following emphasis is especially on
product related communication with consumers.
Information media
Communication with consumers takes place using different kinds of media (Figure 24).
Electronic and printed media are typically associated with  advertising, which usually
means one-way communication. However they make also an interactive communication
possible even though printed media (e.g. posted letters) are usually less convenient for
that purpose. Personal media are used, for example,  as a health professional meet with a
consumer face to face or when consumers rely on other consumers as sources of infor-
mation.  
   Media
electronic
printed
Transmitter foods+ package            Receiver
personal
Figure 24. Types of media in food related communication
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In the food context the role of foods and its package as a media has traditionally been
emphasised. This is very much based on the knowledge that in many cases the actual
choice of foods does not occur until at the shop level.  It can however be assumed that
there are certain limits to these spontaneous choice processes. Not all foods are alterna-
tives, which can be used in making such decisions. Then it can be asked at what point are
functional foods included to food choices?  It can be expected that also other media than
foods and their labels are of significance specially before a health-promoting food enters
a consumer’s potential selection basket.
Health related claims
Health related claims have become one of the most debated subjects in the health-
functional context. They are thought to be of major significance when the consumer ac-
ceptance of functional foods is considered. It has even been suggested that the core cate-
gory of functional foods could consist of those food products that make specific health
claims on the packaging or advertisements  (Hilliam 1999).
This significance is understandable from a commercial actor point of view, if the choice
of health-functional foods takes place in a similar fashion as traditional foods, where not
very much information concerning products is looked for and the information is required
at the last minute just before the purchase decision. Health related claims are then ex-
pected to be able to convey the implications of the research to consumers.
What specially raises the issue is the fact that there is a lot of regulation concerning
health-related claims. In the Finnish context direct health claims concerning foods are as
a rule forbidden. This situation applies to most developed countries. In some countries
though health claims are approved for certain generic ingredients.
Health claims are not specified in the Finnish norms, but according to the FDA they are:
any claim made on the label or in labelling of a food, including a dietary supplement, in-
cluding “third-party” references, written statements (e.g., a brand name including a term
such as “heart”), symbols (e.g., a heart symbol), or vignettes, characterising the relation-
ship of any substance to a disease or health-related condition.21
Within health related claims in a broader sense nutrition claims are in a special position.
What is typical is that nutrition claims are more often allowed in advertising than other
types of claims. There are two basic types of nutrition claims. There are claims concern-
ing nutrition as a whole. Such claims emphasise the totality of the diet. They are usually
highly ambitious and not disease specific. Their purpose is usually to lead to more sig-
nificant changes in food habits than just a change in a consumption of single foods. An-
other type of nutrition claim is linked to specific details within the domain of nutrition.
For example concerning the advantages of vitamins.
Internationally there are different kinds of procedures for how health claims can be ap-
proved. In such systems health claims can even be extended to factual medical claims
(relationship with a disease). In a system that exist for example in Sweden and USA gen-
eral substance specific claims are approved whereas in other systems, for example, in Ja-
pan also food specific claims are approved.
                                                
21
 21 Code of Federal Regulations § 101.14(a)(1)(1995)
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There is also a third category of health related claims which is called functional (or
structural) claims. They are often permitted in the food context. In such claims there is no
extrapolation to the health level but they concern the relationship of a food and a specific
function (or structure) within the body. These claims could also be called expert claims
because obviously it is expected that it is the health experts who can evaluate the respec-
tive food’s significance for health.
Another factor concerns the tightness of the control of how the rules concerning health
claims are being followed. When the cases were examined it was observed that a tight-
ening of control was apparent in Finland as the significance of the EU regulations and
their context were increasing. In these cases the regulation concerning communication
was not a major barrier, probably because there was not yet very many such products on
the markets and the products that were on markets received a lot of free publicity in
which the relation to health was a major topic. It is probable that the more health-
functional products there are on the market the more important role will communication
related questions have. It is also probable that if health claims are defined in the above
mentioned broad sense and if the credibility of the control is going to be remained, a sig-
nificant control machinery will be needed, in order to monitor the daily activities on the
markets.
From a consumer point of view the basic problem with a health related claim is that they
indicate a direction but they make it difficult to assess when a change to use certain spe-
cific product is actually advantageous. Usually there are several ways to improve the
health promoting effect of a food flow. Every individual, however, sets limits to what
changes are optional and it is within these possible changes that a value of a specific
health-functional food product needs to be assessed.
This lack of clear reference points means also that health claims are actually context
bound. With time goes and as new improved products appear on markets the old claims
may lose their true significance.  Also the more there are different kinds of health-
functional products the more there will be pressures for more diversified claims, which
take into consideration the special aspects of individual products.  If almost every prod-
uct claims to be cholesterol lowering such a claim will probably gradually lose most of
its significance.
Labels
Because in the food context the physical closeness to products is so emphasised the role
of labels or in a larger sense the information close to a physical product in a place of pur-
chase in general is of major significance.  Then it can be asked what kind of information
is needed on the labels and what kind of information needs to be otherwise available?
From a health point of view every food has both positive and negative characteristics.
They could be called health active characteristics.  In principle it is not so much the in-
gredients than the outcome that matters. However, food labels do not reflect this. Other-
wise it would be required that a producer should have to know the content of its products
and then health active characteristics would be labelled, no matter how they became part
of the foods in the first place.   In a transparent information system it could be thought
that a large amount of information would be available in some form and only some key
information concerning most of the consumers would be required on the labels.
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Communication – behaviour relationships
It can be asked why communication concerning the relationships between foods and
health has been so regulated?  It is hardly that scientific information as such is too com-
plicated to be interpreted in order to make proper claims. There are many other products
groups which are based on use of scientific information and which do not need similar
regulation. It is not a matter of products that have significant negative side effects and
would therefore need to be controlled (like strong alcohol and medicines). However,
there must be reasons why they are considered as potentially harmful. Regulation of
communication is in today’s world a strong control mechanism.
The reason for this control is probably linked to the proper ways to achieve nutritional
goals. There is a highly recommended way to achieve a proper nutritional status, which is
based on the selection of certain traditional foods or food components. New develop-
ments are easily a threat in such a situation. It is not difficulty to find examples of such
potential conflict situations. For example, there are certain edible fats that contain nega-
tive characteristics from a health point of view. They are traditionally found in certain
foods. If ways are found to eliminate the negative aspects in specific foods, an obvious
conflict situation emerges. These fats are still harmful but no longer in these specific
foods.  The normative system is not well adjusted to cope with this kind of situation. It
cannot make product specific exceptions. Such a development is a threat because it com-
plicates the original messages. The easiest solution is therefore to rely on the old basis
and try to keep new developments on the sideline.
Food specific communication
It was proposed that health-functional foods are from the communication point of view
different from many traditional foods. The significance of indirect, especially cognitive
information was emphasised. This could mean that actually the value of a health-
functional food would be decided before it is actually tasted. However based on empiri-
cal experiences it seems that the situation is not as simple. Especially, the experience
from the LGG and Yosa cases indicated that it is difficult to anticipate which character-
istics are the most significant. It seems more realistic to assume that different consumers
weigh food characteristics differently.
From a communication point of view it seems that if all the communication is based only
on cognitively identifiable health attributes it will mean that only very specific types of
consumers are reached. It can be thought that based on the indirect information consum-
ers are being persuaded to buy health-functional products. Consumers thus become like
temporary members in a foodweb. In such a situation there is a risk that if the actual or-
ganoleptical properties do not meet the expectations customers would not stay but would
leave the foodweb.
Another risk is that the products are accepted based on their organoleptical qualities but
no extra value is given to their health-functional characteristics. In practice this could
mean that for example the price of a product will be considered too high and consumers
will leave or will not even enter the respective foodweb.  In the studied cases these risks
did not actualise but then it has to be remembered that the case were chosen because the
products had been successful and these risks were avoided. However, even these success-
ful cases seem to show that there are always communication gaps in the foodwebs. This
brings major uncertainties to the development process.
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6.2.4. Progress of product design
Progress in product design means that products evolve gradually. If the characteristics of
products are considered to be their elementary building blocks, then there are concerns
for bundles of these characteristics. Based on the initial assumptions concerning products
in a foodweb it is assumed that not all characteristics can be substituted at every phase of
such a flow. There are restrictions to what extent the design can take place.
Design properties
It can be assumed that the progress of product design consists of phases in which major
changes concerning products take place (Figure 25). It is not necessarily only one actor
that is influential in such a phase (e.g. the producer). It need not even be matter of only
one activity  (e.g. production).
phase 1    phase 2   phase 3   phase 4
Figure 25. Progress in product design
In the cases that were examined there were different kinds of phases that were critical
from the development point of view. The cases showed that such phases are complex in
their nature. For example in some cases the technological problems were so evident that
they formed a separate critical phase in the development (e.g. Benecol).
What was seen in the Finnish context was that individual actors were functioning rather
independently. Especially at the beginning of the development it was not typical that
permanent forms of co-operation (e.g. organisations) could have been formed. Develop-
ment activities were typically embedded in the existing structures of the actors. This
meant also very much reliance was placed on certain persons.
Design does not mean only changes in the physical products, although such changes are
common, it is also matter of the design of the image or mental picture of the product.  At
certain time interval, even if the physical product remains the same, the image of the
product may change significantly. Example of such change can be seen in xylitol-based
chewing gums. Even though the products remained physically practically the same, in the
1990s their image was very different from that what it had been in the 1970s. This also
indicated that as design takes place in a foodweb context, part of it can be considered in-
tentional and some of it unintentional.
There are also value-related changes taking place.  In contrast to the usual assumptions of
the value chain on markets, in a foodweb it seems that it is not a matter only of increasing
the value of a product. It may also be that for one reason or another the value at least
temporarily decreases.  For example a negative research result may cause such an occur-
rence. It also seemed that in a development process there is a certain tolerance for tempo-
rary decrease in product value if the expectations for future value are not being severely
reduced.
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Relation to a foodweb
Based on the cases it seems that behind the progress of product design, that can consist of
many different separate phases, on a foodweb level there are three major states: the inter-
nal state, transition state and open state (Figure 25). These three states could be
described based on the three basic elements of a foodweb: activities, actors and re-
sources.
Internal           Transition             Open
 state  state state
Figure 25.   Different states of a foodweb in the development of a product
In an internal state there is a limited number of actors and it is typical that there are no
major changes in actor compositions as soon as a core group of actors has been found.
In its activities research is very much oriented to basic natural or body-related phenom-
ena. Production takes place on laboratory scale and marketing means relationship build-
ing among the existing actors.  Regulation is very much based on self-regulation within
the foodweb and consumption is represented by assumptions concerning consumers. Re-
sources are local, natural resources, technology is aimed to produce robust products and
capabilities are based on the histories of the core actors.
In the transition state a foodweb itself orientates outwards.  New actors are still mainly
experts in different fields (e.g. health, business etc.). This same difference in orientation
is apparent in foodweb’s activities. Production is on a semi-industrial scale. Market re-
search is being done and outside relationships are formed. Outside regulatory aspects are
taken into consideration. Consumption is still dominated by expert influence.
In an open state the actor base is changing. This does not mean that the original actors are
not any more members but it means that as a whole actor base is changing for example as
consumers enter and exit the web. Activities are oriented very much along this openness
which means that the borderlines between what is inside and what is outside the foodweb
become more difficult to distinguish. The broader foodweb may then divide into smaller
sub webs dominated by different types of activities, actors and resources. On a product
level this means the emergence of differentiated products.
Dynamics of the progress
It is to be expected that the timeframe within which the development takes place vary.
Because it was assumed that different phases are not necessary commensurable,
another basis for comparisons of cases is needed. In the following, four key events are
chosen that can be distinguished in all the cases: emergence of the product idea, finding
an industrial partner, launching the product on markets, and beginning a major sales
growth.  These events are set on a time dimension in Figure 26. Only in the Hyla case
could the emergence of the product idea not be dated and also sales growth was relatively
stable during the period under consideration.
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    Product idea      Industrial partner  Launch of the product   Major sales growth
Xylitol          1972 <1   3   11
Hyla                           not identified
LGG             1983 4    3     6
Yosa             1987 8    1  < 1
Benecol        1985     3    8  < 1
Figure 26.  Time in years between key events in the development
When the dynamics in different cases are compared it is difficult to find clear patterns.
The most recent products did not necessarily reach consumers more quickly than older
products.  The more there was need for basic safety and clinical studies the longer was
the research period. Even if these tests can be rationalised to certain extent, it does not
necessary mean that research time will be shorter as new demands will arise concerning
what needs to be studied. What seems to have happened is that newer products are ex-
pected to enter major sales growth periods sooner than in case of older products. There is
less tolerance for organic sales growth.
It seems that any of the stages can take several years and that the total time from the
emergence of a product idea to the major sales growth, that means that consumers are
joining the foodweb, is easily over ten years.  A long development period means that
there are many uncertainties. If this is combined with the trend that sales are expected to
grow in an ever shorter time, this means that the timing in market entry is becoming ever
more important.
The above mentioned time periods do not give a picture of the intensity in the change. It
could be assumed that the shorter the time period the more intensive are the changes.
However this is not always so. It may well happen that in a development process, that is
longer in years, there are more difficulties than in another that is shorter in years. The
actual changes may then take place in a very short period of time. Or there can many dif-
ferent activities, actors and resources involved, which complicates the development.
Therefore, it is difficult to compare development processes based on very simplified
measures.
Factors behind differences in dynamics
In the cases examined only in one case (LGG) did the development start with a health
characteristic level. In the other cases the characteristics were already in those substances
that were to be basic substances in the products. The product ideas and a specific sub-
stances were linked to each other at the very beginning. In this latter case actually one
phase in the development is passed as the development starts from the material level.
One key factor that affected the time needed for development was the amount of research
needed to guarantee the safety of the product and then establish the health-promoting ef-
fects in clinical studies. The newer the subject under consideration the more such basic
research was needed. The safety issue seemed to especially cause concern. Clearly it was
difficult to evaluate how much research should be done at an initial phase, especially if it
was a matter of a subject that was already to certain extent known. To what extent it was
possible to rely on studies that were done with a similar type of substances or earlier in
time (see especially Xylitol and Benecol)?
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Research results were one of the most influential factors behind the progress of product
design both in a positive and a negative sense. Positive research results were a necessity
as the product characteristics were developed. However, as the Xylitol case showed
negative research results can have drastic consequences from a development point of
view.
With positive results it was also noticed that research results are not necessary univer-
sally accepted even though there is an assumption that scientific methods are same all
over the world and even when no differences based on population differences was ex-
pected to be. From the flow point of view this means retarded development as the results
have to be duplicated in different contexts.
Even if it could be assumed that after a process where health experts are first thoroughly
informed before consumers are approached, the sales of products would increase faster,
the cases do not support such an assumption.  In the case of LGG health experts were in-
formed of the developments even before actual products were ready. However it took
over five years until a more significant increase in sales was observed. In the case of
Benecol, the product was introduced simultaneously to the consumers and experts and
still the sales started to rapidly increase.
It seems that there are certain times when sales of the products start to increase, which
probably cannot be based on any single factor.  In the case of Xylitol this happened in the
middle of the 1980s and in case of LGG, Yosa and Benecol this took place in the middle
of the 1990s. It was only in the case of Hyla that a more gradual growth in sales took
place.
6.3. Change in the development environment
In this section the change in the development environment is under consideration.
A foodweb is an open system and therefore what takes place in the development envi-
ronment will affect the development itself. There are many change factors. The difficulty
is that there is seldom a clear causality from a certain single change factor to a certain
specific consequence. Usually, there are several factors that are needed to produce this.
For example it is well known that the proportion of elderly people in western societies is
increasing. However, it is difficult to predict what kinds of consequences this alone will
have for the development of health-functional foods. It is therefore not the intention of
this section to predict how the development of health-functional foods will actually take
place in the future, but to describe what kind of factors influence changes and how the
exploitation of these changes could possibly take place.
6.3.1 Change factors
In the following some major change factors are considered. It is not expected that the en-
tire field of factors be covered. The approach is very selective in nature. Especially such
issues are raised that have not often been considered in the context of health-functional
foods.
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1. Knowledge concerning human body
An increase in knowledge concerning the human body will probably be one of the key
factors affecting the development of health-functional foods. Clydesdale (1998, 417) pre-
sented a scenario for the components that will affect functional foods (or all foods) in the
future. According to this the development of health-functional foods will in future be
based on the knowledge that is acquired of the relationship between chronic diseases and
specific genes. As the genes are identified the impact of food ingredients on the gene ex-
pression can be studied. Combined with biomarkers that are used to predict development
of specific diseases, this would form the basis for the development of new individualised
health-functional products.
                  Genome
    Technology Functional foods           Gene expression
          Biological markers
Figure 27. The components necessary to define the physiological functionality of
foods in the diet Clydesdale (1998, 417).
There is also another aspect here that is based on the key role of foods as the material ba-
sis of the body. Whereas foods have been considered as a general raw material for re-
petitive bodily metabolism on a daily basis in fact they simultaneously affect other proc-
esses and the body structure in which those processes are taking part. As has been stated
above the influence of foods can probably be noticed even behind gene expression. In
fact there are no genes without foods first being involved. Modifying the old saying it
could be said that a body (including genes) could only be as good as the raw materials
(foods) that are used to build it.
2. Knowledge concerning traditional foods
As interest at the more and more elementary biological (and other material) level is in-
creasing this means that simultaneously the complexity of traditional foods is becoming
more apparent. It is already known that foods contain a large number of substances
whose health related significance is not known. It was previously not possible to examine
these substances. In the future this will change. It is very probable that some of these
factors will exhibit positive and some negative potential from the health point of view.
The wish to avoid negative factors and to strengthen the positive factors will be a strong
leverage that will validate changes in traditional foods.
Many foods are linked to natural cycles which mean that the characteristics that foods
have alter as natural conditions vary. In developed societies the link to natural cycles is
not any more so strong that it would lead to a lack of food in an absolute sense. A famine
is not a major threat. However, the more there are demands concerning the qualitative
aspects in foods the more probable it will be that there are situations where even the
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natural variation that is tolerated in today’s foods will not be positive from a health sup-
porting point of view in the future. This does not only concern the open nature conditions
where foods are produced but that also natural processes that take place in factory type
settings. In fact, the whole physical food chain causes a certain natural variability that
will affect the health-related quality of foods.
3. Technology
Technology plays an important part as a change factor. Information technology here does
not mean only information technology in social communication. Of special significance
is technology that makes it possible to receive information from nature. In this case the
sensors put into the nature are of specific importance. The more sensible and specific the
sensors are the more deeply it is possible to go to gain knowledge about it. This means
that natural processes can be followed more closely in their early phases. Like in social
communication the more capacity there is in technological sense, the easier it is to follow
natural phenomena even on-line. Natural phenomena taking place at a molecular level
can be magnified and visualised to make them easier to follow. This in turn is of impor-
tance when issues are looked at in a social context with an intention to raise interest to-
wards them.
Materials technology has advanced and it has become possible to operate on a miniature
scale in nature. It is common to modify natural macro objects (like plants) by different
technologies. Now more precise modifications are possible even on the micro (cell) level.
Technology can even be embedded within natural objects. It means that new opportuni-
ties are opening also to steer existing food processes. This will open up new possibilities
for controlling and directing the formation of health relevant factors in foods. The tech-
nological focus in food production changes. As the primary production of foods takes
place on a molecular and cellular level, then it is only of secondary importance whether it
will be taken into industrial scale on a field or in a factory. If a cell is considered to be a
factory it can be asked how small is the relevant size of elementary food components?
4. Social trends
In developed countries the ageing of population is one of the major tendencies that is of
significance when health related matters are examined. Age brings with it special re-
quirements for the nutritional content and for example organoleptic properties of foods.
People who have already reached a later senior phase in their lives, probably value the
readily apparent effects rather than the very long-term effects in their foods. This means
that for them the area between foods and medicines will be of special interest.
Children and teenagers learn their food habits at home, at school, and from their friends.
Their food choices are also influenced by youth culture. In the relationship between
youth culture and health there are two different aspects. Firstly, it can be thought that in
youth culture health is of certain value as such and secondly it can be thought that youth
culture can have positive or negative influence on health related matters that is not inten-
tional. For example, a growing tendency in Finland has been the growth of number of
pupils at schools who choose a vegetarian diet. However, it can be asked what are the
directing forces in this development. Is it long-term health concerns or more temporary
social pressures?  There is no certainty that young people will start eating healthier diets
than their parents. What is a fact is that from health-functional food perspective young
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people are an important group because in their case the long-term perspective is of most
importance.
In matters of health consciousness of consumers in a food context, it is the middle-aged
women who are the most knowledgeable of the relation of foods and health (see e.g.
Childs 1999,81). What is of importance here is that their influence is not only limited to
themselves but for example they are often responsible of the food purchases of families
and typically they have a significant role in public and commercial foodservices.
What has been a major trend also in food context is the growth of service type of opera-
tions. More and more service type food solutions are expected to appear. Typically food
services have been linked to the very physical preparation of foods. As health-functional
foods are concerned the information content is of special importance. This means that in
food service these aspects should be taken also into consideration.
Despite all the changes in food context there also seems to be a significant inertia in
changing food habits. For example in the USA the top-ten lunch/dinner entrees consumed
at home in 1996 were almost the same as they were in 1987. Only the order of these en-
trees had changed (Sloan 1998,37). This does not tell us whether the content of these en-
trees, which is more significant in health sense, has changed.  Also it does not tell about
changes of the roles of these entrees in relation to other food components that are used
daily (e.g. snacks). However, the more difficult it is to change food habits the more vi-
able option it is to change the composition of those foods that are part of the food habits.
5. Food related policies
There is no single policy area that affects the development of health related foods but
there are many policy areas that are of relevance. Especially of relevance in the health
context are nutritional policies because they deal explicitly with food and health related
matters. The policies consist of subjects like what are the aims of the policies, who are
key parties involved and what are the means by which these aims are to be a ttained.
Traditionally the nutritional policies have been targeted on a national level, they concern
the average consumer, and the means that are used are very traditional There may be spe-
cial groups, who do not get proper attention as the focus is on the national level. Every
consumer is also different and therefore it can be assumed that the more there are differ-
ent means by which certain health objects can be attained, the more probable it is that a
proper combination that suits a specific consumer can be attained.
Agriculture provides most of the raw materials for foods. Agricultural policies therefore
directly affect the development of health-functional foods.  For example there are ques-
tions of what are the incentives to produce special raw materials for health-functional
foods. Why would a farmer take into consideration special demands that the production
of such materials might require? Compared with, for example, production of organic
foods these requirements could be more demanding as there are often more specific re-
quirements concerning the content of foods. It can be asked whether agricultural policies
support such developments or whether they more support production of traditional food
commodities and respective raw materials.
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It is probable that new questions will arise involving consumer policies? For example a
situation can be assumed where products are being developed which give significant
health benefits to certain consumer groups but the prices of which become so high that
they practically prevent the use of such products. Then it can be asked should there not
be financial measures taken that make those products available to these specific consum-
ers.  The general question of what kind of foods should be available to citizens of a na-
tion is a complex one. In a developed country it can hardly be the aim that only the daily
subsistence level is guaranteed.
In the long run health policies are dependent on changes in general attitudes. It is already
known that some food products cause negative health effects.  Often it is tradition that
validates such products. In the long run changes are possible. What can be learned, for
example, from the development in tobacco industry is that at some point a producer of
traditional products  that cause negative health effects, can become responsible for the
negative consequences that the products cause. It is not impossible that at some point in
the future also a food producer might be held similarly responsible.
6. Changes in the health care system
Significant increases in costs in health care systems have been a major trend in developed
countries.  There are many reasons for this like ageing populations, new advanced treat-
ments for diseases and generally the growth of medical domain as far as the body is con-
cerned. To slow down the increase one alternative has been to put more emphasis on pre-
vention of diseases. It is here that the role of functional foods are of special significance,
because there are many diseases where there is a causal link between foods and diseases.
In principle, it is already possible with proper selection of current foods on the markets to
achieve positive health effects. For individuals it usually means making significant
changes compared with their present food habits. However, it can be expected that
change of habits are difficult to achieve and if such changes are to be made a lot of re-
sources have to be available. It is doubtful whether such resources are available in future
taking into consideration the general trends in health care. Health-functional foods could
be considered as an alternative way of achieving the same goals, which would bring with
it cost savings. In the USA it has been found that with health maintenance organisations
there is already an interest in using nutraceuticals to maintain patient health, and to re-
duce prescription costs and the number of office visits (Brower, 1998, 729).
On the other hand, the need for more information is a factor that increases costs.  If
health-functional foods become mass-market products just like current foods the costs
will not necessarily be very significant. However, the more there is pressure towards in-
dividualised products the more there is also a need to first invest in supporting infra-
structures which make it possible to analyse and monitor individual needs that are then
used as a basis for the development and production of new foods.  It is questionable
whether such investments will be done only for food related purposes. If they are done
for example for medical reasons, they could be used also in the food context.
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7. Return on invest opportunities
For commercial partners to get interested in the area there have to be profit opportunities.
It is useful to examine the subject based on a return on investment approach as there can
be seen two different basic starting points in one investments have already been made in
the other investments have to be made in the future.
When there are investments that have already being done and which are not fully utilised
it means that in principle the return on investment can be lower, at least temporarily, than
in case of a new investment. There are many parties that have already made such invest-
ments that are of significance for health-functional foods but which have not been util-
ised in the food context. An example of such obvious parties are actors operating in the
pharmaceutical context developing new medicines.  The more there are new investments
that need first to be made the higher will be needs for return on investments and conse-
quently the higher will be barriers to invest on this area. This is typical in traditional food
context.
Based on the cases it seems that the role of the various capabilities are critical. Invest-
ments in infrastructure and technology are necessities but the returns are very much de-
pendent on the development of different kind of capabilities. For example not only in-
vestments in research capabilities guarantee commercially successful products. They are
as well dependent on how many consumers invest in new consumption capabilities.
What also influences expectations concerning the return on investment are uncertainties.
In the case of functional foods there are more uncertainties than simply uncertainties
concerning the acceptance of products by consumers. For example there is a continuous
uncertainty concerning research results.  There is also uncertainty concerning product
approval and if a product is approved what kind of communication is allowed.  On the
other hand these major barriers also protect those products that succeed getting in pass
them and consequently increase the return on investment opportunities.
There are many bioingredients that used to be part of specific natural products, towards
which there has been only a little commercial interest. This has led to concerns that this
would lead to a situation where most biomaterials will be patented and the natural prod-
uct industry will be completely controlled by pharmaceutical multinationals (Rona 1999).
This same concern could be raised in case of foods. New foods altered in some respect
from traditional foods can already be patented.
8. Globalisation
Globalisation has in traditional food context been seen in the context of the differences in
food habits in the relationship between national cuisines and respective foods. This basis
is different for functional foods, as it is more based on body related differences. There
can be factors that are related to differences in race or some other genetic factor that unite
consumers in different parts of the world. In principle even now there could be actors that
serve globally, for example, consumers suffering from celiac.
In the foodweb context it is not only a matter of globalisation among certain types of ac-
tors, like firms. Research actors, authorities and consumers have a global position as
well.  In the food context such a positioning is not very typical even though there are
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global firms. In the pharmaceutical context research, production and consumption are to
a large extent global. Probably consumers are seldom interested inn the country of origin
of a certain medicine.
Globalisation means that the control of communication becomes more difficult as the
borders between nations do not hinder information flows.  Technology makes it possible
for an individual to search for globally available information. For example if health
claims are allowed in one country but not in another, it will become more and more diffi-
cult to prevent information from spreading among those who are interested in a certain
issue.
9. Environment
Environmental changes have effects both on the body and the foods. The body is influ-
enced both by heritage and environment related factors. There has been a lot of interest in
heritage and gene related factors. It is probable that environment related factors will also
continue to be of major significance. Whether it is a matter of an individual with the right
genes in the wrong environment or with the wrong genes in the right environment is not a
major issue in a food context. In every case there will be new challenges to the develop-
ment of health-functional foods in future as foods need to be adjusted to new demands.
6.3.2. Dynamics in change
When the dynamics of change is considered three types of changes can be assumed.
Gradual changes in which there are minor developments taking place one after another.
Radical changes, which means that major changes take place within a short period of
time. A third alternative is based on a learning type of a process in which the structure
and the way of operation changes.
Gradual changes are probably the most common type of change. There are continuously
changes taking place in the foodwebs and in the development concerning functional
foods. What is special for food products is that the changes that are taking place are not
always very obvious at the physical product level. Or at least in appearance there are
many food products on the markets that have not changed very radically in hundreds of
years.
Radical changes take place, when food products that have never before existed appear.
Radical here is a relative concept. It can both relate to physical appearance or content but
in health context it is mainly related to content. An analogy can be taken from another
necessary product group: clothes.  Clothes also have certain basic features, which have
remained unchanged throughout history.  In  the case of raw materials at certain periods
of time new materials have appeared besides the traditional ones. There are also notice-
able changes in styles when clothes from different periods of time are compared.  Behind
these changes there are also the changes that have a health dimension. Even it can be ar-
gued that new clothes are not necessary more healthier in all respect, it is very probable
that if it were necessary to rely only on old raw materials it would be detrimental to many
health aspects.
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What is a radical change in clothes is not the appearance of a new material as such. It is
the combination of a raw material in a product used for a special purpose. New raw mat e-
rial can be used in many ways in combinations with old traditional raw materials.  It may
mean for example lighter, more protective clothing. There is no reason to assume that
these same considerations could not be valid also in a food context. New foods and food
materials are probably not superior in all conditions, but they add new possibilities to re-
spond to the needs of modern times. It can be asked how food ‘nylons’ and modern cas-
ual foods should be compared with more traditional materials?
It could be asked what kind of changes could trigger major changes in foodwebs or in the
development processes of health-functional foods. Technology combined with research is
a major potential trigger of such changes. For example if a new health relevant layer is
found behind the nutrient substances that are currently considered as critical from health
perspective. Radical changes could also take place if specific links between genetic fac-
tors, foods and diseases could be established. These kinds of findings would alter the
whole basis by which the value of foods can be assessed in health context.
A major change could also take place if some regulation barriers were removed. For ex-
ample concerning the commercial communication with consumers. It would give new
incentives especially for the commercial actors in foodwebs but also for all others who
are potentially included in a process that aims to develop new commercial functional
foods.  What makes such a change appear radical is that probably in the beginning there
would be overreactions like in most cases when a major regulated phenomenon is freed.
If a long perspective is taken even dramatic changes are part of a gradual change. For ex-
ample Elias (1978) studied changes that have taken place historically in meal habits un-
der the theme of the civilisation process. Civilisation was considered as a long process
that took hundreds of years. It can be assumed that in the food context there are similar
processes taken place that are not only limited to the consumption of foods. Besides meal
habits also the selection of raw materials, processing, and preparation of foods have
changed. Certain products simply fit better with new conditions. It could be argued that if
meal habits today are more civilised than before the food system as a whole is probably
more civilised than it used to be.
Change that is attached to a learning process can have gradual or radical nature. What is
special is, however, that due to the learning process is not only a single incident or col-
lection of such incidents but it is related to the behaviour of foodwebs or especially to the
product development activity in them.  As a result of learning there can be many kinds of
changes. What is typical is that they have a relation to the past whether it is based on
one’s own activities or whether it is learning from others.
A typical area in case of functional foods has been that linked to research. A learning
process is needed in order to be able to assess to what extent and to what kind of research
it is necessary to get involved and for example what kind of new resources are needed.
This does not concern only commercial firms but other actors as well are included in this
learning process.
What is evident from this study was that consumers were also involved in the learning
process and at certain point of time they were ready to participate in a foodweb as con-
sumers. When the physical products are being introduced to consumers it is not an end of
the development process but it actually means that the development continues with
123
consumers being potential members of a foodweb.  All that is happening within a food-
web and even outside will give input also to the learning process that consumers are in-
volved in.
7. Discussion
7.1. Conclusions from the study
The overall purpose of the study was more to describe and to increase understanding than
to explain and to predict the development of health-promoting foods. What was noticed
was the difficulty of fully separate these two different approaches. Especially the de-
scription of a foodweb of health-functional foods on a general level is inevitably inter-
twined with explanation and prediction. However, these should be seen from the per-
spective of a qualitative research and therefore they are very tentative in nature.
There were four questions that needed to be answered in order to fulfil the aims of the
study. They concerned the position of health-promoting foods within other foods, the
content of a foodweb as a framework for the development process, the special problems
encountered in an empirical development context and the initial generalisations that
could be made concerning foodwebs and product development in this special context.
Even though these questions were presented separately they are to large extent interre-
lated.  Answers to one of those questions were dependent on the answers given to the
other questions. This made the study particularly challenging, as there were many differ-
ent kinds of themes that have to be dealt with.
As an example of these interrelationships, the significance of the first two questions can
be examined. When the position of health-promoting foods within other foods is con-
cerned, a new reference point of body-centred foods was compiled. Foodwebs were in
turn based on the industrial networks, which gave a framework to describe development
processes. The former helped to understand the possible development directions and the
latter the actual development. If either of these had been lacking, it is probable that many
empirical developments would have been less understandable than they were now.
The study revealed that it was not only matter of foods. The relevant question concerns
not only the position of health-functional foods within foods in general but within a
larger spectrum of industrial consumer products. It has been usual to refer to tradition in
a general food context. However, the more technology brings new opportunities and the
more there are actors who come outside the traditional area of foods the more difficult it
is to rely only on tradition. It seems that health-functional foods are part of a change
where the traditional area of foods is becoming ever more diversified and where foods
overlap even more with other non-food product areas.
It is difficult to predict what will be the future of functional foods. It may happen like
Winkler (1998,193) suggests that “ In time, the term ‘functional foods’ will lose its con-
notations of futuristic trendiness and may be discarded. But the perspective of function-
ality will continue and strengthen….”. To this could be added that on a longer perspec-
tive it may happen that even the term “foods” will be discarded at least, as far as con-
sumers are concerned. What is then ingested is a composition of what is now called
foods, medicine, pleasurables etc. under different brands targeted for specific individuals.
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At the present time functional foods (or equivalent concepts) however seems to form a
valid concept under which certain developments that are taking place in food context can
be examined.
Compared with the traditional approach in food product development (see e.g. Graf and
Saguy 1990 ) this study had a new perspective.  In organisation centred development the
emphasis has been on the concurrent participation of actors representing different organ-
isational tasks. What was specially emphasised in this new approach is the breadth of
factors that influence the product development. Product development is not an isolated
activity within a  single organisation. Specifically it would have been difficult to describe
and understand the development processes of health-functional foods starting from the
traditional producer-consumer or producer-customer dyads.  What would probably have
happened in such cases is that the role of those activities, actors and resources that did
not take place or were located within the focal organisation, would have been underval-
ued.
What is also obvious is that the traditional food chain approach (see e.g. Street 1990) is
not very well tuned to development aspects. The idea of a food chain emphasises the
constancy of products and the repetitive nature of their production. In a development
context it would either mean only minor changes or such a distant perspective that all
changes are minor changes.  However, it is possible that as/if health-functional foods be-
comes an established part of food products, there will also be development processes that
will justify an analytical approach based on a food chain model.
This study indicated that in very many cases there are activities and actors that are not
part of the traditional food chain but which are of crucial importance from a product de-
velopment point of view.  In this respect it seems that the foodweb approach represents a
change towards market orientation where the value chain and the value of a product is in
a dominant position irrespective of the specific types of activities or actors.
Foodwebs can be considered as a change towards market orientation also in another di-
mension. This is due to emphasis on products in a foodweb. Products can be assumed to
form an essential part of markets. Not in a specific technical sense but as a basis of
valuation.  It is  very difficult to assume markets without products, even though the con-
tent given to products can vary. Even relationships can be considered as products. In
health-functional foodwebs the starting point is the industrial network structure where the
relationships between industrial actors dominate. Product development also takes place
mainly between these actors. Markets in turn form a more complex setting for exchanges
and interaction where industrial actors are in monopolistic position in only specific cases.
Products are not only important in the foodweb structure from the market point of view.
Compared to the basic model of industrial networks (Håkansson 1987) the foodweb
framework could be considered as a special case where a specific activity - product de-
velopment- is raised to a dominating position. However, when it comes to product devel-
opment it can be argued that it is matter of critical activity within industrial networks. It
is a key ingredient that ties networks together. Industrial networks are not just social net-
works even though they are also social networks. They are also not only economic net-
works where pure price values would dominate. To demonstrate the value of a product in
networks it could be assumed that there are no products, not even ideas for products. A
very critical part of the identity of networks would be missing.
125
What was necessary to elaborate was the content given to concept of product. A product
is not only a tangible exchangeable item or even an intangible service product produced
by a firm and its customer.  In a foodweb there are many different types of actors with
different interests all of which do not have similar influences on products. A product is
therefore not a homogeneous structure of attributes but it consists internally of hierarchi-
cal layers. What in a market context are choices made by a producer and a consumer
concern typically only some layer of attributes within a total product.
The well-respected model of dominant designs22 represents another approach to the sub-
ject (Utterback 1996). In that it is postulated that a dominant design appears usually due
to major changes in the background factors. For foods it could be assumed that there are
several levels where dominant products can appear. If foods were seen from a distance
some dominant products could appear that were considered to be new dominant foods.
They could represent for example foods typical for specific decades.
On a closer look it can be thought that there are dominant food products, for example,
within health-functional foods. It could be though that in case of foods the new dominant
foods are foods that break in some sense the typical boundaries for foods. They would
respond to different questions than the old foods. What this study shows is that evidently
there is a change going on that will lead to new dominant foods to appear. Whether those
already on the markets are dominant products was not of concern in this study.
The foodweb, as it was derived from the model of industrial networks, was described on
a very general level. In examining the cases were examined it was used mainly in order
to assist the description of cases.  There was also the intention that based on empirical
data, a foodweb would be constructed in order to describe the general characteristics of
the development of health-functional foods. Because the study was very much based on
cases and it was not possible to assume that they would represent the whole phenomenon
sufficiently, the respective foodweb (Figure 28) is hypothetical in nature.
Activities and activity patterns
    - research, production, marketing
  regulation, and consumption
Product development
- initial choice of product characteristics
- formation of product barriers
- product related communication
- progress of development process
Actors and actor coalitions       Resources and resource constellations
- scientific research-, commercial-, - natural endowments, technology and
  author-, consumer actors   capabilities
Figure 28. Hypothetical foodweb of health-functional foods
                                                
22
 Dominant designs being those that win allegiance of the marketplace within a product class (Utterback
1996).
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The activities that are often considered only on an organisation level were extrapolated to
the foodweb level because empirical reality seemed to show that this is the case. For ex-
ample it is not only firms that perform marketing. Research institutions and public bodies
have for a long time been involved in the marketing of issues such as proper nutrition.
Actually it is matter of different types of activities. They could have been given different
names but in this study the use of activity categories typically used in business context
seemed appropriate. It is another question whether the quality of the respective activity is
good or bad from some specific perspective. In this study, however, it was not the pur-
pose to assess the quality of any specific development process or part of it.
There seems to be two basic strategies that industrial firms can follow. In one the mini-
mum amount of research is done to meet different demands. Another strategy is to do
research that goes well beyond these minimums.  In the former case research is consid-
ered as a necessity that needs to be done. An industrial partner acts like a reactor to dif-
ferent demands. In the latter case research enables a more powerful position within a
foodweb to be acquired. An industrial partner is also a proactor in the foodweb.
Actually no specific assumptions was made concerning actors other than that they were
not necessary the same as formal organisations. What was learnt is that trying to deter-
mine the actor basis is a difficult task. This was one of the main shortcomings of the
study. A formal organisation or part of it gives a specific context. In this study the per-
spective was however not on administrative questions and therefore the relationship be-
tween a specific development process with formal organisations or with other develop-
ment processes taking place in this context, was not explored.
Another approach to define actors would be to start from the individual level. This would
though have required very detailed knowledge of the case and would probably best be
suited to a single case study. In this study much reliance was placed on the opinions of
the interviewees in how they spontaneously interpreted the role of individuals. Individ-
ual’s roles were not explicitly asked for. What was noticed here is that in some context
and some interviewees it was more natural to bring out the role of individuals whereas in
some other contexts and with some other interviewees it was more natural to emphasise
the collective effort.  All in all it is evident that more should have been done to define
properly the informal actors that lie between individuals and formal organisations.
What was found also in this study was that compared to typical traditional food devel-
opment projects different resources are needed.  Natural resources have been in a key
role in many traditional development projects especially the more foods have been con-
sidered as natural products. It can be argued that even health-functional foods are natural
products, but then the content of the concept is very different.
When technology as a resource was examined a broad basis of technology was observed.
Technology is not always directly related to something to be achieved. What has been in
a key position even in the food context has been technology that makes the new informa-
tion concerning nature possible.  It has opened up new views to nature and makes possi-
ble controlled operations in this new microcosm. It seems that in product specific tech-
nology there are often combinations of general food technology combined with other
major technologies. It is probable that for example combinations of traditional food tech-
nologies with new information and biotechnology will have major significance in the
future.
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Development of health-functional foods clearly shows the broadness of capabilities that
are needed as products are developed. Capabilities from many different professions and
individuals with very different backgrounds are needed. It is however not necessary that
they have to be located in a single location. In most cases it is not even possible to as-
sume that a self-sufficient development within a single organisation would be possible. A
key special capability in this context is related to consumption. Consumption capabilities
here do not mean the same as how products are physically prepared or eaten but they are
more related to how products are used as bundles of information. How a consumer can
relate a product in relation to his/her health needs.
The role of health experts in the foodweb is important not only in the research phase but
also, when consumers are involved in the development. It is often a matter of such com-
plicated subjects that it seems that it is even for a well-informed consumer difficult to
take a stance on a product. When it comes to health experts it seems that in many cases it
is easier for those that work within medicine to see the positive contribution of these new
products than for those working with nutrition with strong ties to specific nutrients and
traditional foods.  This is understandable because in medicine a specialisation has devel-
oped and the contribution of these new foods is seen from the point of view of this spe-
cialisation.
The cases that were examined were often pioneers in their field. There was a lot of dis-
cussion concerning them and they received a lot of publicity. This meant that commercial
communication with consumers was only part of the total communication. The regulation
concerning specially health claims was then not as crucial as it can be if a new product is
entering markets and the general media interest on the subject is not as high.
When it comes to consumer acceptance it was seemingly difficult to anticipate consum-
ers attitudes because it was a matter of significantly different products compared with
traditional foods. Consumers were used to link foods, nutrients and health but in these
products it was in many case a matter of links between foods, unfamiliar substances and
specific diseases or corresponding unbalanced body states. However, it seemed that there
was a significant proportion of consumers that were ready to accept these new solutions
and buy the respective products.
Analytically a distinction was made between the development of products and the devel-
opment of the foodwebs that lay behind them.  This did not mean that product develop-
ment is a separate activity within foodwebs. It meant that the development of products is
a result of the functioning of foodweb and that the development of products has to be
considered at a general product level, which consists of product characteristics. Based on
the empirical findings it was concluded this development could be described under four
themes: initial choice of product characteristics, formation of product barriers, product-
related communication, and progress of the product development process.
In the product development process the beginning seems to be of crucial importance. It
was already at the very beginning that the basic feature of the products was established
and usually they did not change significantly as the development continued. By the time
the products were introduced to consumers they were already in such a form that the con-
sumer was left only with the choice of either to buy or not to buy the product. It also
seemed that in many cases the opinions of experts differed. There were some that sup-
ported new developments and some that did not even if they did not deny the results of
specific studies. Usually a result concerning physiological effects was just a starting point
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and many other factors were taken into consideration as the results were interpreted in a
social realm. The internal and transition phases were not necessary smooth and trouble
free.
Formation of product barriers is of major significance in product development.  Usually
this is considered only at the level of barriers to existing commercial products. From the
development perspective the question of barriers is far more complex as along the devel-
opment path the question of product barriers comes up in many phases. The kinds of
characteristics included in a product influence the shield that a product gets from other
products. Even in the health-functional food context it seems that health-functional char-
acteristics are not the only source of barriers that needs to be considered. Traditional food
characteristics are of significant importance.
Product related communication was of specific significance in the health-functional food
context as there are special uncertainties concerning communication possibilities. They
especially concern communication with consumers of the characteristics that are the core
of the health-functional foods. In the cases that were studied the key concern was usually
how to communicate of the complex issues in a way that would give enough information
but would not be too technical from a consumer point of view.  As there were not many
new products on the markets the issue was not so much how to differentiate, for example,
competing cholesterol lowering products from each other.
Progress of development was not always a smooth process but there were times when in
a short period of time, a lot of things happened that were significant from the develop-
ment point of view. Then there were times when development took place more gradually.
It was also discovered that there is a certain amount of stability in the development proc-
ess. For example even in the cases where serious difficulties emerged, the development
process did not immediately cease. It seems that different kinds of assets (e.g. human,
financial, infrastructure) that have been allocated to the development raised the opportu-
nity costs of this option.
In the cases that were examined the development was based in a certain amount of pre-
paredness. Typically there was research that had been done for a long time in some other
context.  As this research was then by some link brought to the food context an opportu-
nity arose.  What is however probable is that in the future the importance of more tar-
geted research will increase. A certain health effect is the starting point and using re-
search new ways are looked for to produce these effects.
The validity and reliability of the empirical part of the study was previously examined.
There is however a need to address some issues on a level of the study as a whole. It
could be argued that especially in qualitative research the validity of the research actually
consists of the validity of the different parts of the research. It does not mean that it is
possible to aggregate validity, but in the same way as there is a relationships between a
theory as an outcome and certain procedures in the research (see especially Strauss and
Corbin 1990), it can be thought that there is a relationship between the validity of a re-
search project and the procedures that have been taken.
The study can be divided into two parts. Firstly, there is the key framework construction
(foodweb) which is partly linked to deductive processes (e.g. from older models to new
frameworks) partly to inductive processes (the researchers general knowledge) including
also cause-and-effect relationships (e.g. from network operation to product creation)
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which lead to frameworks considered as static designs. Secondly, there is the empirical
part where cases are examined. In this part there is simultaneous shaping of factors and
emerging designs. This means that the study is not purely qualitative in nature. It could
be characterised of being of a quantitative-within-qualitative type. In these different parts
the questions of validity have different emphases.
The framework consists of concepts and relationships between them. Internal validity of
the framework itself, as far as causal relationships are concerned, relied very much on
that provided by industrial networks. A related validity question could be asked: what
kind of information would the application of industrial networks model provide? There
were changes made because it seemed that the basic model was not satisfactory in this
respect. Especially product development was explicitly added to the model. Taking into
consideration the purpose of this study, this was expected to change the focus of the
framework in a way that improved the validity. and it seemed to have done so. For op-
erationalisations of the concepts, there were no final operationalisations but an open
situation prevailed. This was due to the fact that that also an opposite direction was as-
sumed: empirical findings could affect concept formation.
External validity was dependent on the theoretical content of the network. It could have
been possible for example to first modify industrial networks to general product based
networks. However, this would have meant that a lot of more emphasis would have had
to be given to general theory based product development. In this study, in order to in-
crease external validity, such a step was not taken but initially the generalisability was
restricted to a specific food context: health-functional foods.
As far as external validity is concerned it can be asked how well the study captures the
different factors linked to the phenomena. Childs presented a nutraceutical business
model (Childs 1999, 78). According to her model there are eight components with their
respective drivers. These eight components were consumers, private and public agencies,
the FDA, health care industry, food industry, pharmaceutical industry, international ac-
tivity, and nutrition science.  The model was obviously constructed to take into consid-
eration the special features of the US context.  It seems that there are similar types of de-
velopment factors as found in this study that can be considered of importance. There is
reason to assume that the study captured some of the key factors that are influential to
this development.
What has to be pointed out is that the starting point of the empirical study was that all the
product cases represented commercially successful products. This meant that in the de-
velopment no such problems were encountered that would have been so critical that the
foodweb would have disintegrated and product development ceased. However, even in
these cases there were situations where that could have happened. It seems that the dif-
ference whether a development leading to successful or unsuccessful products can be
very small.
The purpose of the study was to describe and to increase understanding of the develop-
ment of health-promoting foods. It can be asked how well that aim was attained? The
problem is that as such there is no end point for the purpose chosen. The description
could always be more accurate and it could be improved using better analytical tools.
Going deeper and deeper into the studied phenomena could also increase understanding.
What is however obvious is that the overall aim was attained.
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The scientific contribution of this study is especially based on small steps taken in many
areas. Foods were given a new analytical framework which was however, not yet vali-
dated. The foodweb was derived from a model of industrial networks and it was given a
hypothetical form. Some questions that have not been previously raised were also
brought up.
7.2. Practical implications
In the following based on the results of the study some practical implications are pre-
sented concerning the development of health-functional foods.  It was found that there
are many factors that affect the development of these new products, but which for one
reason or another have not been given very much attention. There are no right answers to
many questions but it is important that they are first discussed and if needed appropriate
actions are taken.
It is obvious that it will become more and more difficult to consider foods as a single
product group. Even if it is assumed that for foods it is not the physical product but the
service that matters, it is doubtful whether there is a single service to which all foods
contribute. What was suggested in this study was that foods should be seen more in the
context of what kind of service they are expected to deliver.
In the health context it can be asked what makes health-functional foods differ from other
health products? Or is there any need to make such a separation?  We could think of a
situation where an individual daily uses a cocktail of traditional foods, separate nutrient
products (e.g. vitamins), medicines (e.g. for cholesterol lowering) and other health prod-
ucts (e.g. toothpaste). It is in this context that any new products actually should be con-
sidered and not within a context such as the foods themselves.
There can be expectations that the science basis of functional foods will provide meas-
ures of how to define the value of foods in an absolute sense. The reality is probably
quite the opposite. It is more probable that based on old customs and habits more stability
will be achieved, as there is no need for change. Change is inevitable in science. As more
knowledge is acquired old knowledge can lose its value even in a short period of time.
There can also be single studies that point to in opposite directions to what is normally
done.  For those not familiar with science this can be quite stressful and may lead to a
situation where consumers lose their interest in health questions. A major issue in the
future will be how to find a proper balance where changes in foods are considered to be
positive but that the consumer is not overloaded with information that they cannot cope
with.
The food and health area has been very much health expert dominated.  However, there
are many questions that not only experts can answer but where a more general discussion
is needed. As an example of such political elements linked to nutrition it can be assumed
that there are two different elements in nutrition: public nutrition and private nutrition.
Public nutrition is linked to that how we should behave especially when the national
health interests are taken into consideration. Then there is private nutrition that is linked
to what people actually eat or would like to eat. Private nutrition causes problems. There
are too many foods that are difficult to control. Private nutrition causes many health
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accidents and produces all kinds of harmful consequences to the social and natural envi-
ronment.
From the nutrition policy perspective this is, however, a crucial distinction. There is a
difference between whether attempts are made to change from the private nutrition to
public nutrition than if attempts are made within the field of private nutrition. A change
made to a single food within private nutrition is not necessarily very remarkable from the
point of view of public nutrition. It can however be so from the point of an individual
food user.
Development within health-functional foods shows that the old system has been very
much tuned to support public nutrition. It has mostly operated on a very general level.
Reality at the market product level has not been of much of a concern. The situation is
now changing.  Market products are being backed up with the same kinds of research ef-
forts that used to be found in the domain of public nutrition. This is a very significant
change. It means that health related changes will more and more take place in connection
with different commercial products.
There are problems in this change. Traditionally, the food industry has been very much
raw material oriented. This could mean that research might concentrate more and more
only on those single raw materials sources. If this is combined with a situation where
only minor changes in foods are permitted, this could mean that most of research re-
sources are used in single food investigations and the significance of such research can
be asked.  Such research could be led based mainly marketing aspects.
There is the problem is that because health related information for most actors in food-
webs has simply been given, the related service structure is underdeveloped. There are no
actors that would, for example, compare different products on markets for their health
enhancing characteristics from a consumer perspective. The same problem exists in the
business-to-business side.  There are no actors that would compare ingredients in respect
to their health-promoting characteristics and would then help food industry firms to make
informed choices. Currently the situation is not yet very acute but it can be assumed that
in the future the situation will be different as a single food can potentially contain hun-
dreds of characteristics that are significant from a health point of view.
Traditional foodservice operators have not been very interested in health related subjects,
even if they are closer to consumers and not so much dependant on specific raw materials
or ingredients.  On the other hand they know the power of food habits and probably
therefore the old approach that is based on expectation that food habits should be
changed first, has not been very appealing. Health-functional foods would offer possi-
bilities also in this sector.
What can not be found in markets are operators whose key capabilities of are based on
knowledge concerning the relationship between foods and the body. In the food industry
the hardware (physical foods) has usually been more important than the software (know-
how as a basis of service products).  New health-functional food operators should base
their operations more on the software. A modern food factory of health-functional foods
could respectively be seen as a place where products are assembled from components
provided by different subcontractors. Ingredients and substances with special character-
istics could be acquired and marketed globally.
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There is the question of health related recommendations. Current nutritional recommen-
dations contain problematic aspects. Even though the health related properties in foods
may not be organoleptically sensed, health related recommendations are very much
linked to the sensed properties of foods. In the background there is an assumption that
these properties of foods will be linked to a certain specific traditional appearance of
foods.  To what extent will this be true in the future? The more there are changes in the
physical content of specific foods the less the appearance or even general raw material
basis of foods can be used as an indicator of specific health related content.
How do these recommendations respond to expectations that more and more foods will in
the future be more and more prepared and consist of different modified components?
How can such new products be positioned in general health relevant scales? It is also
probable that there will be need for different kinds of recommendations. For example,
different kind of recommendations for those food specialists that are not nutritionists but
who are in a key role as new service products are developed, for those who are consum-
ers and have a basic knowledge of nutrition, and for those consumers who are unaware of
even the basic facts.
There are research results that indicate that most consumers think that they eat healthily
and that there is no need for them to make changes, What is the basis of this attitude? In
many other product groups one would think that new products mean improvements. Why
cannot new health-functional foods be better than traditional foods. Not in all respects,
but for example when the requirements of the new living conditions are taken into con-
sideration? There are few other product groups where history has validated the products
to the same extent as in foods.
There is clearly a need to know food consumers better in order to make information-
related decisions.  Currently simplified claims and food labels are very much emphasised
where food information is concerned. This is probably due to the assumption that food
consumers are not very much interested in the health content of foods and that they make
last minute decisions at the shop level. Is this also picture we have of a consumer choos-
ing health-functional foods in the future?
Safety was not a direct concern of this study. Safety here means that the probability that
user of a product will only be affected by the intended health effects of the product. In
practise safety is a major issue. It can be asked what is the value of health-promoting ef-
fects if there is high probability that a food, before being used, contains negative health
features that make the intended health value marginal.  It is probable that in this product
context sensitivity to health related matters in general is greater and threats that in a tra-
ditional food context would not be of concern will be emphasised.  This means that de-
velopment of health-functional foods has other implications that need to be taken into
consideration in the whole physical distribution chain.
Whether it is wanted or not social markers will emerge that will indicate the value of
these products to individual customers.  One critical question here is to what extent these
markers are based on scientific research and to what extent they are based on old beliefs
and customs. It is obvious that in order for these products to be successful there is the
need for different kinds of information.  Knowledge concerning the physiological level is
just a starting point.
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7.3. Applicability of the foodweb in food contexts in general
Even though the purpose of the study was not primarily to be a methodological contribu-
tion, as foodwebs were in such a central role in the study, in the following an evaluation
concerning the general applicability of the foodweb framework in food context is made.
Assumptions
There were general assumptions concerning foodwebs. One of those concerned rational-
ity. Rationality was linked to the institutional basis. This is probably a valid level to ex-
amine rationality in foodwebs in general.  This is due to the heterogeneity of the food-
webs. In the market context the situation is different as it is based on more homogeneous
starting point. It would probably be too demanding to assume that all actors in foodwebs
would be rational in a way that had no relations to their habits and customs.
In the food context it is also probable that rationality cannot only be based on individual
based characteristics (like bounded rationality, see e.g. Simon 1957). Change in the so-
cial setting can bring out differences in rationality under ceteris paribus conditions. Even
environmental change can alter rationality patterns. Rationality under a state of famine is
probably different from that in an affluent society.
If rationality is considered in very specific context, namely as a consumer makes choices
concerning food products, it is probable that there is a difference in how traditional foods
and health-functional foods are chosen.  In the case of health-functional foods, when the
cognitive information is more emphasised, this could mean that also rationality in choice
is different from the case of traditional foods. This does not mean that intellectual choice
is necessarily more rational than emotional choice, but that they are different.
The scope of a foodweb that is ultimately based on revealed interactions is probably as
valid in a health-functional context as in other food contexts. It emphasises the empirical
links and also the relativity of foodwebs. Usually not all interactions are known which
means that an attempt to capture the foodweb leads to a partial picture of the real food-
web. Foodwebs in all context have also similar problems like the question of importance
of different interactions or which are the driving forces that unite foodwebs? For descrip-
tive purposes it is simply sufficient to assume that products unite a web. There are though
questions like what is the driving forces behind the development of products and whether
some kind of network mechanism can be assumed to direct foodwebs.
Assessment of applicability
The generality of a foodweb means that in principle there are no reasons why it could not
be applied to other than health-functional food contexts. It is probably flexibly applicable
to very different food contexts. Then probably the basic structure can remain unchanged
even though the elements will have variable content, as different factors will be of im-
portance. The structure and processes make it possible to analyse very turbulent envi-
ronments where a lot of changes are taking place. In fact the more turbulent environment
is the better suited is foodwebs simple and flexible structure to analyse such a situation.
In this study the framework was used in an ex-post type of analysis. That meant that there
were already certain products. This meant that the product formation was easier to ana-
lyse.
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In a situation where the products are only on an idea level the emphasis will probably
have to be more on the elements of a web and on the process of how a product emerges
based on some initial characteristics. It seems that anticipation of future products is diffi-
cult based on foodweb alone. Future foodwebs are not necessary based on past foodwebs.
Then other kinds of analyses, like in this study concerning body-centred foods, will be
needed that will directly deal with the product environment.
Even though it was said that in a traditional food context product development did not
alter traditional products very deeply in a materialistic sense, it does not mean that devel-
opment is easier or simple.  There are probably even same kinds of elements that can be
identified in health-functional context. Research in traditional context is probably more
oriented to social research, for example, in the form of marketing or consumer research,
than biological and technological research.  Developments takes place more in a con-
sumer context whereas health-functional foods were characterised by an expert approach.
Even for traditional foods there is continuity in development even though some apparent
product characteristics seemed to be unchanged.  This could be explained by assuming
that the stable core of the product is expanding, at least temporarily. The area of interest
and the related characteristics in the development context are continuously changing. It is
to a large extent a matter of sensitivity concerning development. An idea of a process
where no development takes place could be borrowed from markets. Production in which
all other factors but product volume remain unchanged would be closest to pure markets.
In reality there are no production processes in which volume is the only variable.
The so-called free markets in the food context mean typically fewer restrictions between
the nations trade and less technical barriers. It does not mean that producers and consum-
ers can freely decide what type of products will be available. Even if the role of direct
public regulation on national level decreases, it means that other regulation systems will
become effective. It is more important to find out how a foodweb is actually regulated
and how it regulates itself. The foodweb will probably be a valid analysis framework
even if there is further movement towards free markets in the food systems.
It can be thought that the foodweb would be as a service product web. There are activi-
ties, actors and resources also in this context and service product is also the result of a
development process that is not necessary only limited to a firm-customer dyad. Then a
uniting link would not be a physical food product but a service idea linked to the needs
that lie behind foods. In fact there is such a service idea even behind concrete food prod-
ucts.  It could lead to very different physical product solutions if the starting point is, for
example, in some physical needs of a body than in some physical substances.
The product of a foodweb could be located between a hierarchy product and a market
product (Figure 29). It is not produced by a closed hierarchy and it is not only based on
price valued market decisions, but it is a commercial product that is influenced by forces
that can be considered to be both of hierarchical and market origin.
Hierarchy ---------------Foodweb------------Market
product     product            product
Figure 29. General product types
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It seems that foodweb offers the potential to be used as an analytical, mainly descriptive,
framework in many different food contexts. It can not replace other approaches because
it has inherent problems but it offers a new flexible holistic approach to specially de-
scribe problems and questions that are of empirical origin.
7.4. Suggestions for further research
A most obvious area of research would be to try to validate the initial hypothetical food-
web that was constructed in this study. There are more and more health-functional prod-
ucts being developed for markets which means that there are actually foodwebs all over
the world in which development work is being done.  The empirical background is there-
fore becoming stronger.  A key question would then be whether the hypothetical food-
web presented in this study will capture the most important features in the development
process?
Foodweb could also be applied as a descriptive framework in different food context to
what was discussed in the previous section.  As a qualitative approach is very much de-
pendent on the researcher, it would probably be beneficial if the foodweb approach were
applied by researchers that have different backgrounds. It would mean that different as-
pects in the development process were emphasised.
For the foodweb approach in general an important theme that was not directly dealt with
is competition between foodwebs.  In this study foodwebs were either relatively inde-
pendent from each other or one single foodweb was assumed (around health-functional
foods). However, as products compete, there also will be foodwebs and respective devel-
opment processes competing with each other.  This mean, for example, that products that
are meant to lower cholesterol will be considered as substitutes and respective foodwebs
has to find ways how to survive in this competition.
The idea of competition leads to the question of what factors affect the competitiveness
of a foodweb. Not all foodwebs are in the same position.  Analogies could be drawn from
market thinking, like the assumption that a foodweb could be in a monopoly position.
What is realistic to assume is that actually it is not so much producers or consumers that
are competing but coalitions (as foodwebs) that have a common interest the expression of
which is a specific product. This would mean that a producer and a consumer of a health-
functional food could be closer to each other than a producer and consumer of another
type of food product.
It was simply assumed that foodwebs aim for development of commercial products. This
is not necessarily so. There can well be differences in foodwebs in this respect, which
could be examined along the market orientation of foodwebs (Grunert and all. 1996).
Market orientation is the organisation-wide generation of market intelligence, pertaining
to current and future customer needs, dissemination of the intelligence across depart-
ments and organisation-wide responsiveness to it (Kohli and Javorski.1990).
When we look at the internal structure and processes of a foodweb, there are many open
questions.  Some of them were already mentioned when the applicability of foodwebs in
food context was evaluated.  Other themes are, for example, the relationship between
product development and the basic elements of a foodweb.  How differences in these
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elements affect product development and what kind of a causal direction there is from
product development to the elements in a foodweb?
Foodwebs, like networks, have usually been used in descriptive sense. If the aim were
more predictive, there would have to be a certain mechanism that explains the workings
of a foodweb. When it comes to the general mechanisms within well industrial networks
it has drawn mainly based from the transaction cost23 based approaches (see e.g. Lund-
vall 1993; Johansson and Mattsson 1991 and Blois 1989). It is an open question what
could be relevant mechanisms within foodwebs.
There are many structure and process related themes. For example the position of con-
sumers in a foodweb needs more research. The consumer’s relationship to a foodweb is
probably more complexes than what buying behaviour can reveal. When it comes to pro-
cesses an important theme that was not much treated in this study was the integration and
disintegration of a foodweb. Does integration for example mean that formal ownership
structures change and will there be changes on how communication within a foodweb
takes place? What was also a weakness is that the psychological process linked to devel-
opment was not of explicit interest even if it can be thought to be of major significance
especially as it is matter of innovative products.
There is also need to study more deeply the essence of foods. It is surprisingly a little re-
searched area taking into consideration its significance. Foods are still to large extent
based on traditional products or to an implicit idea that there is no need for evaluations
because we all know what foods are. However, as more and more new actors with differ-
ent backgrounds are entering the field, more research is needed to lay a proper founda-
tion.
There seems to be also a need for sociological research concerning health-functional
foods as a research subject. Even older approaches might be applicable. An example of
this is the semantic fields that were developed by Lévi-Strauss (1979). Adapting them to
today’s situation would probably show that many old questions are still valid. One di-
mension Lévi-Strauss (1979) was exploring was the rawness-preparedness of the foods
linked to masculinity and femininity considerations. It could be thought that there are
links to these considerations such as those concerning health-functional foods.
There are also other possibilities for the idea of a foodweb to be applied in a research.
The conceptual foodweb construction was not explicit when the interviews were made
and empirical material was collected for this study. An alternative would have been to
involve the interviewees in such a way that they would have directly given content to the
foodweb as a core concept (see e.g. Checkland and Scholes 1991, Checkland 1981). An
advantage of this would be that one interpretation layer that was made by the researcher
concerning the foodweb could have been avoided.
                                                
23
 see eg. Williamsson 1975, 1987,1991, 1993
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Summary
The study has an empirical basis as there are new health promoting products that have
emerged on the food markets. Their share of the food markets has been relatively low but
it is expected that it would grow in the future.  Relatively few scientific studies deal with
this phenomena and those that have been made typically represent only partial views. A
more holistic view of the subject area is missing.  The main audience of the research was
considered to consist of researchers interested in the area traditionally treated under the
theme of markets of health-promoting foodstuffs.
The objectives of the study were: to position health-promoting foods within foods in
general; to describe the empirical development process of health-promoting foods using a
foodweb as a conceptual framework; to increase understanding of the underlying prob-
lems in the development process, specifically of those which are new in a food develop-
ment context; and to make hypothesis concerning general properties of the foodweb in
the context of health-promoting foods.
The key framework used in the study – the foodweb- was based on the model of indus-
trial networks, specifically on the so-called Uppsala school of networks. As the model
was adapted for the purposes of this study, a product within a network was given an ex-
plicit role in the model. The specific food context that was studied was given more em-
phasis than the general properties of a foodweb. The empirical part of the study was
based mainly on five cases. The criteria for the cases were that they were commercially
successful products that had already some history behind them. The following cases,
identified by their respective trademarks, were selected: Benecol, Hyla, LGG, Xylitol,
and Yosa. Besides information considering the cases also other data obtained specifically
from the international context were utilised.
As health-promoting foods were positioned within foods it was found that new questions
emerged that are not usually treated within a food context. This led to the development of
a specific framework for foods – body-centred foods. It was assumed that there are dif-
ferent body related purposes under which foods can be functional. Health-functionality
was one of the respective functionalities.  It was also found that foods have no clear-cut
boundaries towards other product groups.
Empirical development processes described using the foodweb as a conceptual frame-
work showed the interdependency of the development process from many activities, ac-
tors, and resources that usually cannot be captured if the development is viewed from a
single organisation point of view.  It also seemed that development is empirically a multi-
layered process of many concurrent and sequential interactions only part of which are
being revealed.
Based on the empirical findings it seemed that in every case there are different critical
questions that have to be answered in order to make the development of a commercially
successful product possible. Even for successful products there are typically periods of
uncertainty when the continuity of the development is at stake. This indicated that there
is a thin line between whether a development process will either result in a commercially
successful product or not.  It seemed that success in that sense is not dependent on any
specific resources as such but on the capabilities to use different kinds of resources along
the development process.  One key capability here is the capability of consumers to con-
sume the new food products.
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The study resulted in initial hypotheses concerning the development process of health-
functional foods in general.  These hypotheses were presented as extensions to the basic
foodweb framework. It seems obvious that besides those factors that have been tradition-
ally relevant in food development context, there are new factors that have to be taken into
consideration. There are activities like research that are essential but which have not pre-
viously been emphasised in food development context.  The specific activities are also
not single events in the progress of development. For example research is usually a criti-
cal activity throughout the development process.  There are also actors that are often
critical in the context of health-functional foods even though they have not been signifi-
cant in the traditional food context.  Capabilities that are needed are more and more in-
formation related. This can be understood as the information content of health-functional
foods become ever more important because the health-promoting characteristics of these
foods can not usually be tasted or organoleptically assessed.
This increasing complexity of this development process also means new challenges. It
seems that there are many obstacles within the food system, consisting of the food con-
sumers, producers, regulators and research that hinder development processes of these
specific foods. There are many unresolved questions and questions that have not yet ex-
plicitly been asked that have to be encountered before it is relevant to expect goal ori-
ented smooth development processes for health-functional foods specifically in the Euro-
pean context.
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Appendix 1
Interviewed persons
Case Xylitol
Name Position Date
Lindholm, Bengt         Production Director, Cultor Group 10.12.1997
Mäkinen, Kauko K.         Professor, University of Turku 22.10.1997
Taskinen, Sakari         Development Director, Leaf-Hellas Oy 29.10.1997
Case Hyla
Name Position Date
Leporanta, Kalle         Product Development Manager,Valio 7.10.1997
Luoma, Laura                Product Manager, Valio Group 8.10.1997
Case LGG
Name Position Date
Luoma, Laura                  Product Manager, Valio Group  8.10.1997
Salminen, Kari          Research Director, Valio Group             20.1.1998
Saxelin, Maija          Researcher, Valio Group 13.10.1997
Case Yosa
Name Position Date
Salovaara, Hannu           Professor, University of Helsinki 26.9.1997
Scharlin, Merja           Managing Director, Bioferme Oy 5.11.1997
Case Benecol
Name Position Date
Miettinen, Tatu A.           Professor emer., University Central
                    Hospital Helsinki 21.10.1997
Palmu, Tapio           Development Manager, Raisio Group 29.10.1997
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Appendix 2
Interviews
Before the interviews were carried out, a letter was sent to each person to be interviewed.
In that letter the purpose of the study was explained, and the themes and questions that
were going to be discussed were presented. These themes and questions varied to some
extent depending on the role the person had had in the development process. In some
cases information concerning the case was received even prior to the interview, which
made it easier for the researcher to become orientated to the case and also prepare de-
tailed questions. Interviews lasted an average of 1.5 hours.
In the following the interview themes and some of the respective questions are presented:
1. The background of the product:
e.g.
* Which are the main factors behind the emergence of the product idea?
* Who are the main persons or organisations that have contributed to this idea?
* Are there some previous developments that are especially important from the product
point of view?
2. Research concerning the product
e.g.
* What is the background of the functionality of the product
* What kind of research is being done concerning the product?
* Who have been partners in the research?
3.  Commercialisation of the product
e.g.
* How was research involved in the commercialisation?
* What partners wee involved and what kind of resources were needed?
* What were the biggest problem areas in the commercialisation?
4. Influence of public authorities
e.g.
* How did public authorities influence the development process?
* How and at what stage were the authorities contacted?
* Would the product be different without the influence of the public authorities?
5. General questions:
e.g.
* What have been the most critical phases in the overall development of the product?
* What is the current dependency of the product on research?
* Are there changes expected to take place that would affect the position of the product?
6. What other factors not yet treated during the interview are of significance as the prod-
uct was developed from a product idea to a commercial product?
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